<SEC-DOCUMENT>0001104659-25-110357.txt : 20251112
<SEC-HEADER>0001104659-25-110357.hdr.sgml : 20251112
<ACCEPTANCE-DATETIME>20251112161030
ACCESSION NUMBER:		0001104659-25-110357
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251112
DATE AS OF CHANGE:		20251112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEAP THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001509745
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				274412575
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37990
		FILM NUMBER:		251472783

	BUSINESS ADDRESS:	
		STREET 1:		47 THORNDIKE STREET
		STREET 2:		SUITE B1-1
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617 252 4343

	MAIL ADDRESS:	
		STREET 1:		47 THORNDIKE STREET
		STREET 2:		SUITE B1-1
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Dekkun Corp
		DATE OF NAME CHANGE:	20110107
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tm2530735d3_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Proxy Statement Pursuant to Section&nbsp;14(a)&nbsp;of<BR>
the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant <FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Preliminary Proxy Statement</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><B>Confidential, for Use of the Commission Only (as permitted
by Rule&nbsp;14a-6(e)(2))</B></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Definitive Proxy Statement</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD><TD STYLE="text-align: justify">Definitive Additional Materials</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Soliciting Material under &sect;240.14a-12</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2530735d3_defa14aimg01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cypherpunk Technologies Inc.</B></P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(Name of Registrant
as Specified In Its Charter)</FONT><FONT STYLE="font-size: 14pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s)&nbsp;Filing Proxy Statement,
if other than the Registrant)&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check all boxes that apply):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD><TD STYLE="text-align: justify">No fee required.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Fee paid previously with preliminary materials.</TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Fee computed on table in exhibit required by Item&nbsp;25(b)&nbsp;per
Exchange Act Rules&nbsp;14a-6(i)(1)&nbsp;and 0-11.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>UNITED STATES</B></FONT></P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SECURITIES AND
EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Washington, D.C.
20549</B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<B>November 11, 2025</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm2530735d3_defa14aimg01.jpg" ALT=""></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cypherpunk Technologies Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center; width: 32%"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%">&#160;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; width: 32%"><FONT STYLE="font-size: 10pt"><B>001-37990</B></FONT></TD>
    <TD STYLE="width: 2%">&#160;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; width: 32%"><FONT STYLE="font-size: 10pt"><B>27-4412575</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction<BR> of Incorporation)</FONT></TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: center">(Commission <BR>
File Number)</TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: center">(I.R.S. Employer<BR>
Identification No.)</TD></TR>
</TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT><B>47 Thorndike Street, Suite B1-1</B></FONT> <BR> <FONT STYLE="background-color: white"><B>Cambridge, MA</B></FONT> <FONT STYLE="font-size: 10pt; background-color: white"><B>02141</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">(Address of Principal Executive Office)</FONT> <FONT STYLE="font-size: 10pt">(Zip Code)</FONT></P>


<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <B>(617)&#160;714-0360</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Registrant&#8217;s telephone
number, including area code)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Leap Therapeutics, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since last report)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:&#160;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%">&#160;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Common Stock, par value $0.001 per share</FONT></TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">LPTX</FONT></TD>
    <TD>&#160;</TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">The Nasdaq Capital Market</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &#167;240.12b-2).&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0; width: 100%"><DIV STYLE="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Explanatory Note</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As described in Item 5.03 below, Leap Therapeutics,&#160;Inc. has changed
its name to Cypherpunk Technologies Inc., effective as of November&#160;12, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt"><B>Item 1.01</B></FONT></TD><TD STYLE="text-align: justify"><B>Entry into a Material Definitive Agreement.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Consulting Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;11, 2025,
Cypherpunk Technologies Inc. (f./k/a Leap Therapeutics,&#160;Inc.), a Delaware corporation (the &#8220;Company&#8221;), entered into a
Consulting Agreement (the &#8220;Consulting Agreement&#8221;) with CoinXit Ltd. (&#8220;CoinXit&#8221;), effective as of November&#160;11,
2025. Under the Consulting Agreement, CoinXit will provide consulting services to the Company as set forth in project assignments to be
mutually agreed from time to time. Mr.&#160;Khing Oei is the sole director and employee of CoinXit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Consulting
Agreement, CoinXit will receive the fees specified in each project assignment and is also entitled to receive equity compensation in the
form of restricted stock unit (&#8220;RSU&#8221;) awards under the Company&#8217;s equity incentive plans, subject to Board or compensation
committee approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective November&#160;11,
2025, the compensation committee (the &#8220;Compensation Committee&#8221;) of the Board of Directors
of the Company (the &#8220;Board&#8221;) approved an award under the Company&#8217;s 2022 Equity Incentive Plan, as amended (the &#8220;2022
Plan&#8221;), of 2,411,700 RSUs to CoinXit (each representing the right to receive one share of the Company&#8217;s common stock, par
value $0.001 per share) (the &#8220;First RSUs&#8221;). The First RSUs will vest as to 12/36ths on October&#160;8, 2026 and as to 1/36th
each month thereafter on the 8th day of the applicable month, subject to CoinXit Ltd.&#8217;s continuous service through each vesting
date. Vested RSUs will be settled in accordance with the terms of the related RSU agreement (the &#8220;CoinXit RSU Agreement&#8221;),
generally on the earliest to occur of the Company&#8217;s first payroll date on or after (i)&#160;CoinXit&#8217;s cessation of service,
(ii)&#160;June&#160;8 of the applicable year, or (iii)&#160;December&#160;8 of the applicable year, subject to any further deferral as
provided in the CoinXit RSU Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Consulting Agreement provides
for an additional award under an equity incentive plan of the Company of 3,036,457 RSUs to CoinXit, subject to equitable adjustment in
certain circumstances (the &#8220;Second RSUs&#8221;), following (i)&#160;stockholder approval of an amendment to the Company&#8217;s
certificate of incorporation to effect a reverse stock split and/or to increase authorized common shares to at least 490,000,000 shares,
(ii)&#160;stockholder approval of a new equity plan with a sufficient share reserve, (iii)&#160;SEC effectiveness of a Form&#160;S-8 for
such plan, and (iv)&#160;Board or Compensation Committee approval. The Second RSUs will vest on
the same schedule and settle on the same terms as the First RSUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">CoinXit will serve as an
independent contractor and not as an employee of the Company. The Consulting Agreement has a three-year initial term, subject to
earlier termination by the Company on five days&#8217; notice or by CoinXit on 15 days&#8217; notice when no project assignment is
in effect. The Consulting Agreement contains customary terms regarding ownership of work product, confidentiality, non-solicitation,
and indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summary of the
Consulting Agreement and the CoinXit RSU Agreement do not purport to be complete and are qualified in their entirety by reference to the
full text of each such agreement, copies of which are filed with this Current Report on Form&#160;8-K as Exhibits 10.1 and 10.2, respectively,
and are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Employment Agreement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;11, 2025,
the Company entered into an Employment Agreement (the &#8220;Employment Agreement&#8221;) with Mr.&#160;William McEvoy, effective as of
November&#160;11, 2025 (the &#8220;Effective Date&#8221;). Under the Employment Agreement, Mr.&#160;McEvoy will serve as the Company&#8217;s
Chief Investment Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Employment Agreement provides
for an initial annual base salary of $250,000, payable in accordance with the Company&#8217;s normal payroll practices and subject to
applicable withholding, which will be reviewed at least annually and may be increased, but not decreased, in the discretion of the Board. Pursuant to the terms of the Employment Agreement, Mr.&#160;McEvoy is eligible to participate in the Company&#8217;s annual incentive
compensation program for senior executives and has a target annual bonus opportunity equal to 40% of base salary, based on performance
criteria established by the Board (or its Compensation Committee), generally payable at the same time as bonuses to other senior executives,
subject to continued employment through the payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to stockholder approvals
and other conditions described in the Employment Agreement (including stockholder approval of certain amendments to the Company&#8217;s
certificate of incorporation, adoption of a new equity plan, registration of the related shares on a Form&#160;S-8, and Board or Compensation
Committee approval), Mr.&#160;McEvoy will receive an award under an equity incentive plan of the Company of 5,616,906 RSUs, each representing
the right to receive one share of the Company&#8217;s Common Stock, subject to equitable adjustment in certain circumstances. The RSUs
will vest as to 12/36ths on October&#160;8, 2026, and as to 1/36th on the 8th day of each month thereafter, in each case subject to Mr.&#160;McEvoy&#8217;s
continued employment or other qualifying service relationship through the applicable vesting date. Vested RSUs will be settled in shares
of Common Stock pursuant to the terms of a restricted stock unit agreement to be entered into by the Company and Mr.&#160;McEvoy in connection
with the grant to Mr.&#160;McEvoy of such 5,616,906 RSUs, which agreement is expected to provide for settlement on the earliest to occur
of (i)&#160;the Company&#8217;s first payroll date on or after the date Mr.&#160;McEvoy ceases to be a service provider, (ii)&#160;the
Company&#8217;s first payroll date on or after June&#160;8 of the applicable year, or (iii)&#160;the Company&#8217;s first payroll date
on or after December&#160;8 of the applicable year, subject to any further deferral as provided therein. The RSUs will be governed by
the applicable equity plan and award agreement under which the RSUs are granted. The Employment Agreement also provides that any outstanding
unvested equity awards held by Mr.&#160;McEvoy will become fully vested and exercisable immediately prior to a qualifying Change in Control
(as defined therein) that occurs after the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Employment Agreement includes
customary termination and severance provisions. If Mr.&#160;McEvoy&#8217;s employment is terminated by the Company without &#8220;Cause&#8221;
or by Mr.&#160;McEvoy for &#8220;Good Reason&#8221; (each as defined in the Employment Agreement), and subject to his timely execution
and non-revocation of a general release of claims, Mr.&#160;McEvoy will be entitled to: (i)&#160;accrued but unpaid compensation and benefits
and other accrued obligations; (ii)&#160;a severance payment equal to his annual base salary,
payable in substantially equal installments over 12 months; and (iii)&#160;reimbursement of a portion of COBRA premiums for continued
health and dental coverage for up to 12 months, in each case subject to the conditions set forth in the Employment Agreement. The Employment
Agreement also contains customary provisions addressing potential excise taxes under Sections 280G and 4999 of the Internal Revenue Code,
and is intended to comply with or be exempt from Section&#160;409A of the Internal Revenue Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Employment Agreement further
incorporates an Employee Proprietary Information,&#160;Invention, Non-Competition and Non-Solicitation Agreement between the Company and
Mr.&#160;McEvoy and includes customary representations, covenants and other employment terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Employment
Agreement, a copy of which is filed as Exhibit&#160;10.3 to this Current Report on Form&#160;8-K and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>RSU Grants to Directors and Employees</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective November&#160;11, 2025, the Compensation
Committee approved the issuance of an aggregate of 3,241,687 RSUs to the directors and certain employees of the Company, of which 2,560,674
RSUs were issued pursuant to the Company&#8217;s 2016 Equity Incentive Plan, as amended (the &#8220;2016 Plan&#8221;), and 681,013 RSUs
were issued pursuant to the 2022 Plan. Of the 2,560,674 RSUs issued pursuant to
the 2016 Plan, 2,485,974 RSUs were issued to employees of the Company (with the Company&#8217;s Chief Executive Officer and President,
Mr.&#160;Douglas Onsi, receiving an award of 2,087,287 RSUs) (collectively, the &#8220;2016 Employee RSUs&#8221;) and 74,700 RSUs were
issued to non-employee directors (the &#8220;2016 Director RSUs&#8221;). Of the 681,013 RSUs issued pursuant to the 2022 Plan, 413 were
issued to employees (the &#8220;2022 Employee RSUs&#8221;, and together with the 2016 Employee RSUs, the &#8220;Employee RSUs&#8221;)
and 680,600 were issued to non-employee directors (the &#8220;2022 Director RSUs&#8221;, and together with the 2016 Director RSUs, the
&#8220;Director RSUs&#8221;). The Employee RSUs and the Director RSUs shall be subject to equitable adjustment under certain circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the terms of the restricted stock unit
agreement entered into by the Company and each non-employee director of the Company in connection with the grant to such director of his
or her Director RSUs, such Director RSUs are fully vested as of their November&#160;11, 2025 issuance dates. Pursuant to the terms of
the restricted stock unit agreement entered into by the Company and each employee of the Company in connection with the grant to such
employee of his or her Employee RSUs, such Employee RSUs will vest as to 12/36ths on October&#160;8, 2026, and as to 1/36th on the 8th
day of each month thereafter, in each case subject to forfeiture pursuant to the terms of the awards. The Director RSUs and Employee RSUs,
when vested pursuant to their terms, entitle the recipient to one share of the Company&#8217;s Common Stock per RSU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Vested Employee RSUs will be settled in shares
of Common Stock pursuant to the terms of the restricted stock unit agreement entered into by the Company and each employee in connection
with the grant of Employee RSUs to such employee, which agreement provides for settlement on the earliest to occur of (i)&#160;the Company&#8217;s
first payroll date on or after the date the applicable employee ceases to be a service provider, (ii)&#160;the Company&#8217;s first payroll
date on or after June&#160;8 of the applicable year, or (iii)&#160;the Company&#8217;s first payroll date on or after December&#160;8
of the applicable year, subject to any further deferral as provided in such restricted stock unit agreement. Vested Director RSUs will
be settled in shares of Common Stock pursuant to the terms of the restricted stock unit agreement entered into by the Company and each
non-employee director in connection with the grant of Director RSUs to such director, which agreement provides for settlement on the earlier
to occur of (i)&#160;the date the applicable director ceases for any reason to be a member of the Board or (ii)&#160;the date of the first
annual meeting of stockholders of the Company that occurs following the grant date of Director RSUs to the applicable director, subject
to any further deferral as provided in such restricted stock unit agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summary of the
Director RSUs and Employee RSUs do not purport to be complete and are qualified in their entirety by reference to the full text of the
forms of Director RSU Agreements pursuant to the 2016 Plan and the 2022 Plan, and the forms of Employee RSU Agreements pursuant to the
2016 Plan and the 2022 Plan, copies of which are filed with this Current Report on Form&#160;8-K as Exhibits 10.4, 10.5, 10.6 and 10.7,
respectively, and are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in; text-align: left"><FONT STYLE="font-size: 10pt"><B>Item &#8201;2.02.</B></FONT></TD><TD STYLE="text-align: justify"><B>Results
of Operations and Financial Condition.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;12, 2025,
the Company issued a press release announcing its financial results for the third quarter ended September&#160;30, 2025. The text of the
press release is included as Exhibit&#160;99.2 to this Form&#160;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information disclosed
under this Item 2.02, including Exhibit&#160;99.2 hereto, is being &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221;
by the Company for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or
otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any filing under the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act, except as shall be expressly set forth by specific reference
in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 5.02.</B></TD><TD STYLE="text-align: justify"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information set forth
under Item 1.01 of this Current Report on Form&#160;8-K is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Appointment of Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Private
Placement (as defined below), on November&#160;11, 2025, the Board appointed each of Mr.&#160;Khing Oei and Mr.&#160;William McEvoy as
a director of the Board, effective immediately, with Mr.&#160;Oei appointed as a Class&#160;II director and to serve in such capacity
until the 2028 annual meeting of stockholders, and with Mr.&#160;McEvoy appointed as a Class&#160;III director and to serve in such capacity
until the 2026 annual meeting of stockholders, or until the earlier of such director&#8217;s death, resignation or removal. Mr.&#160;Oei
has also been elected to serve as non-executive Chairman of the Board, effective as of November&#160;11, 2025. Concurrently with Mr.&#160;Oei&#8217;s
appointment, Christopher Mirabelli, PhD, will step down from his role as Chairman, while remaining a member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>Khing
Oei</I></FONT>, age 49, has more than 20 years of experience in global finance, alternative asset management, and digital-asset investing.
Since August&#160;2025, he has served as Founder and Chief Executive Officer of Treasury B.V., a Netherlands-based Bitcoin treasury company
backed by institutional investors including Winklevoss Capital and Nakamoto Holdings. Since November&#160;2022, Mr.&#160;Oei has also
served as Senior Advisor &#8211; Crypto at Attestor Limited, a multi-billion-dollar hedge fund focused on distressed and special situations
investments in the digital-asset sector. He is a member of the Board of Directors of Genesis Global Holdco LLC and Genesis Asia Pacific
Pte. Ltd., and a member of the Valuation Committee of Privium Fund Management B.V., a $4 billion AUM asset manager with operations across
Europe and Asia. From 2019 to 2022, Mr.&#160;Oei was Founder and Chief Executive Officer of Captur Ltd. (formerly AlphaSwap), a decentralized
crypto asset-management platform within the DeFi ecosystem. Earlier in his career, he held senior investment roles at SC Lowy, Eyck Capital
Management (where he was Chief Investment Officer and Managing Partner), and Bardin Hill Investment Partners LP (where he served as Portfolio
Manager and Managing Principal and Chief Executive Officer of European operations). He began his career at Goldman Sachs, Fortress Investment
Group, and Merrill Lynch, focusing on special-situations and distressed credit investing. Mr.&#160;Oei holds an M.Sc. in Econometrics
from Vrije Universiteit Amsterdam and completed coursework at Tulane University in Economics under a Fulbright Scholarship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><I>William
McEvoy</I></FONT>, age 29, is a finance and investment professional with expertise in financial close processes, cash-flow forecasting,
corporate finance, and company valuation. He currently serves as Principal at Winklevoss Capital Management in New York City, where he
focuses on investments across social networks, gaming and eSports, education, and Web3 / blockchain sectors. Mr.&#160;McEvoy has been
with Winklevoss Capital since 2022. Before joining Winklevoss Capital, Mr.&#160;McEvoy was a member of the Bitcoin and Crypto Research
team at Fundstrat Global Advisors, LLC from 2021 to 2022 and served in finance roles with Dynasty Financial Partners from 2018 to 2021
and Cassaday&#160;&amp; Company,&#160;Inc. from 2017 to 2018. He began his career in investment banking at CSG Partners, specializing
in ESOP advisory transactions. In addition to his executive and investment roles, Mr.&#160;McEvoy serves on the board of Real Bedford
FC. He holds a degree from The George Washington University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr.&#160;Oei and Mr.&#160;McEvoy
have each been appointed to the Board as an &#8220;Investor Designee&#8221; pursuant to the terms of the Lead Investor Agreement, dated
October&#160;6, 2025, by and between the Company and Winklevoss Treasury Investments, LLC (the &#8220;Lead Investor&#8221;). The Company
entered into the Lead Investor Agreement in connection with the Securities Purchase Agreement, dated October&#160;6, 2025, by and among
the Company and the purchasers named therein (the &#8220;Securities Purchase Agreement&#8221;) for the private placement of an aggregate
of 15,212,311 shares of Common Stock, 80,768,504 pre-funded warrants to purchase Common Stock, and 71,985,605 common warrants to purchase
Common Stock (the &#8220;Private Placement&#8221;), as previously disclosed in the Company&#8217;s Current Report on Form&#160;8-K filed
with the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) on October&#160;9, 2025 (the &#8220;Closing Form&#160;8-K&#8221;).
Pursuant to these agreements, for so long as the Lead Investor continues to beneficially own at least 16.7% of the Common Stock of the
Company, the Lead Investor shall have the right to designate two Investor Designees, one of whom shall also be chair of the Board, and
for so long as the Lead Investor continues to beneficially own at least 8.33% but less than 16.7% of the Common Stock, the Lead Investor
shall have the right to designate one Investor Designee, who shall also be the chair of the Board. The Company has also agreed to use
its reasonable best efforts to cause the Investor Designees to be elected to the Board (including recommending that the Company&#8217;s
stockholders vote in favor of the election of the Investor Designees).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than as described herein,
there are no arrangements or understandings between any of the individuals listed above and any other person pursuant to which such individuals
were selected as directors. There are no transactions involving any of the individuals listed above that would be required to be reported
under Item 404(a)&#160;of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><B><I>Appointment of
Chief Investment Officer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective November&#160;11,
2025, and in connection with the Employment Agreement discussed above, the Board also appointed Mr.&#160;McEvoy as Chief Investment Officer
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than as disclosed herein,
there are no arrangements or understandings between Mr.&#160;McEvoy and any other person pursuant to which Mr.&#160;McEvoy was appointed
as Chief Investment Officer. There are no family relationships between Mr.&#160;McEvoy and any director or executive officer of the Company,
and the Company is not aware of any transactions with Mr.&#160;McEvoy that are reportable pursuant to Item 404(a)&#160;of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt"><B>Item 5.03.</B></FONT></TD><TD STYLE="text-align: justify"><B>Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Certificate of Amendment to the Fourth
Amended and Restated Certificate of Incorporation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective November&#160;12,
2025, the Company changed its name to Cypherpunk Technologies Inc. pursuant to a Certificate of Amendment to its Fourth Amended and Restated
Certificate of Incorporation (the &#8220;Certificate of Amendment&#8221;) filed with the Secretary of State of the State of Delaware (the
&#8220;Name Change&#8221;). Pursuant to the Delaware General Corporation Law, a stockholder vote was not necessary to effectuate the Name
Change and it does not affect the rights of the Company&#8217;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Amendment and Restatement of Bylaws</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective November&#160;12,
2025, the Company adopted Amended and Restated Bylaws of the Company (the &#8220;Amended and Restated Bylaws&#8221;), which reflect the
Company&#8217;s new name and include miscellaneous revisions to remove outdated provisions, as set forth in Exhibit&#160;3.2 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Certificate of Amendment and Amended and Restated Bylaws do not purport to be complete and are qualified in their entirety by reference
to the full text of the Certificate of Amendment and the Amended and Restated Bylaws, which are filed with this Current Report on Form&#160;8-K
as Exhibits 3.1 and 3.2, respectively, and are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt"><B>Item 7.01</B></FONT></TD><TD STYLE="text-align: justify"><B>Regulation FD&#160;Disclosure</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;12, 2025,
the Company issued a press release announcing the Name Change and unveiled a digital asset treasury strategy to accumulate Zcash&#8217;s
native coin, ZEC. The Company has to date used $50 million of proceeds from the previously announced Private Placement to purchase
203,775 ZEC at a weighted average cost of $245.37 per token, for an aggregate purchase price of $50 million. A copy of the press release
is furnished as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;12, 2025,
the Company issued an additional press release announcing its financial results for the third quarter ended September&#160;30, 2025 and
other supplemental information. A copy of the press release is furnished as Exhibit&#160;99.2 to this Current Report on Form&#160;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company intends to announce material information
to the public through a variety of means, including filings with the Securities and Exchange Commission, the investor relations page on
our website (http://www.cypherpunk.com or http://www.leaptx.com), press releases, public conference calls, public webcasts, our X account
(@cypherpunktech), and our LinkedIn page, in order to achieve broad, non-exclusionary distribution of information to the public, and for
compliance with disclosure obligations under Regulation FD. The information disclosed in the foregoing channels could be deemed to be
material information. As such, the Company encourages investors, the media, and others to follow the channels listed above and to review
the information disclosed through such channels. Any updates to the list of disclosure channels through which we will announce information
will be posted on the investor relations page on our website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this Item
7.01, including Exhibits 99.1 and 99.2 of this Current Report on Form&#160;8-K are intended to be furnished and shall not be deemed &#8220;filed&#8221;
for purposes of Section&#160;18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall they be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth
by specific reference in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt"><B>Item 8.01</B></FONT></TD><TD STYLE="text-align: justify"><B>Other Events.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>ZEC Purchases</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As discussed under Item 7.01,
on November&#160;12, 2025, the Company issued a press release announcing the Name Change and unveiled a digital asset treasury strategy
to accumulate Zcash&#8217;s native coin, ZEC. The Company has to date used $50 million of proceeds from the previously announced Private
Placement to purchase  203,775 ZEC at a weighted average cost of $245.37 per token, for an aggregate purchase price of $50 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Ticker Symbol Change</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Name
Change, the Company&#8217;s common stock, par value $0.001 per share, which trades on the Nasdaq Capital Market, will cease trading under
the ticker symbol &#8220;LPTX&#8221; and commence trading under the ticker symbol &#8220;CYPH&#8221; (the &#8220;Symbol Change&#8221;).
The Symbol Change is anticipated to become effective as of the market open on November&#160;13, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>New Subsidiary</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;6, 2025,
in connection with internal corporate and organizational matters, the Company formed a new wholly owned subsidiary, which will operate
under the name &#8220;Leap Therapeutics,&#160;Inc.&#8221;, and will conduct the Company&#8217;s ongoing research and development activities
and operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>9.01 Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d)&#160;Exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt"><B>Exhibit&#160;No.</B></FONT></TD><TD STYLE="text-align: justify"><B>Description</B></TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in; text-align: left"><A HREF="#ss01" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.1</FONT></A></TD><TD STYLE="text-align: justify"><A HREF="#ss01" STYLE="-sec-extract: exhibit">Certificate of Amendment to Fourth Amended and Restated Certificate
of Incorporation of Cypherpunk Technologies Inc. (f/k/a Leap Therapeutics, Inc.).</A></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><A HREF="#ss02" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">3.2</FONT></A></TD><TD STYLE="text-align: justify"><A HREF="#ss02" STYLE="-sec-extract: exhibit">Amended and Restated Bylaws of Cypherpunk Technologies Inc.</A></TD>
</TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><A HREF="#ss03" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">10.1</FONT></A></TD><TD STYLE="text-align: justify"><A HREF="#ss03" STYLE="-sec-extract: exhibit">Consulting Agreement, dated November&#160;11, 2025, by and between
the Company and CoinXit Ltd.</A></TD>
</TR>
<TR STYLE="vertical-align: top">
<TD><A HREF="#ss04" STYLE="-sec-extract: exhibit">10.2</A></TD><TD STYLE="text-align: justify"><A HREF="#ss04" STYLE="-sec-extract: exhibit">Restricted Stock Unit Grant Agreement, dated November&#160;11, 2025, by and between the Company and CoinXit
Ltd.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD><A HREF="#ss05" STYLE="-sec-extract: exhibit">10.3</A></TD><TD STYLE="text-align: justify"><A HREF="#ss05" STYLE="-sec-extract: exhibit">Executive Employment Agreement, dated November&#160;11, 2025, by and between the Company and William McEvoy</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD><A HREF="#ss06" STYLE="-sec-extract: exhibit">10.4</A></TD><TD STYLE="text-align: justify"><A HREF="#ss06" STYLE="-sec-extract: exhibit">Form&#160;of Director Restricted Stock Unit Agreement pursuant to the 2016 Equity Incentive Plan.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD><A HREF="#ss07" STYLE="-sec-extract: exhibit">10.5</A></TD><TD STYLE="text-align: justify"><A HREF="#ss07" STYLE="-sec-extract: exhibit">Form&#160;of Director Restricted Stock Unit Agreement pursuant to the 2022 Equity Incentive Plan.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD><A HREF="#ss08" STYLE="-sec-extract: exhibit">10.6</A></TD><TD STYLE="text-align: justify"><A HREF="#ss08" STYLE="-sec-extract: exhibit">Form&#160;of Employee Restricted Stock Unit Agreement pursuant to the 2016 Equity Incentive Plan.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD><A HREF="#ss09" STYLE="-sec-extract: exhibit">10.7</A></TD><TD STYLE="text-align: justify"><A HREF="#ss09" STYLE="-sec-extract: exhibit">Form&#160;of Employee Restricted Stock Unit Agreement pursuant to the 2022 Equity Incentive Plan.</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD><A HREF="#ss10" STYLE="-sec-extract: exhibit">99.1</A></TD><TD STYLE="text-align: justify"><A HREF="#ss10" STYLE="-sec-extract: exhibit">Press Release of Cypherpunk Technologies Inc., dated November&#160;12, 2025 (Name Change).</A></TD></TR>
<TR STYLE="vertical-align: top">
<TD><A HREF="#ss11" STYLE="-sec-extract: exhibit">99.2</A></TD><TD STYLE="text-align: justify"><A HREF="#ss11" STYLE="-sec-extract: exhibit">Press Release of Cypherpunk Technologies Inc., dated November&#160;12, 2025 (Earnings).</A></TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">104</FONT></TD><TD STYLE="text-align: justify">Cover Page&#160;Interactive Data File (embedded within the Inline
XBRL document).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 50%">&#160;</TD>
    <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CYPHERPUNK TECHNOLOGIES INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&#160;</TD>
    <TD STYLE="text-align: justify">&#160;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November&#160;12, 2025</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Douglas E. Onsi</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&#160;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&#160;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President&#160;&amp; CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="ss01"></A>Exhibit&nbsp;3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE OF AMENDMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOURTH AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEAP THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LEAP THERAPEUTICS,&nbsp;INC.,
a corporation organized and existing under the General Corporation Law of the State of Delaware (the &ldquo;Corporation&rdquo;), does
hereby certify as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FIRST: The name of the Corporation
is Leap Therapeutics,&nbsp;Inc., and the Corporation was originally incorporated under the name Dekkun Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECOND: Article&nbsp;FIRST
of the Fourth Amended and Restated Certificate of Incorporation of the Corporation, as heretofore amended (the &ldquo;Certificate of Incorporation&rdquo;),
is hereby amended and restated in its entirety to read as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;FIRST: The name of the Corporation
is Cypherpunk Technologies Inc.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIRD: The foregoing amendment
to the Certificate of Incorporation has been duly adopted in accordance with the provisions of Section&nbsp;242 of the General Corporation
Law of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOURTH: Except to the extent
amended in the manner provided above in this Certificate of Amendment, the terms and provisions of the Certificate of Incorporation are
hereby ratified and confirmed and remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Corporation
has caused this Certificate of Amendment to be duly adopted and executed in its corporate name and on its behalf by its duly authorized
officer this 12<SUP>th</SUP> day of November, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">LEAP THERAPEUTICS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/ Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">President and Chief Executive Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><A NAME="ss02"></A>Exhibit 3.2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BYLAWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; color: red"><B><STRIKE>LEAP
THERAPEUTICS,</STRIKE></B></FONT><B><FONT STYLE="text-decoration: underline double; color: blue">CYPHERPUNK TECHNOLOGIES</FONT> INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(a Delaware corporation)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; text-decoration: underline double; color: blue"><B>(Amended
and Restated </B></FONT><B><FONT STYLE="text-decoration: underline double; color: green">as of </FONT></B><B><FONT STYLE="text-decoration: underline double; color: blue">November&nbsp;12,
2025)</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT><B><U>Page</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;I &mdash; CORPORATE OFFICES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.1</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REGISTERED OFFICE</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">OTHER OFFICES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;II &mdash; MEETINGS OF STOCKHOLDERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PLACE OF MEETINGS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ANNUAL MEETING</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SPECIAL MEETING</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ADVANCE NOTICE PROCEDURES FOR BUSINESS BROUGHT BEFORE A MEETING</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ADVANCE NOTICE PROCEDURES FOR NOMINATIONS OF DIRECTORS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">NOTICE OF STOCKHOLDERS&rsquo; MEETINGS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">QUORUM</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ADJOURNED MEETING; NOTICE</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CONDUCT OF BUSINESS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">VOTING</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">RECORD DATE FOR STOCKHOLDER NOTICE; VOTING</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.14</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PROXIES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.15</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">LIST OF STOCKHOLDERS ENTITLED TO VOTE</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.16</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">POSTPONEMENT AND CANCELLATION OF MEETING</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.17</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">INSPECTORS OF ELECTION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;III &mdash; DIRECTORS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">POWERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">NUMBER OF DIRECTORS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">RESIGNATION AND VACANCIES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PLACE OF MEETINGS; MEETINGS BY TELEPHONE</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REGULAR MEETINGS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.7</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SPECIAL MEETINGS; NOTICE</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">QUORUM</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">BOARD ACTION BY CONSENT WITHOUT A MEETING</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">FEES AND COMPENSATION OF DIRECTORS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REMOVAL OF DIRECTORS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>SPECIAL GOVERNANCE PROVISIONS</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">[RESERVED]</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;IV &mdash; COMMITTEES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">COMMITTEES OF DIRECTORS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">COMMITTEE MINUTES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>19</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">4.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MEETINGS AND ACTION OF COMMITTEES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>19</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;V &mdash; OFFICERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>20</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">OFFICERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>20</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">APPOINTMENT OF OFFICERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>20</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SUBORDINATE OFFICERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>20</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REMOVAL AND RESIGNATION OF OFFICERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>20</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">VACANCIES IN OFFICES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REPRESENTATION OF SHARES OF OTHER CORPORATIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">AUTHORITY AND DUTIES OF OFFICERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>21</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;VI &mdash; RECORDS AND REPORTS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>21</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">6.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MAINTENANCE OF RECORDS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>21</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;VII &mdash; GENERAL MATTERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>21</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>21</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">STOCK CERTIFICATES; PARTLY PAID SHARES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>21</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SPECIAL DESIGNATION ON CERTIFICATES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>22</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">LOST CERTIFICATES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>22</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CONSTRUCTION; DEFINITIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>22</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">DIVIDENDS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">FISCAL YEAR</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>23</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SEAL</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>23</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TRANSFER OF STOCK</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>23</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">STOCK TRANSFER AGREEMENTS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>23</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REGISTERED STOCKHOLDERS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>23</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">WAIVER OF NOTICE</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>24</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">23</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;VIII &mdash; NOTICE BY ELECTRONIC TRANSMISSION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>24</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">8.1</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">NOTICE BY ELECTRONIC TRANSMISSION</FONT></TD>
    <TD STYLE="text-align: right; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>24</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">8.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">DEFINITION OF ELECTRONIC TRANSMISSION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>25</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;IX &mdash; INDEMNIFICATION AND ADVANCEMENT</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>25</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ACTIONS, SUITS AND PROCEEDINGS OTHER THAN BY OR IN THE RIGHT OF THE CORPORATION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>25</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ACTIONS OR SUITS BY OR IN THE RIGHT OF THE CORPORATION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>26</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">INDEMNIFICATION FOR EXPENSES OF SUCCESSFUL PARTY</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>26</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">NOTIFICATION AND DEFENSE OF CLAIM</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>27</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ADVANCE OF EXPENSES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>27</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PROCEDURE FOR INDEMNIFICATION AND ADVANCEMENT OF EXPENSES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>28</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">27</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">REMEDIES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>28</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">27</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">LIMITATIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>29</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SUBSEQUENT AMENDMENT</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>29</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">OTHER RIGHTS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>29</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">PARTIAL INDEMNIFICATION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>29</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">INSURANCE</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>30</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SAVINGS CLAUSE</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>30</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.14</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">DEFINITIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>30</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;X &mdash; AMENDMENTS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase; color: red"><STRIKE>30</STRIKE></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: underline double; text-transform: uppercase; color: blue">29</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED BYLAWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt; color: red"><B><STRIKE>LEAP
THERAPEUTICS,</STRIKE></B></FONT><B><FONT STYLE="text-decoration: underline double; color: blue">CYPHERPUNK TECHNOLOGIES</FONT> INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;I
&mdash;CORPORATE OFFICES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">REGISTERED OFFICE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The registered office of <FONT STYLE="color: red"><STRIKE>Leap
Therapeutics,</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">Cypherpunk Technologies</FONT> Inc. (the &ldquo;<I>Corporation</I>&rdquo;)
shall be fixed in the Corporation&rsquo;s certificate of incorporation, as the same may be amended or restated from time to time (the
&ldquo;<I>Certificate of Incorporation</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">OTHER OFFICES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation&rsquo;s board
of directors (the &ldquo;<I>Board</I>&rdquo;) may at any time establish other offices at any place or places where the Corporation is
qualified to do business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;II
&mdash;MEETINGS OF STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">PLACE OF MEETINGS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Meetings of stockholders shall
be held at any place, within or outside the State of Delaware, designated by the Board. The Board may, in its sole discretion, determine
that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized
by the General Corporation Law of the State of Delaware (the &ldquo;<I>DGCL</I>&rdquo;). In the absence of any such designation or determination,
stockholders&rsquo; meetings shall be held at the Corporation&rsquo;s principal executive office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">ANNUAL MEETING.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board shall designate
the date and time of the annual meeting. At the annual meeting, directors shall be elected and other proper business properly brought
before the meeting in accordance with Section&nbsp;2.4 of these bylaws may be transacted. Written notice of the annual meeting shall be
provided in accordance with Section&nbsp;2.6 of these bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.3</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">SPECIAL MEETING.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise prescribed
by law or by the Certificate of Incorporation, a special meeting of the stockholders may be called at any time by the Board, chairperson
of the Board, chief executive officer or president (in the absence of a chief executive officer), but such special meetings may not be
called by any other person or persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No business may be transacted
at such special meeting other than the business specified in such notice to stockholders. Nothing contained in this paragraph of this
Section&nbsp;2.3 shall be construed as limiting, fixing, or affecting the time when a meeting of stockholders called by action of the
Board may be held.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.4</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">ADVANCE NOTICE PROCEDURES FOR BUSINESS BROUGHT BEFORE A MEETING.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>At
an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To
be properly brought before an annual meeting, business must be (i)&nbsp;brought before the meeting by the Corporation and specified in
the notice of meeting given by or at the direction of the Board, (ii)&nbsp;brought before the meeting by or at the direction of the Board
or (iii)&nbsp;otherwise properly brought before the meeting by a stockholder who (A)&nbsp;was a stockholder of record of the Corporation
(and, with respect to any beneficial owner, if different, on whose behalf such business is proposed, only if such beneficial owner was
the beneficial owner of shares of the Corporation) both at the time of giving the notice provided for in this Section&nbsp;2.4 and at
the time of the meeting, (B)&nbsp;is entitled to vote at the meeting and (C)&nbsp;has complied with this Section&nbsp;2.4 as to such business.
Except for proposals properly made in accordance with Rule&nbsp;14a-8 under the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and
regulations promulgated thereunder (as so amended and inclusive of such rules&nbsp;and regulations, the &ldquo;<I>Exchange Act</I>&rdquo;),
and included in the notice of meeting given by or at the direction of the Board, the foregoing clause (iii)&nbsp;shall be the exclusive
means for a stockholder to propose business to be brought before an annual meeting of the stockholders. Stockholders shall not be permitted
to propose business to be brought before a special meeting of the stockholders, and the only matters that may be brought before a special
meeting are the matters specified in the notice of meeting given by or at the direction of the person calling the meeting pursuant to
Section&nbsp;2.3 of these bylaws. Stockholders seeking to nominate persons for election to the Board must comply with Section&nbsp;2.5
of these bylaws, and this Section&nbsp;2.4 shall not be applicable to nominations except as expressly provided in Section&nbsp;2.5 of
these bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Without
qualification, for business to be properly brought before an annual meeting by a stockholder, the stockholder must (i)&nbsp;provide Timely
Notice (as defined below) thereof in writing and in proper form to the secretary of the Corporation and (ii)&nbsp;provide any updates
or supplements to such notice at the times and in the forms required by this Section&nbsp;2.4. To be timely, a stockholder&rsquo;s notice
must be delivered to, or mailed and received at, the principal executive offices of the Corporation not less than ninety (90) days nor
more than one hundred twenty (120) days prior to the first anniversary of the preceding year&rsquo;s annual meeting; <I>provided</I>,
<I>however</I>, that (x)&nbsp;if the date of the annual meeting is more than thirty (30) days before or more than sixty (60) days after
such anniversary date or (y)&nbsp;with respect to the first annual meeting held after the Company&rsquo;s initial public offering of its
shares pursuant to a registration statement on Form&nbsp;S-4, notice by the stockholder to be timely must be so delivered, or mailed and
received, not earlier than the one hundred twentieth (120th) day prior to such annual meeting and not later than the ninetieth (90th)
day prior to such annual meeting or, if later, the tenth (10th) day following the day on which public disclosure of the date of such annual
meeting was first made (such notice within such time periods, &ldquo;<I>Timely Notice</I>&rdquo;). In no event shall any adjournment or
postponement of an annual meeting or the announcement thereof commence a new time period for the giving of Timely Notice as described
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>To
be in proper form for purposes of this Section&nbsp;2.4, a stockholder&rsquo;s notice to the secretary of the Corporation shall set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>As
to each Proposing Person (as defined below), (A)&nbsp;the name and address of such Proposing Person (including, without limitation, if
applicable, the name and address that appear on the Corporation&rsquo;s books and records) and (B)&nbsp;the class or series and number
of shares of the Corporation that are, directly or indirectly, owned of record or beneficially owned (within the meaning of Rule&nbsp;13d-3
under the Exchange Act) by such Proposing Person, except that such Proposing Person shall in all events be deemed to beneficially own
any shares of any class or series of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at
any time in the future (the disclosures to be made pursuant to the foregoing clauses (A)&nbsp;and (B)&nbsp;are referred to as &ldquo;<I>Stockholder
Information</I>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
to each Proposing Person, (A)&nbsp;any derivative, swap or other transaction or series of transactions engaged in, directly or indirectly,
by such Proposing Person, the purpose or effect of which is to give such Proposing Person economic risk similar to ownership of shares
of any class or series of the Corporation, including, without limitation, due to the fact that the value of such derivative, swap or other
transactions are determined by reference to the price, value or volatility of any shares of any class or series of the Corporation, or
which derivative, swap or other transactions provide, directly or indirectly, the opportunity to profit from any increase in the price
or value of shares of any class or series of the Corporation (&ldquo;<I>Synthetic Equity Interests</I>&rdquo;), which Synthetic Equity
Interests shall be disclosed without regard to whether (x)&nbsp;the derivative, swap or other transactions convey any voting rights in
such shares to such Proposing Person, (y)&nbsp;the derivative, swap or other transactions are required to be, or are capable of being,
settled through delivery of such shares or (z)&nbsp;such Proposing Person may have entered into other transactions that hedge or mitigate
the economic effect of such derivative, swap or other transactions, (B)&nbsp;any proxy (other than a revocable proxy or consent given
in response to a solicitation made pursuant to, and in accordance with, Section&nbsp;14(a)&nbsp;of the Exchange Act by way of a solicitation
statement filed on Schedule 14A), agreement, arrangement, understanding or relationship pursuant to which such Proposing Person has or
shares a right to vote any shares of any class or series of the Corporation, (C)&nbsp;any agreement, arrangement, understanding or relationship,
including, without limitation, any repurchase or similar so-called &ldquo;stock borrowing&rdquo; agreement or arrangement, engaged in,
directly or indirectly, by such Proposing Person, the purpose or effect of which is to mitigate loss to, reduce the economic risk (of
ownership or otherwise) of shares of any class or series of the Corporation by, manage the risk of share price changes for, or increase
or decrease the voting power of, such Proposing Person with respect to the shares of any class or series of the Corporation, or which
provides, directly or indirectly, the opportunity to profit from any decrease in the price or value of the shares of any class or series
of the Corporation (&ldquo;<I>Short Interests</I>&rdquo;), (D)&nbsp;any rights to dividends on the shares of any class or series of the
Corporation owned beneficially by such Proposing Person that are separated or separable from the underlying shares of the Corporation,
(E)&nbsp;any performance related fees (other than an asset based fee) that such Proposing Person is entitled to based on any increase
or decrease in the price or value of shares of any class or series of the Corporation, or any Synthetic Equity Interests or Short Interests,
if any, (F)&nbsp;(x)&nbsp;if such Proposing Person is not a natural person, the identity of the natural person or persons associated with
such Proposing Person responsible for the formulation of and decision to propose the business to be brought before the meeting (such person
or persons, the &ldquo;<I>Responsible Person</I>&rdquo;), the manner in which such Responsible Person was selected, any fiduciary duties
owed by such Responsible Person to the equity holders or other beneficiaries of such Proposing Person, the qualifications and background
of such Responsible Person and any material interests or relationships of such Responsible Person that are not shared generally by any
other record or beneficial holder of the shares of any class or series of the Corporation and that reasonably could have influenced the
decision of such Proposing Person to propose such business to be brought before the meeting, and (y)&nbsp;if such Proposing Person is
a natural person, the qualifications and background of such natural person and any material interests or relationships of such natural
person that are not shared generally by any other record or beneficial holder of the shares of any class or series of the Corporation
and that reasonably could have influenced the decision of such Proposing Person to propose such business to be brought before the meeting,
(G)&nbsp;any significant equity interests or any Synthetic Equity Interests or Short Interests in any principal competitor of the Corporation
held by such Proposing Persons, (H)&nbsp;any direct or indirect interest of such Proposing Person in any contract with the Corporation,
any affiliate of the Corporation or any principal competitor of the Corporation (including, without limitation, in any such case, any
employment agreement, collective bargaining agreement or consulting agreement), (I)&nbsp;any pending or threatened litigation in which
such Proposing Person is a party or material participant involving the Corporation or any of its officers or directors, or any affiliate
of the Corporation, (J)&nbsp;any material transaction occurring during the prior twelve months between such Proposing Person, on the one
hand, and the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation, on the other hand, (K)&nbsp;a
summary of any material discussions regarding the business proposed to be brought before the meeting (x)&nbsp;between or among any of
the Proposing Persons or (y)&nbsp;between or among any Proposing Person and any other record or beneficial holder of the shares of any
class or series of the Corporation (including, without limitation, their names) and (L)&nbsp;any other information relating to such Proposing
Person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations
of proxies or consents by such Proposing Person in support of the business proposed to be brought before the meeting pursuant to Section&nbsp;14(a)&nbsp;of
the Exchange Act (the disclosures to be made pursuant to the foregoing clauses (A)&nbsp;through (L)&nbsp;are referred to as &ldquo;<I>Disclosable
Interests</I>&rdquo;); <I>provided</I>, <I>however</I>, that Disclosable Interests shall not include any such disclosures with respect
to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who is a Proposing Person
solely as a result of being the stockholder directed to prepare and submit the notice required by these bylaws on behalf of a beneficial
owner; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
to each item of business that the stockholder proposes to bring before the annual meeting, (A)&nbsp;a reasonably brief description of
the business desired to be brought before the annual meeting, the reasons for conducting such business at the annual meeting and any material
interest in such business of each Proposing Person, (B)&nbsp;the text of the proposal or business (including, without limitation, the
text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend the bylaws of the
Corporation, the language of the proposed amendment), (C)&nbsp;a reasonably detailed description of all agreements, arrangements and understandings
between or among any of the Proposing Persons or between or among any Proposing Person and any other person or entity (including, without
limitation, their names) in connection with the proposal of such business by such stockholder, (D)&nbsp;a representation that the stockholder
is a holder of record of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the
meeting to propose such business, (E)&nbsp;a representation whether the Proposing Person intends or is part of a group which intends (1)&nbsp;to
deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation&rsquo;s outstanding capital stock
required to approve or adopt the proposal and/or (2)&nbsp;otherwise to solicit proxies or votes from stockholders in support of such proposal
and (F)&nbsp;any other information relating to such item of business that would be required to be disclosed in a proxy statement or other
filing required to be made in connection with solicitations of proxies in support of the business proposed to be brought before the meeting
pursuant to Section&nbsp;14(a)&nbsp;of the Exchange Act; <I>provided</I>, <I>however</I>, that the disclosures required by this paragraph
(c)&nbsp;shall not include any disclosures with respect to any broker, dealer, commercial bank, trust company or other nominee who is
a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these bylaws on behalf
of a beneficial owner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>For
purposes of this Section&nbsp;2.4, the term &ldquo;<I>Proposing Person</I>&rdquo; shall mean (i)&nbsp;the stockholder providing the notice
of business proposed to be brought before an annual meeting, (ii)&nbsp;the beneficial owner or beneficial owners, if different, on whose
behalf the notice of the business proposed to be brought before the annual meeting is made, (iii)&nbsp;any affiliate or associate (each
within the meaning of Rule&nbsp;12b-2 under the Exchange Act for the purposes of these bylaws) of such stockholder or beneficial owner
and (iv)&nbsp;any other person with whom such stockholder or beneficial owner (or any of their respective affiliates or associates) is
Acting in Concert (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>A
person shall be deemed to be &ldquo;<I>Acting in Concert</I>&rdquo; with another person for purposes of these bylaws if such person knowingly
acts (whether or not pursuant to an express agreement, arrangement or understanding) in concert with, or towards a common goal relating
to the management, governance or control of the Corporation in parallel with, such other person where (i)&nbsp;each person is conscious
of the other person&rsquo;s conduct or intent and this awareness is an element in their decision-making processes and (ii)&nbsp;at least
one additional factor suggests that such persons intend to act in concert or in parallel, which such additional factors may include, without
limitation, exchanging information (whether publicly or privately), attending meetings, conducting discussions, or making or soliciting
invitations to act in concert or in parallel; <I>provided</I>, that a person shall not be deemed to be Acting in Concert with any other
person solely as a result of the solicitation or receipt of revocable proxies or consents from such other person in response to a solicitation
made pursuant to, and in accordance with, the Section&nbsp;14(a)&nbsp;of the Exchange Act by way of a proxy or consent solicitation statement
filed on Schedule 14A. A person Acting in Concert with another person shall be deemed to be Acting in Concert with any third party who
is also Acting in Concert with such other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>A
stockholder providing notice of business proposed to be brought before an annual meeting shall further update and supplement such notice,
if necessary, so that the information provided or required to be provided in such notice pursuant to this Section&nbsp;2.4 shall be true
and correct as of the record date for determining stockholders entitled to notice of the annual meeting and as of the date that is ten
(10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered
to, or mailed and received by, the secretary of the Corporation at the principal executive offices of the Corporation not later than five
(5)&nbsp;business days after the record date for determining stockholders entitled to notice of the annual meeting (in the case of the
update and supplement required to be made as of the record date), and not later than eight (8)&nbsp;business days prior to the date for
the meeting or, if practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior
to the date to which the meeting has been adjourned or postponed) (in the case of the update and supplement required to be made as of
ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>Notwithstanding
anything in these bylaws to the contrary, no business shall be conducted at an annual meeting except in accordance with this Section&nbsp;2.4.
The presiding officer of an annual meeting shall, if the facts warrant, determine that the business was not properly brought before the
meeting in accordance with this Section&nbsp;2.4, and if he or she should so determine, he or she shall so declare to the meeting and
any such business not properly brought before the meeting shall not be transacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>The
foregoing notice requirements of this Section&nbsp;2.4 shall be deemed satisfied by a stockholder with respect to business other than
a nomination if the stockholder has notified the Corporation of his, her or its intention to present a proposal at an annual meeting in
compliance with applicable rules&nbsp;and regulations promulgated under the Exchange Act and such stockholder&rsquo;s proposal has been
included in a proxy statement that has been prepared by the Corporation to solicit proxies for such annual meeting. Nothing in this Section&nbsp;2.4
shall be deemed to affect the rights of stockholders to request inclusion of proposals in the Corporation&rsquo;s proxy statement pursuant
to Rule&nbsp;14a-8 under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>For
purposes of these bylaws, &ldquo;public disclosure&rdquo; shall mean disclosure in a press release reported by a national news service
or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Sections 13, 14 or 15(d)&nbsp;of
the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
the foregoing provisions of this Section&nbsp;2.4, unless otherwise required by law, if the stockholder (or a qualified representative
of the stockholder) does not appear at the annual meeting to present proposed business, such proposed business shall not be transacted,
notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section&nbsp;2.4,
to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such
stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder
to act for such stockholder as proxy at the annual meeting and such person must produce such writing or electronic transmission, or a
reliable reproduction of the writing or electronic transmission, at the annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.5</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">ADVANCE NOTICE PROCEDURES FOR NOMINATIONS OF DIRECTORS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Nominations
of any person for election to the Board at an annual meeting or at a special meeting (but only if the election of directors is a matter
specified in the notice of meeting given by or at the direction of the person calling such special meeting) may be made at such meeting
only (i)&nbsp;by or at the direction of the Board, including, without limitation, by any committee or persons appointed by the Board,
or (ii)&nbsp;by a stockholder who (A)&nbsp;was a stockholder of record of the Corporation (and, with respect to any beneficial owner,
if different, on whose behalf such nomination is proposed to be made, only if such beneficial owner was the beneficial owner of shares
of the Corporation) both at the time of giving the notice provided for in this Section&nbsp;2.5 and at the time of the meeting, (B)&nbsp;is
entitled to vote at the meeting and (C)&nbsp;has complied with this Section&nbsp;2.5 as to such nomination. The foregoing clause (ii)&nbsp;shall
be the exclusive means for a stockholder to make any nomination of a person or persons for election to the Board to be considered by the
stockholders at an annual meeting or special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Without
qualification, for a stockholder to make any nomination of a person or persons for election to the Board at an annual meeting, the stockholder
must (i)&nbsp;provide Timely Notice (as defined in Section&nbsp;2.4(b)&nbsp;of these bylaws) thereof in writing and in proper form to
the secretary of the Corporation and (ii)&nbsp;provide any updates or supplements to such notice at the times and in the forms required
by this Section&nbsp;2.5. Without qualification, if the election of directors is a matter specified in the notice of meeting given by
or at the direction of the person calling such special meeting, then for a stockholder to make any nomination of a person or persons for
election to the Board at a special meeting, the stockholder must (i)&nbsp;provide timely notice thereof in writing and in proper form
to the secretary of the Corporation at the principal executive offices of the Corporation and (ii)&nbsp;provide any updates or supplements
to such notice at the times and in the forms required by this Section&nbsp;2.5. To be timely, a stockholder&rsquo;s notice for nominations
to be made at a special meeting must be delivered to, or mailed and received at, the principal executive offices of the Corporation not
earlier than the one hundred twentieth (120th) day prior to such special meeting and not later than the ninetieth (90th) day prior to
such special meeting or, if later, the tenth (10th) day following the day on which public disclosure (as defined in Section&nbsp;2.4(i)&nbsp;of
these bylaws) of the date of such special meeting was first made. In no event shall any adjournment or postponement of an annual meeting
or special meeting or the announcement thereof commence a new time period for the giving of a stockholder&rsquo;s notice as described
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>To
be in proper form for purposes of this Section&nbsp;2.5, a stockholder&rsquo;s notice to the secretary of the Corporation shall set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
to each Nominating Person (as defined below), the Stockholder Information (as defined in Section&nbsp;2.4(c)(i)&nbsp;of these bylaws)
except that for purposes of this Section&nbsp;2.5, the term &ldquo;Nominating Person&rdquo; shall be substituted for the term &ldquo;Proposing
Person&rdquo; in all places it appears in Section&nbsp;2.4(c)(i);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>As
to each Nominating Person, any Disclosable Interests (as defined in Section&nbsp;2.4(c)(ii), except that for purposes of this Section&nbsp;2.5
the term &ldquo;Nominating Person&rdquo; shall be substituted for the term &ldquo;Proposing Person&rdquo; in all places it appears in
Section&nbsp;2.4(c)(ii)&nbsp;and the disclosure in clause (L)&nbsp;of Section&nbsp;2.4(c)(ii)&nbsp;shall be made with respect to the election
of directors at the meeting);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
to each person whom a Nominating Person proposes to nominate for election as a director, (A)&nbsp;all information with respect to such
proposed nominee that would be required to be set forth in a stockholder&rsquo;s notice pursuant to this Section&nbsp;2.5 if such proposed
nominee were a Nominating Person, (B)&nbsp;all information relating to such proposed nominee that is required to be disclosed in a proxy
statement or other filings required to be made in connection with solicitations of proxies for election of directors in a contested election
pursuant to Section&nbsp;14(a)&nbsp;under the Exchange Act (including, without limitation, such proposed nominee&rsquo;s written consent
to being named in the proxy statement as a nominee and to serving as a director if elected), (C)&nbsp;a description of all direct and
indirect compensation and other material monetary agreements, arrangements and understandings during the past three (3)&nbsp;years, and
any other material relationships, between or among any Nominating Person, on the one hand, and each proposed nominee, his or her respective
affiliates and associates and any other persons with whom such proposed nominee (or any of his or her respective affiliates and associates)
is Acting in Concert (as defined in Section&nbsp;2.4(e)&nbsp;of these bylaws), on the other hand, including, without limitation, all information
that would be required to be disclosed pursuant to Item 404 under Regulation S-K if such Nominating Person were the &ldquo;registrant&rdquo;
for purposes of such rule&nbsp;and the proposed nominee were a director or executive officer of such registrant (the disclosures to be
made pursuant to the foregoing clauses (A)&nbsp;through (C)&nbsp;are referred to as &ldquo;<I>Nominee Information</I>&rdquo;), (D)&nbsp;a
representation that the Nominating Person is a holder of record of stock of the Corporation entitled to vote at such meeting and intends
to appear in person or by proxy at the meeting to propose such nomination, (E)&nbsp;a representation whether the Nominating Person intends
or is part of a group which intends (1)&nbsp;to deliver a proxy statement and/or form of proxy to holders of at least the percentage of
the Corporation&rsquo;s outstanding capital stock required to elect the nominee and/or (2)&nbsp;otherwise to solicit proxies or votes
from stockholders in support of such nomination and (F)&nbsp;a completed and signed questionnaire, representation and agreement as provided
in Section&nbsp;2.5(g); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>The
Corporation may require any proposed nominee to furnish such other information (A)&nbsp;as may reasonably be required by the Corporation
to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation in accordance with the listing
standards of the principal U.S. exchange upon which the Corporation&rsquo;s capital stock is listed, any applicable rules&nbsp;of the
Securities and Exchange Commission and any publicly disclosed standards used by the Board in determining and disclosing the independence
of the Corporation&rsquo;s directors (the &ldquo;<I>Applicable Independence Standards</I>&rdquo;) or (B)&nbsp;that could be material to
a reasonable stockholder&rsquo;s understanding of the independence or lack of independence of such proposed nominee. If the Board determines
that the proposed nominee is not independent under the Applicable Independence Standards, the Shareholder Nominee will not be eligible
for inclusion in the Corporation&rsquo;s proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>For
purposes of this Section&nbsp;2.5, the term &ldquo;<I>Nominating Person</I>&rdquo; shall mean (i)&nbsp;the stockholder providing the notice
of the nomination proposed to be made at the meeting, (ii)&nbsp;the beneficial owner or beneficial owners, if different, on whose behalf
the notice of the nomination proposed to be made at the meeting is made, (iii)&nbsp;any affiliate or associate of such stockholder or
beneficial owner and (iv)&nbsp;any other person with whom such stockholder or such beneficial owner (or any of their respective affiliates
or associates) is Acting in Concert.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>A
stockholder providing notice of any nomination proposed to be made at a meeting shall further update and supplement such notice, if necessary,
so that the information provided or required to be provided in such notice pursuant to this Section&nbsp;2.5 shall be true and correct
as of the record date for determining stockholders entitled to notice of the meeting and as of the date that is ten (10)&nbsp;business
days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed
and received by, the secretary of the Corporation at the principal executive offices of the Corporation not later than five (5)&nbsp;business
days after the record date for determining stockholders entitled to notice of the meeting (in the case of the update and supplement required
to be made as of the record date), and not later than eight (8)&nbsp;business days prior to the date for the meeting or, if practicable,
any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the meeting
has been adjourned or postponed) (in the case of the update and supplement required to be made as of ten (10)&nbsp;business days prior
to the meeting or any adjournment or postponement thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
anything in these bylaws to the contrary, no person shall be eligible for election as a director of the Corporation unless nominated in
accordance with this Section&nbsp;2.5. The presiding officer at the meeting shall, if the facts warrant, determine that a nomination was
not properly made in accordance with this Section&nbsp;2.5, and if he or she should so determine, he or she shall so declare such determination
to the meeting and the defective nomination shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>To
be eligible to be a nominee for election as a director of the Corporation, the proposed nominee must deliver (in accordance with the time
periods prescribed for delivery of notice under this Section&nbsp;2.5) to the secretary of the Corporation at the principal executive
offices of the Corporation a written questionnaire with respect to the background and qualification of such proposed nominee (which questionnaire
shall be provided by the secretary upon written request) and a written representation and agreement (in form provided by the secretary
upon written request) that such proposed nominee (i)&nbsp;is not and will not become a party to (A)&nbsp;any agreement, arrangement or
understanding with, and has not given any commitment or assurance to, any person or entity as to how such proposed nominee, if elected
as a director of the Corporation, will act or vote on any issue or question (a &ldquo;<I>Voting Commitment</I>&rdquo;) that has not been
disclosed to the Corporation or (B)&nbsp;any Voting Commitment that could limit or interfere with such proposed nominee&rsquo;s ability
to comply, if elected as a director of the Corporation, with such proposed nominee&rsquo;s fiduciary duties under applicable law, (ii)&nbsp;is
not, and will not become a party to, any agreement, arrangement or understanding with any person or entity other than the Corporation
with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director
that has not been disclosed to the Corporation and (iii)&nbsp;in such proposed nominee&rsquo;s individual capacity and on behalf of the
stockholder (or the beneficial owner, if different) on whose behalf the nomination is made, would be in compliance, if elected as a director
of the Corporation, and will comply with applicable publicly disclosed corporate governance, conflict of interest, confidentiality and
stock ownership and trading policies and guidelines of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>In
addition to the requirements of this Section&nbsp;2.5 with respect to any nomination proposed to be made at a meeting, each Nominating
Person shall comply with all applicable requirements of the Exchange Act with respect to any such nominations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
the foregoing provisions of this Section&nbsp;2.5, unless otherwise required by law, if the stockholder (or a qualified representative
of the stockholder) does not appear at the meeting to present the proposed nomination, such proposed nomination shall not be considered,
notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section&nbsp;2.5,
to be considered a qualified representative of the stockholder, a person must be a duly authorized officer, manager or partner of such
stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder
to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission,
or a reliable reproduction of the writing or electronic transmission, at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.6</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">NOTICE OF STOCKHOLDERS&rsquo; MEETINGS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise provided
by law, the certificate of incorporation or these bylaws, the notice of any meeting of stockholders shall be sent or otherwise given in
accordance with either Section&nbsp;2.7 or Section&nbsp;8.1 of these bylaws not less than ten (10)&nbsp;nor more than sixty (60) days
before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders
entitled to notice of the meeting. The notice shall specify the place, if any, date and hour of the meeting, the record date for determining
the stockholders entitled to vote at the meeting (if such date is different from the record date for stockholders entitled to notice of
the meeting), the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person
and vote at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.7</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whenever written notice is
required by law, the Certificate of Incorporation or these bylaws, to be given to any director on the Board, member of a committee of
the Board stockholder, such notice shall be deemed given:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>if
mailed, when deposited in the United States mail, postage prepaid, directed to the director or stockholder at such person&rsquo;s address
as it appears on the Corporation&rsquo;s records; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>if
electronically transmitted, as provided in Section&nbsp;8.1 of these bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An affidavit of the secretary
or an assistant secretary of the Corporation or of the transfer agent or any other agent of the Corporation that the notice has been given
by mail or by a form of electronic transmission, as applicable, shall, in the absence of fraud, be prima facie evidence of the facts stated
therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.8</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">QUORUM.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise provided
by law, the certificate of incorporation or these bylaws, the holders of a majority in voting power of the capital stock issued and outstanding
and entitled to vote, present in person, or by remote communication, if applicable, or represented by proxy, shall constitute a quorum
for the transaction of business at all meetings of the stockholders. A quorum, once established at a meeting, shall not be broken by the
withdrawal of enough votes to leave less than a quorum. If, however, a quorum is not present or represented at any meeting of the stockholders,
then either (a)&nbsp;the chairperson of the meeting or (b)&nbsp;a majority in voting power of the stockholders entitled to vote thereon,
present in person, or by remote communication, if applicable, or represented by proxy, shall have power to adjourn the meeting from time
to time in the manner provided in Section&nbsp;2.9 of these bylaws until a quorum is present or represented. At such adjourned meeting
at which a quorum is present or represented, any business may be transacted that might have been transacted at the meeting as originally
noticed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.9</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">ADJOURNED MEETING; NOTICE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When a meeting is adjourned
to another time or place, unless these bylaws otherwise require, notice need not be given of the adjourned meeting if the time, place,
if any, thereof, and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in
person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the
Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than thirty
(30) days, or if after the adjournment a new record date for determining the stockholders entitled to vote is fixed for the adjourned
meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the adjourned meeting as of
the record date for determining the stockholders entitled to notice of the adjourned meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.10</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">CONDUCT OF BUSINESS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The date and time of the opening
and the closing of the polls for each matter upon which the stockholders will vote at a meeting shall be announced at the meeting by the
person presiding over the meeting. The Board may adopt by resolution such rules&nbsp;and regulations for the conduct of the meeting of
stockholders as it shall deem appropriate. Except to the extent inconsistent with such rules&nbsp;and regulations as adopted by the Board,
the person presiding over any meeting of stockholders shall have the right and authority to convene and (for any or no reason) to recess
and/or adjourn the meeting, to prescribe such rules, regulations and procedures (which need not be in writing) and to do all such acts
as, in the judgment of such presiding person, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures,
whether adopted by the Board or prescribed by the presiding person of the meeting, may include, without limitation, the following: (a)&nbsp;the
establishment of an agenda or order of business for the meeting; (b)&nbsp;rules&nbsp;and procedures for maintaining order at the meeting
and the safety of those present (including, without limitation, rules&nbsp;and procedures for removal of disruptive persons from the meeting);
(c)&nbsp;limitations on attendance at or participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized
and constituted proxies or such other persons as the presiding person of the meeting shall determine; (d)&nbsp;restrictions on entry to
the meeting after the time fixed for the commencement thereof; and (e)&nbsp;limitations on the time allotted to questions or comments
by participants. The presiding person at any meeting of stockholders, in addition to making any other determinations that may be appropriate
to the conduct of the meeting (including, without limitation, determinations with respect to the administration and/or interpretation
of any of the rules, regulations or procedures of the meeting, whether adopted by the Board or prescribed by the person presiding over
the meeting), shall, if the facts warrant, determine and declare to the meeting that a matter or business was not properly brought before
the meeting and if such presiding person should so determine, such presiding person shall so declare to the meeting and any such matter
or business not properly brought before the meeting shall not be transacted or considered. Unless and to the extent determined by the
Board or the person presiding over the meeting, meetings of stockholders shall not be required to be held in accordance with the rules&nbsp;of
parliamentary procedure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.11</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">VOTING.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The stockholders entitled
to vote at any meeting of stockholders shall be determined in accordance with the provisions of Section&nbsp;2.13 of these bylaws, subject
to Section&nbsp;217 (relating to voting rights of fiduciaries, pledgors and joint owners of stock) and Section&nbsp;218 (relating to voting
trusts and other voting agreements) of the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as may be otherwise
provided in the certificate of incorporation or these bylaws, each stockholder shall be entitled to one (1)&nbsp;vote for each share of
capital stock held by such stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At all duly called or convened
meetings of stockholders, at which a quorum is present, for the election of directors, a plurality of the votes cast shall be sufficient
to elect a director. Except as otherwise provided by the certificate of incorporation, these bylaws, the rules&nbsp;or regulations of
any stock exchange applicable to the Corporation, or applicable law or pursuant to any regulation applicable to the Corporation or its
securities, all other elections and questions presented to the stockholders at a duly called or convened meeting, at which a quorum is
present, shall be decided by the affirmative vote of the holders of a majority in voting power of the votes cast affirmatively or negatively
(excluding abstentions) at the meeting by the holders entitled to vote thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.12</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any action required or permitted
to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders of the
Corporation and may not be effected by any consent in writing by such stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.13</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">RECORD DATE FOR STOCKHOLDER NOTICE; VOTING.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order that the Corporation
may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment thereof, the Board may fix a record
date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board, and which
record date shall, unless otherwise required by law, not be more than sixty (60) nor less than ten (10)&nbsp;days before the date of such
meeting. If the Board so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such
meeting unless the Board determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall
be the date for making such determination. If no record date is fixed by the Board, the record date for determining stockholders entitled
to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice
is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination
of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting;
<I>provided</I>, <I>however</I>, that the Board may fix a new record date for determination of stockholders entitled to vote at the adjourned
meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or
an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order that the Corporation
may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled
to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board
may fix a record date, which shall not be more than sixty (60) days prior to such other action. If no such record date is fixed, the record
date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board adopts the resolution
relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.14</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">PROXIES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each stockholder entitled
to vote at a meeting of stockholders may authorize another person or persons to act for such stockholder by proxy authorized by an instrument
in writing or by a transmission permitted by law filed in accordance with the procedure established for the meeting, but no such proxy
shall be voted or acted upon after three (3)&nbsp;years from its date, unless the proxy provides for a longer period. The revocability
of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section&nbsp;212 of the DGCL. A proxy
may be in the form of a telegram, cablegram or other means of electronic transmission which sets forth or is submitted with information
from which it can be determined that the telegram, cablegram or other means of electronic transmission was authorized by the stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.15</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">LIST OF STOCKHOLDERS ENTITLED TO VOTE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The officer who has charge
of the stock ledger of the Corporation shall prepare and make, at least ten (10)&nbsp;days before every meeting of stockholders, a complete
list of the stockholders entitled to vote at the meeting (<I>provided</I>, <I>however</I>, if the record date for determining the stockholders
entitled to vote is less than ten (10)&nbsp;days before the date of the meeting, the list shall reflect the stockholders entitled to vote
as of the tenth day before the date of the meeting), arranged in alphabetical order, and showing the address of each stockholder and the
number of shares registered in the name of each stockholder. The Corporation shall not be required to include electronic mail addresses
or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane
to the meeting for a period of at least ten (10)&nbsp;days prior to the meeting: (a)&nbsp;on a reasonably accessible electronic network,
provided that the information required to gain access to such list is provided with the notice of the meeting, or (b)&nbsp;during ordinary
business hours, at the Corporation&rsquo;s principal executive office. In the event that the Corporation determines to make the list available
on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders
of the Corporation. If the meeting is to be held at a place, then the list shall be produced and kept at the time and place of the meeting
during the whole time thereof, and may be inspected by any stockholder who is present. If the meeting is to be held solely by means of
remote communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a
reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting.
Except as otherwise provided by law, the stock ledger shall be the only evidence as to the identity of the stockholders entitled to vote
in person or by proxy and the number of shares held by each of them, and as to the stockholders entitled to examine the list of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.16</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">POSTPONEMENT AND CANCELLATION OF MEETING.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any previously scheduled annual
or special meeting of the stockholders may be postponed, and any previously scheduled annual or special meeting of the stockholders may
be canceled, by resolution of the Board upon public notice given prior to the time previously scheduled for such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.17</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">INSPECTORS OF ELECTION.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before any meeting of stockholders,
the Board shall appoint an inspector or inspectors of election to act at the meeting or its adjournment or postponement and make a written
report thereof. The number of inspectors shall be either one (1)&nbsp;or three (3). If any person appointed as inspector fails to appear
or fails or refuses to act, then the chairperson of the meeting may, and upon the request of any stockholder or a stockholder&rsquo;s
proxy shall, appoint a person to fill that vacancy. Unless otherwise required by law, inspectors may be officers, employees or agents
of the Corporation. Such inspectors shall have the duties prescribed by law and shall take charge of the polls and, when the vote is completed,
shall make a certificate of the result of the vote taken and of such other facts as may be required by law. The inspectors of election
shall perform their duties impartially, in good faith, to the best of their ability and as expeditiously as is practical. If there are
three (3)&nbsp;inspectors of election, the decision, act or certificate of a majority is effective in all respects as the decision, act
or certificate of all. Any report or certificate made by the inspectors of election is prima facie evidence of the facts stated therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;III
&mdash;DIRECTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">POWERS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the provisions
of the DGCL and any limitations in the certificate of incorporation relating to action required to be approved by the stockholders or
by the outstanding shares, the business and affairs of the Corporation shall be managed and all corporate powers shall be exercised by
or under the direction of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">NUMBER OF DIRECTORS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The authorized number of directors
shall be determined from time to time by resolution of the Board, provided the Board shall consist of at least one (1)&nbsp;member. No
reduction of the authorized number of directors shall have the effect of removing any director before that director&rsquo;s term of office
expires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as provided in Section&nbsp;3.4
of these bylaws, each director, including, without limitation, a director elected to fill a vacancy, shall hold office until the expiration
of the term for which elected and until such director&rsquo;s successor is elected and qualified or until such director&rsquo;s earlier
death, resignation or removal. Directors need not be stockholders unless so required by the certificate of incorporation or these bylaws.
The Corporation may also have, at the discretion of the Board, a chairperson of the Board and a vice chairperson of the Board. The certificate
of incorporation or these bylaws may prescribe other qualifications for directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If so provided in the certificate
of incorporation, the directors of the Corporation shall be divided into three (3)&nbsp;classes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.4</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">RESIGNATION AND VACANCIES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any director of the Corporation
may resign at any time, by giving written notice to the chairperson of the Board of Directors, the Corporation&rsquo;s chief executive
officer, president or secretary. Such resignation shall take effect at the time therein specified or, if no time is specified, immediately;
and, unless otherwise specified in such notice, the acceptance of such resignation shall not be necessary to make it effective. When one
or more directors so resigns and the resignation is effective at a future date, a majority of the directors then in office, including
those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation
or resignations shall become effective, and each director so chosen shall hold office as provided in this section in the filling of other
vacancies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise provided
in the certificate of incorporation or these bylaws, vacancies and newly created directorships resulting from any increase in the authorized
number of directors shall, unless the Board determines by resolution that any such vacancies or newly created directorships shall be filled
by stockholders, be filled only by a majority of the directors then in office, although less than a quorum, or by a sole remaining director.
Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for
which the vacancy was created or occurred and until such director&rsquo;s successor shall have been elected and qualified. A vacancy in
the Board shall be deemed to exist under these bylaws in the case of the death, removal or resignation of any director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.5</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">PLACE OF MEETINGS; MEETINGS BY TELEPHONE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may hold meetings,
both regular and special, either within or outside the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise restricted
by the certificate of incorporation or these bylaws, members of the Board, or any committee designated by the Board, may participate in
a meeting of the Board, or any committee, by means of conference telephone or other communications equipment by means of which all persons
participating in the meeting can hear each other, and such participation in a meeting pursuant to this bylaw shall constitute presence
in person at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.6</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">REGULAR MEETINGS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regular meetings of the Board
may be held without notice at such time and at such place as shall from time to time be determined by the Board; <I>provided</I> that
any director who is absent when such determination is made shall be given notice of the determination. A regular meeting of the Board
may be held without notice immediately after and at the same place as the annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.7</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">SPECIAL MEETINGS; NOTICE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Special meetings of the Board
for any purpose or purposes may be called at any time by the chairperson of the Board, the chief executive officer, the president, the
secretary or a majority of the authorized number of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notice of the time and place
of special meetings shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>delivered
personally by hand, by courier or by telephone;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>sent
by United States first-class mail, postage prepaid;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>sent
by facsimile; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>sent
by electronic mail,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">directed to each director at that director&rsquo;s
address, telephone number, facsimile number or electronic mail address, as the case may be, as shown on the Corporation&rsquo;s records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the notice is (a)&nbsp;delivered
personally by hand, by courier or by telephone, (b)&nbsp;sent by facsimile or (c)&nbsp;sent by electronic mail, it shall be delivered
or sent at least twenty-four (24) hours before the time of the holding of the meeting or such shorter period of time as sufficient for
the convenient assembly of the directors so notified. If the notice is sent by United States mail, it shall be deposited in the United
States mail at least four (4)&nbsp;days before the time of the holding of the meeting. Any oral notice may be communicated to the director.
The notice need not specify the place of the meeting (if the meeting is to be held at the Corporation&rsquo;s principal executive office)
nor the purpose of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.8</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">QUORUM.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The greater of (a)&nbsp;a
majority of the directors at any time in office and (b)&nbsp;one-third of the number of directors established by the Board pursuant to
Section&nbsp;3.2 of these bylaws shall constitute a quorum of the Board for the transaction of business. The vote of a majority of the
directors present at any meeting at which a quorum is present shall be the act of the Board, except as may be otherwise specifically provided
by statute, the certificate of incorporation or these bylaws. If a quorum is not present at any meeting of the Board, then the directors
present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.9</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">BOARD ACTION BY CONSENT WITHOUT A MEETING.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise restricted
by the certificate of incorporation or these bylaws, any action required or permitted to be taken at any meeting of the Board, or of any
committee thereof, may be taken without a meeting if all members of the Board or committee, as the case may be, consent thereto in writing
or by electronic transmission and the writing or writings or electronic transmission or transmissions are filed with the minutes of proceedings
of the Board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form
if the minutes are maintained in electronic form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.10</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">FEES AND COMPENSATION OF DIRECTORS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise restricted
by the certificate of incorporation or these bylaws, the Board shall have the authority to fix the compensation of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.11</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">REMOVAL OF DIRECTORS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the rights of the
holders of the shares of any series of Preferred Stock, the Board or any individual director may be removed from office only for cause
and only by the affirmative vote of the holders of at least two-thirds in voting power of the outstanding shares of capital stock of the
Corporation entitled to vote thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.12</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase; color: red"><STRIKE>SPECIAL GOVERNANCE PROVISIONS</STRIKE></FONT><FONT STYLE="text-decoration: underline double; text-transform: uppercase; color: blue">[RESERVED]</FONT><FONT STYLE="text-transform: uppercase">.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>For purposes
of this Section&nbsp;3.12, the following terms shall have the following meanings:</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>(a)&nbsp;&ldquo;<I>Macrocure
Designated Director</I>&rdquo; means each of the M-CO Designees, as such term is defined in the Merger Agreement;</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: red"><STRIKE>(b)&nbsp;&ldquo;<I>Merger
Agreement</I>&rdquo; means that certain Agreement and Plan of Merger, dated </STRIKE></FONT><FONT STYLE="color: green"><STRIKE>as of </STRIKE></FONT><FONT STYLE="color: red"><STRIKE>August&nbsp;29,
2016, among the Corporation, M-CO Merger Sub Ltd., a company formed under the laws of the State of Israel and registered under No.&nbsp;515506855
with the Israeli Registrar of Companies, and Macrocure Ltd., a company formed under the laws of the State of Israel and registered under
No.&nbsp;514083765 with the Israeli Registrar of Companies, as such Agreement and Plan of Merger may be amended or modified from time
to time;</STRIKE></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>(c)&nbsp;&ldquo;<I>Special
Governance Term</I>&rdquo; means a period of two years commencing on the effective date of the Transaction and terminating on the earlier
to occur of (1)&nbsp;the second (2nd) anniversary of such effective date and (2)&nbsp;the date on which there is no Macrocure Designated
Director serving as a member of the Board; and</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>(d)&nbsp;&ldquo;<I>Transaction</I>&rdquo;
means the merger effected pursuant to the Merger Agreement.</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>During
the Special Governance Term, (i)&nbsp;the Board shall designate and maintain a committee of the Board referred to as the &ldquo;<I>Pricing
Committee;</I>&rdquo; and (ii)&nbsp;the members of the Pricing Committee shall include at least one of the then serving Macrocure Designated
Directors, and at least one other member of the Board that is not a partner, member, stockholder or employee of any entity or person that
(1)&nbsp;was a stockholder of the Corporation immediately prior to the consummation of the Transaction or an affiliate of such a stockholder
and (2)&nbsp;is participating in a Related Party Financing (as defined below) as an investor (each such person being referred to as a
&ldquo;Related Party Director&rdquo;).</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>During
the Special Governance Term, the Corporation shall not engage in any equity financing transaction with an entity or person that was a
stockholder of the Corporation immediately prior to the consummation of the Transaction, or is an affiliate of any such entity or person,
(a &ldquo;<I>Related Party Financing</I>&rdquo;) unless such Related Party Financing has received the prior approval of the Pricing Committee,
by a vote that includes the affirmative vote of a majority of the members of the Pricing Committee who are not Related Party Directors.
With respect to any Related Party Financing, the Corporation shall provide all members of the Pricing Committee at least five (5)&nbsp;business
days&rsquo; notice in advance of any meeting at which the Pricing Committee will be asked to consider and approve such Related Party Financing.</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: red"><STRIKE>This Section&nbsp;3.12
shall automatically terminate and be of no further force and effect from and after the conclusion of the Special Governance Term.</STRIKE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;IV
&mdash;COMMITTEES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">COMMITTEES OF DIRECTORS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may designate one
(1)&nbsp;or more committees, each committee to consist of one (1)&nbsp;or more of the directors of the Corporation. The Board may designate
one (1)&nbsp;or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting
of the committee. In the absence or disqualification of a member of a committee, the member or members thereof present at any meeting
and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of
the Board to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in
the resolution of the Board or in these bylaws, shall have and may exercise all the powers and authority of the Board in the management
of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers that may require
it; but no such committee shall have the power or authority to (a)&nbsp;approve or adopt, or recommend to the stockholders, any action
or matter (other than the election or removal of directors) expressly required by the DGCL to be submitted to stockholders for approval,
or (b)&nbsp;adopt, amend or repeal any bylaw of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">COMMITTEE MINUTES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each committee shall keep
regular minutes of its meetings and report the same to the Board when required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.3</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">MEETINGS AND ACTION OF COMMITTEES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Meetings and actions of committees
shall be governed by, and held and taken in accordance with, the provisions of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Section&nbsp;3.5
of these bylaws (place of meetings and meetings by telephone);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Section&nbsp;3.6
of these bylaws (regular meetings);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Section&nbsp;3.7
of these bylaws (special meetings and notice);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Section&nbsp;3.8
of these bylaws (quorum);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Section&nbsp;7.12
of these bylaws (waiver of notice); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT>Section&nbsp;3.9
of these bylaws (action without a meeting),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">with such changes in the context of those bylaws
as are necessary to substitute the committee and its members for the Board and its members. <I>However</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>the
time of regular meetings of committees may be determined either by resolution of the Board or by resolution of the committee;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>special
meetings of committees may also be called by resolution of the Board; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>notice
of special meetings of committees shall also be given to all alternate members, who shall have the right to attend all meetings of the
committee. The Board may adopt rules&nbsp;for the government of any committee not inconsistent with the provisions of these bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;V
&mdash;OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">OFFICERS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The officers of the Corporation
shall be a president, treasurer and a secretary. The Corporation may also have, at the discretion of the Board, a chief executive officer,
a chief financial officer, one (1)&nbsp;or more vice presidents, one (1)&nbsp;or more assistant vice presidents, one (1)&nbsp;or more
assistant treasurers, one (1)&nbsp;or more assistant secretaries, and any such other officers as may be appointed in accordance with the
provisions of these bylaws. Any number of offices may be held by the same person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">APPOINTMENT OF OFFICERS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board shall appoint the
officers of the Corporation, except such officers as may be appointed in accordance with the provisions of Section&nbsp;5.3 of these bylaws,
subject to the rights, if any, of an officer under any contract of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.3</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">SUBORDINATE OFFICERS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may appoint, or
empower the chief executive officer or, in the absence of a chief executive officer, the president, to appoint, such other officers and
agents as the business of the Corporation may require. Each of such officers and agents shall hold office for such period, have such authority,
and perform such duties as are provided in these bylaws or as the Board may from time to time determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.4</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">REMOVAL AND RESIGNATION OF OFFICERS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the rights, if
any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by the Board at any regular
or special meeting of the Board or, except in the case of an officer chosen by the Board, by any officer upon whom such power of removal
may be conferred by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any officer may resign at
any time by giving written notice to the Corporation. Any resignation shall take effect at the date of the receipt of that notice or at
any later time specified in that notice. Unless otherwise specified in the notice of resignation, the acceptance of the resignation shall
not be necessary to make it effective. Any resignation is without prejudice to the rights, if any, of the Corporation under any contract
to which the officer is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.5</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">VACANCIES IN OFFICES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any vacancy occurring in any
office of the Corporation shall be filled by the Board or as provided in Section&nbsp;5.3 of these bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.6</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">REPRESENTATION OF SHARES OF OTHER CORPORATIONS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The chairperson of the Board,
the president, any vice president, the treasurer, the secretary or assistant secretary of this Corporation, or any other person authorized
by the Board or the president or a vice president, is authorized to vote, represent and exercise on behalf of this Corporation all rights
incident to any and all securities of any other entity or entities standing in the name of this Corporation. The authority granted herein
may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly executed
by such person having the authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">5.7</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">AUTHORITY AND DUTIES OF OFFICERS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All officers of the Corporation
shall respectively have such authority and perform such duties in the management of the business of the Corporation as may be designated
from time to time by the Board and, to the extent not so provided, as generally pertain to their respective offices, subject to the control
of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;VI
&mdash;RECORDS AND REPORTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">MAINTENANCE OF RECORDS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation shall, either
at its principal executive office or at such place or places as designated by the Board, keep a record of its stockholders listing their
names and addresses and the number and class of shares held by each stockholder, a copy of these bylaws as amended to date, accounting
books and other records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;VII
&mdash;GENERAL MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board, except as otherwise
provided in these bylaws, may authorize any officer or officers, or agent or agents, to enter into any contract or execute any instrument
in the name of and on behalf of the Corporation; such authority may be general or confined to specific instances. Unless so authorized
or ratified by the Board or within the agency power of an officer, no officer, agent or employee shall have any power or authority to
bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.2</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">STOCK CERTIFICATES; PARTLY PAID SHARES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of the Corporation
shall be represented by certificates or shall be uncertificated. Certificates for the shares of stock, if any, shall be in such form as
is consistent with the certificate of incorporation and applicable law. Every holder of stock represented by a certificate shall be entitled
to have a certificate signed by, or in the name of the Corporation by the chairperson or vice-chairperson of the Board, or the president
or vice-president, and by the treasurer or an assistant treasurer, or the secretary or an assistant secretary of the Corporation representing
the number of shares registered in certificate form. Any or all of the signatures on the certificate may be a facsimile. In case any officer,
transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer,
transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if he were
such officer, transfer agent or registrar at the date of issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation may issue
the whole or any part of its shares as partly paid and subject to call for the remainder of the consideration to be paid therefor. Upon
the face or back of each stock certificate issued to represent any such partly paid shares, or upon the books and records of the Corporation
in the case of uncertificated partly paid shares, the total amount of the consideration to be paid therefor and the amount paid thereon
shall be stated. Upon the declaration of any dividend on fully paid shares, the Corporation shall declare a dividend upon partly paid
shares of the same class, but only upon the basis of the percentage of the consideration actually paid thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.3</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">SPECIAL DESIGNATION ON CERTIFICATES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Corporation is authorized
to issue more than one class of stock or more than one series of any class, then the powers, the designations, the preferences and the
relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations
or restrictions of such preferences and/or rights shall be set forth in full or summarized on the face or back of the certificate that
the Corporation shall issue to represent such class or series of stock; <I>provided</I>, <I>however</I>, that, except as otherwise provided
in Section&nbsp;202 of the DGCL, in lieu of the foregoing requirements, there may be set forth on the face or back of the certificate
that the Corporation shall issue to represent such class or series of stock a statement that the Corporation will furnish without charge
to each stockholder who so requests the powers, the designations, the preferences and the relative, participating, optional or other special
rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.4</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">LOST CERTIFICATES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as provided in this
Section&nbsp;7.4, no new certificates for shares shall be issued to replace a previously issued certificate unless the latter is surrendered
to the Corporation and cancelled at the same time. The Corporation may issue a new certificate of stock or uncertificated shares in the
place of any certificate theretofore issued by it, alleged to have been lost, stolen or destroyed, and the Corporation may require the
owner of the lost, stolen or destroyed certificate, or such owner&rsquo;s legal representative, to give the Corporation a bond sufficient
to indemnify it against any claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate
or the issuance of such new certificate or uncertificated shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.5</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">CONSTRUCTION; DEFINITIONS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the context requires
otherwise, the general provisions, rules&nbsp;of construction and definitions in the DGCL shall govern the construction of these bylaws.
Without limiting the generality of this provision, the singular number includes the plural, the plural number includes the singular, and
the term &ldquo;person&rdquo; includes both a corporation and a natural person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.6</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">DIVIDENDS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board, subject to any
restrictions contained in either (a)&nbsp;the DGCL or (b)&nbsp;the certificate of incorporation, may declare and pay dividends upon the
shares of its capital stock. Dividends may be paid in cash, in property or in shares of the Corporation&rsquo;s capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may set apart out
of any of the funds of the Corporation available for dividends a reserve or reserves for any proper purpose and may abolish any such reserve.
Such purposes shall include but not be limited to equalizing dividends, repairing or maintaining any property of the Corporation, and
meeting contingencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.7</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">FISCAL YEAR.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fiscal year of the Corporation
shall be fixed by resolution of the Board and may be changed by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.8</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">SEAL.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation may adopt
a corporate seal, which shall be adopted and which may be altered by the Board. The Corporation may use the corporate seal by causing
it or a facsimile thereof to be impressed or affixed or in any other manner reproduced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.9</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">TRANSFER OF STOCK.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shares of the Corporation
shall be transferable in the manner prescribed by law and in these bylaws. Shares of stock of the Corporation shall be transferred on
the books of the Corporation only by the holder of record thereof or by such holder&rsquo;s attorney duly authorized in writing, upon
surrender to the Corporation of the certificate or certificates representing such shares endorsed by the appropriate person or persons
(or by delivery of duly executed instructions with respect to uncertificated shares), with such evidence of the authenticity of such endorsement
or execution, transfer, authorization and other matters as the Corporation may reasonably require, and accompanied by all necessary stock
transfer stamps. No transfer of stock shall be valid as against the Corporation for any purpose until it shall have been entered in the
stock records of the Corporation by an entry showing the names of the persons from and to whom it was transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.10</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">STOCK TRANSFER AGREEMENTS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation shall have
power to enter into and perform any agreement with any number of stockholders of any one or more classes of stock of the Corporation to
restrict the transfer of shares of stock of the Corporation of any one or more classes owned by such stockholders in any manner not prohibited
by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.11</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">REGISTERED STOCKHOLDERS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>shall
be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends and to vote
as such owner;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>shall
be entitled to hold liable for calls and assessments the person registered on its books as the owner of shares; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>shall
not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of another person, whether or
not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">7.12</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">WAIVER OF NOTICE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whenever notice is required
to be given under any provision of the DGCL, the certificate of incorporation or these bylaws, a written waiver, signed by the person
entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time of the event
for which notice is to be given, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of
notice of such meeting, except when the person attends a meeting for the express purpose of objecting at the beginning of the meeting,
to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor
the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice or any waiver by
electronic transmission unless so required by the certificate of incorporation or these bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;VIII
&mdash;NOTICE BY ELECTRONIC TRANSMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">NOTICE BY ELECTRONIC TRANSMISSION.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Without limiting the manner
by which notice otherwise may be given effectively to stockholders pursuant to the DGCL, the certificate of incorporation or these bylaws,
any notice to stockholders given by the Corporation under any provision of the DGCL, the certificate of incorporation or these bylaws
shall be effective if given by a form of electronic transmission consented to by the stockholder to whom the notice is given. Any such
consent shall be revocable by the stockholder by written notice to the Corporation. Any such consent shall be deemed revoked if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>the
Corporation is unable to deliver by electronic transmission two (2)&nbsp;consecutive notices given by the Corporation in accordance with
such consent; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>such
inability becomes known to the secretary or an assistant secretary of the Corporation or to the transfer agent, or other person responsible
for the giving of notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, the inadvertent failure to treat such
inability as a revocation shall not invalidate any meeting or other action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any notice given pursuant
to the preceding paragraph shall be deemed given:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>if
by facsimile telecommunication, when directed to a number at which the stockholder has consented to receive notice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>if
by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>if
by a posting on an electronic network together with separate notice to the stockholder of such specific posting, upon the later of (i)&nbsp;such
posting and (ii)&nbsp;the giving of such separate notice; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>if
by any other form of electronic transmission, when directed to the stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An affidavit of the secretary
or an assistant secretary of the Corporation or of the transfer agent or other agent of the Corporation that the notice has been given
by a form of electronic transmission shall, in the absence of fraud, be prima facie evidence of the facts stated therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">8.2</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">DEFINITION OF ELECTRONIC TRANSMISSION.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the purposes of these
bylaws, an &ldquo;electronic transmission&rdquo; means any form of communication, not directly involving the physical transmission of
paper, that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that may be directly reproduced
in paper form by such a recipient through an automated process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;IX
&mdash;INDEMNIFICATION AND ADVANCEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.1</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">ACTIONS, SUITS AND PROCEEDINGS OTHER THAN BY OR IN THE RIGHT OF
THE CORPORATION.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation shall indemnify
each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation) by reason of the
fact that he or she is or was, or has agreed to become, a director or officer of the Corporation, or, while a director or officer of the
Corporation, is or was serving, or has agreed to serve, at the request of the Corporation, as a director, officer, partner, employee or
trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (including, without
limitation, any employee benefit plan) (all such persons being referred to hereafter as an &ldquo;<I>Indemnitee</I>&rdquo;), or by reason
of any action alleged to have been taken or omitted in such capacity, against all expenses (including, without limitation, attorneys&rsquo;
fees), liabilities, losses, judgments, fines (including, without limitation, excise taxes and penalties arising under the Employee Retirement
Income Security Act of 1974), and amounts paid in settlement actually and reasonably incurred by or on behalf of Indemnitee in connection
with such action, suit or proceeding and any appeal therefrom, if Indemnitee acted in good faith and in a manner which Indemnitee reasonably
believed to be in, or not opposed to, the best interests of the Corporation, and, with respect to any criminal action or proceeding, had
no reasonable cause to believe his or her conduct was unlawful. The termination of any action, suit or proceeding by judgment, order,
settlement, conviction or upon a plea of <I>nolo contendere</I> or its equivalent, shall not, of itself, create a presumption that Indemnitee
did not act in good faith and in a manner which Indemnitee reasonably believed to be in, or not opposed to, the best interests of the
Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his or her conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of any determination
under Sections 9.1 and 9.2 of this Article&nbsp;IX, a person shall be deemed to have acted in good faith and in a manner such person reasonably
believed to be in or not opposed to the best interests of the Corporation, or, with respect to any criminal action or proceeding, to have
had no reasonable cause to believe such person&rsquo;s conduct was unlawful, if such person&rsquo;s action is based on the records or
books of account of the Corporation or another enterprise, or on information supplied to such person by the officers of the Corporation
or another enterprise in the course of their duties, or on the advice of legal counsel for the Corporation or another enterprise or on
information or records given or reports made to the Corporation or another enterprise by an independent certified public accountant or
by an appraiser or other expert selected with reasonable care by the Corporation or another enterprise. The provisions of this paragraph
shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable
standard of conduct set forth in Section&nbsp;9.1 or Section&nbsp;9.2 of this Article&nbsp;IX, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.2</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">ACTIONS OR SUITS BY OR IN THE RIGHT OF THE CORPORATION.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation shall indemnify
any Indemnitee who was or is a party to or threatened to be made a party to any threatened, pending or completed action or suit by or
in the right of the Corporation to procure a judgment in its favor by reason of the fact that Indemnitee is or was, or has agreed to become,
a director or officer of the Corporation, or, while a director or officer of the Corporation, is or was serving, or has agreed to serve,
at the request of the Corporation, as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation,
partnership, joint venture, trust or other enterprise (including, without limitation, any employee benefit plan), or by reason of any
action alleged to have been taken or omitted in such capacity, against all expenses (including, without limitation, attorneys&rsquo; fees)
actually and reasonably incurred by or on behalf of Indemnitee in connection with such action, suit or proceeding and any appeal therefrom,
if Indemnitee acted in good faith and in a manner which Indemnitee reasonably believed to be in, or not opposed to, the best interests
of the Corporation, except that no indemnification shall be made under this Section&nbsp;9.2 in respect of any claim, issue or matter
as to which Indemnitee shall have been adjudged to be liable to the Corporation, unless, and only to the extent, that the Court of Chancery
of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of such
liability but in view of all the circumstances of the case,&nbsp;Indemnitee is fairly and reasonably entitled to indemnity for such expenses
(including, without limitation, attorneys&rsquo; fees) which the Court of Chancery of Delaware or such other court shall deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.3</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">INDEMNIFICATION FOR EXPENSES OF SUCCESSFUL PARTY.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding any other
provisions of this Article&nbsp;IX, to the extent that an Indemnitee has been successful, on the merits or otherwise, in defense of any
action, suit or proceeding referred to in Sections 9.1 and 9.2 of these bylaws, or in defense of any claim, issue or matter therein, or
on appeal from any such action, suit or proceeding,&nbsp;Indemnitee shall be indemnified against all expenses (including, without limitation,
attorneys&rsquo; fees) actually and reasonably incurred by or on behalf of Indemnitee in connection therewith. Without limiting the foregoing,
if any action, suit or proceeding is disposed of, on the merits or otherwise (including, without limitation, a disposition without prejudice),
without (a)&nbsp;the disposition being adverse to Indemnitee, (b)&nbsp;an adjudication that Indemnitee was liable to the Corporation,
(c)&nbsp;a plea of guilty or <I>nolo contendere</I> by Indemnitee, (d)&nbsp;an adjudication that Indemnitee did not act in good faith
and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Corporation and (e)&nbsp;with respect
to any criminal proceeding, an adjudication that Indemnitee had reasonable cause to believe his or her conduct was unlawful,&nbsp;Indemnitee
shall be considered for the purposes hereof to have been wholly successful with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.4</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">NOTIFICATION AND DEFENSE OF CLAIM.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a condition precedent to
an Indemnitee&rsquo;s right to be indemnified, such Indemnitee must notify the Corporation in writing as soon as practicable of any action,
suit, proceeding or investigation involving such Indemnitee for which indemnity will or could be sought. With respect to any action, suit,
proceeding or investigation of which the Corporation is so notified, the Corporation will be entitled to participate therein at its own
expense and/or to assume the defense thereof at its own expense, with legal counsel reasonably acceptable to Indemnitee. After notice
from the Corporation to Indemnitee of its election so to assume such defense, the Corporation shall not be liable to Indemnitee for any
legal or other expenses subsequently incurred by Indemnitee in connection with such action, suit, proceeding or investigation, other than
as provided below in this Section&nbsp;9.4. Indemnitee shall have the right to employ his or her own counsel in connection with such action,
suit, proceeding or investigation, but the fees and expenses of such counsel incurred after notice from the Corporation of its assumption
of the defense thereof shall be at the expense of Indemnitee unless (a)&nbsp;the employment of counsel by Indemnitee has been authorized
by the Corporation, (b)&nbsp;counsel to Indemnitee shall have reasonably concluded that there may be a conflict of interest or position
on any significant issue between the Corporation and Indemnitee in the conduct of the defense of such action, suit, proceeding or investigation
or (c)&nbsp;the Corporation shall not in fact have employed counsel to assume the defense of such action, suit, proceeding or investigation,
in each of which cases the fees and expenses of counsel for Indemnitee shall be at the expense of the Corporation, except as otherwise
expressly provided by this Article&nbsp;IX. The Corporation shall not be entitled, without the consent of Indemnitee, to assume the defense
of any claim brought by or in the right of the Corporation or as to which counsel for Indemnitee shall have reasonably made the conclusion
provided for in clause (b)&nbsp;above. The Corporation shall not be required to indemnify Indemnitee under this Article&nbsp;IX for any
amounts paid in settlement of any action, suit, proceeding or investigation effected without its written consent. The Corporation shall
not settle any action, suit, proceeding or investigation in any manner which would impose any penalty or limitation on Indemnitee without
Indemnitee&rsquo;s written consent. Neither the Corporation nor Indemnitee will unreasonably withhold or delay its consent to any proposed
settlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.5</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">ADVANCE OF EXPENSES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the provisions
of Sections 9.4 and 9.6 of these bylaws, in the event of any threatened or pending action, suit, proceeding or investigation of which
the Corporation receives notice under this Article&nbsp;IX, any expenses (including, without limitation, attorneys&rsquo; fees) incurred
by or on behalf of Indemnitee in defending an action, suit, proceeding or investigation or any appeal therefrom shall be paid by the Corporation
in advance of the final disposition of such matter; <I>provided</I>, <I>however</I>, that the payment of such expenses incurred by or
on behalf of Indemnitee in advance of the final disposition of such matter shall be made only upon receipt of an undertaking by or on
behalf of Indemnitee to repay all amounts so advanced in the event that it shall ultimately be determined by final judicial decision from
which there is no further right to appeal that Indemnitee is not entitled to be indemnified by the Corporation as authorized in this Article&nbsp;IX;
and <I>provided further</I> that no such advancement of expenses shall be made under this Article&nbsp;IX if it is determined (in the
manner described in Section&nbsp;9.6 of these bylaws) that (a)&nbsp;Indemnitee did not act in good faith and in a manner he or she reasonably
believed to be in, or not opposed to, the best interests of the Corporation, or (b)&nbsp;with respect to any criminal action or proceeding,&nbsp;Indemnitee
had reasonable cause to believe his or her conduct was unlawful. Such undertaking shall be accepted without reference to the financial
ability of Indemnitee to make such repayment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.6</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">PROCEDURE FOR INDEMNIFICATION AND ADVANCEMENT OF EXPENSES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to obtain indemnification
or advancement of expenses pursuant to Section&nbsp;9.1, 9.2, 9.3 or 9.5 of these bylaws, an Indemnitee shall submit to the Corporation
a written request. Any such advancement of expenses shall be made promptly, and in any event within 60 days after receipt by the Corporation
of the written request of Indemnitee, unless (a)&nbsp;the Corporation has assumed the defense pursuant to Section&nbsp;9.4 of these bylaws
(and none of the circumstances described in Section&nbsp;9.4 of these bylaws that would nonetheless entitle the Indemnitee to indemnification
for the fees and expenses of separate counsel have occurred) or (b)&nbsp;the Corporation determines within such 60-day period that Indemnitee
did not meet the applicable standard of conduct set forth in Section&nbsp;9.1, 9.2 or 9.5 of these bylaws, as the case may be. Any such
indemnification, unless ordered by a court, shall be made with respect to requests under Section&nbsp;9.1 or 9.2 of these bylaws only
as authorized in the specific case upon a determination by the Corporation that the indemnification of Indemnitee is proper because Indemnitee
has met the applicable standard of conduct set forth in Section&nbsp;9.1 or 9.2 of these bylaws, as the case may be. Such determination
shall be made in each instance (a)&nbsp;by a majority vote of the directors of the Corporation consisting of persons who are not at that
time parties to the action, suit or proceeding in question (&ldquo;<I>disinterested directors</I>&rdquo;), whether or not a quorum, (b)&nbsp;by
a committee of disinterested directors designated by majority vote of disinterested directors, whether or not a quorum, (c)&nbsp;if there
are no disinterested directors, or if the disinterested directors so direct, by independent legal counsel (who may, to the extent permitted
by law, be regular legal counsel to the Corporation) in a written opinion or (d)&nbsp;by the stockholders of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.7</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">REMEDIES.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The right to indemnification
or advancement of expenses as granted by this Article&nbsp;IX shall be enforceable by Indemnitee in any court of competent jurisdiction.
Neither the failure of the Corporation to have made a determination prior to the commencement of such action that indemnification is proper
in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Corporation pursuant
to Section&nbsp;9.6 of these bylaws that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action
or create a presumption that Indemnitee has not met the applicable standard of conduct. In any suit brought by Indemnitee to enforce a
right to indemnification or advancement, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of
an undertaking, the Corporation shall have the burden of proving that Indemnitee is not entitled to be indemnified, or to such advancement
of expenses, under this Article&nbsp;IX. Indemnitee&rsquo;s expenses (including, without limitation, attorneys&rsquo; fees) reasonably
incurred in connection with successfully establishing Indemnitee&rsquo;s right to indemnification or advancement, in whole or in part,
in any such proceeding shall also be indemnified by the Corporation to the fullest extent permitted by law. Notwithstanding the foregoing,
in any suit brought by Indemnitee to enforce a right to indemnification hereunder it shall be a defense that the Indemnitee has not met
any applicable standard for indemnification set forth in the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.8</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">LIMITATIONS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything to
the contrary in this Article&nbsp;IX, except as set forth in Section&nbsp;9.7 of these bylaws, the Corporation shall not indemnify an
Indemnitee pursuant to this Article&nbsp;IX in connection with a proceeding (or part thereof) initiated by such Indemnitee unless the
initiation thereof was approved by the Board. Notwithstanding anything to the contrary in this Article&nbsp;IX, the Corporation shall
not indemnify (or advance expenses to) an Indemnitee to the extent such Indemnitee is reimbursed (or advanced expenses) from the proceeds
of insurance, and in the event the Corporation makes any indemnification (or advancement) payments to an Indemnitee and such Indemnitee
is subsequently reimbursed from the proceeds of insurance, such Indemnitee shall promptly refund indemnification (or advancement) payments
to the Corporation to the extent of such insurance reimbursement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.9</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">SUBSEQUENT AMENDMENT.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No amendment, termination
or repeal of this Article&nbsp;IX or of the relevant provisions of the DGCL or any other applicable laws shall adversely affect or diminish
in any way the rights of any Indemnitee to indemnification or advancement of expenses under the provisions hereof with respect to any
action, suit, proceeding or investigation arising out of or relating to any actions, transactions or facts occurring prior to the final
adoption of such amendment, termination or repeal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.10</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">OTHER RIGHTS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indemnification and advancement
of expenses provided by this Article&nbsp;IX shall not be deemed exclusive of any other rights to which an Indemnitee seeking indemnification
or advancement of expenses may be entitled under any law (common or statutory), agreement or vote of stockholders or disinterested directors
or otherwise, both as to action in Indemnitee&rsquo;s official capacity and as to action in any other capacity while holding office for
the Corporation, and shall continue as to an Indemnitee who has ceased to be a director or officer, and shall inure to the benefit of
the estate, heirs, executors and administrators of Indemnitee. Nothing contained in this Article&nbsp;IX shall be deemed to prohibit,
and the Corporation is specifically authorized to enter into, agreements with officers and directors providing indemnification and advancement
rights and procedures different from those set forth in this Article&nbsp;IX. In addition, the Corporation may, to the extent authorized
from time to time by the Board, grant indemnification and advancement rights to other employees or agents of the Corporation or other
persons serving the Corporation and such rights may be equivalent to, or greater or less than, those set forth in this Article&nbsp;IX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.11</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">PARTIAL INDEMNIFICATION.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Indemnitee is entitled
under any provision of this Article&nbsp;IX to indemnification by the Corporation for some or a portion of the expenses (including, without
limitation, attorneys&rsquo; fees), liabilities, losses, judgments, fines (including, without limitation, excise taxes and penalties arising
under the Employee Retirement Income Security Act of 1974) or amounts paid in settlement actually and reasonably incurred by or on behalf
of Indemnitee in connection with any action, suit, proceeding or investigation and any appeal therefrom but not, however, for the total
amount thereof, the Corporation shall nevertheless indemnify Indemnitee for the portion of such expenses (including, without limitation,
attorneys&rsquo; fees), liabilities, losses, judgments, fines (including, without limitation, excise taxes and penalties arising under
the Employee Retirement Income Security Act of 1974) or amounts paid in settlement to which Indemnitee is entitled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.12</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">INSURANCE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation may purchase
and maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation,
partnership, joint venture, trust or other enterprise (including, without limitation, any employee benefit plan) against any expense,
liability or loss incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation
would have the power to indemnify such person against such expense, liability or loss under the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.13</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">SAVINGS CLAUSE.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Article&nbsp;IX or
any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the Corporation shall nevertheless
indemnify each Indemnitee as to any expenses (including, without limitation, attorneys&rsquo; fees), liabilities, losses, judgments, fines
(including, without limitation, excise taxes and penalties arising under the Employee Retirement Income Security Act of 1974) and amounts
paid in settlement in connection with any action, suit, proceeding or investigation, whether civil, criminal or administrative, including,
without limitation, an action by or in the right of the Corporation, to the fullest extent permitted by any applicable portion of this
Article&nbsp;IX that shall not have been invalidated and to the fullest extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">9.14</TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase">DEFINITIONS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Terms used in this Article&nbsp;IX
and defined in Section&nbsp;145(h)&nbsp;and Section&nbsp;145(i)&nbsp;of the DGCL shall have the respective meanings assigned to such terms
in such Section&nbsp;145(h)&nbsp;and Section&nbsp;145(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;X
&mdash;AMENDMENTS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the limitations
set forth in Section&nbsp;9.9 of these bylaws or the provisions of the certificate of incorporation, the Board is expressly empowered
to adopt, amend or repeal the bylaws of the Corporation<FONT STYLE="color: red"><STRIKE>; <I>provided</I>, <I>however</I>, that during
the Special Governance Term, any amendment or repeal of Section&nbsp;3.12 of these bylaws shall require the approval of the Board (including
the affirmative vote of at least one Macrocure Designated Director, provided that there is at least one Macrocure Director serving as
a member of the Board at the time of such approval)</STRIKE></FONT>. The stockholders also shall have power to adopt, amend or repeal
the bylaws of the Corporation; <I>provided</I>, <I>however</I>, that, <FONT STYLE="color: red"><STRIKE>(i)&nbsp;</STRIKE></FONT>in addition
to any vote of the holders of any class or series of stock of the Corporation required by law or by the certificate of incorporation,
such action by stockholders shall require the affirmative vote of the holders of at least two-thirds in voting power of the outstanding
shares of capital stock of the Corporation entitled to vote thereon<FONT STYLE="color: red"><STRIKE>; and (ii)&nbsp;during the Special
Governance Term, the stockholders of the Corporation shall not have the right, or power, to amend or repeal all or any portion of Section&nbsp;3.12
of these bylaws other than by an affirmative vote of holders of 75% of the outstanding shares of Common Stock (it being understood and
agreed that any amendment or repeal of all or any portion of Section&nbsp;3.12 of these bylaws during the Special Governance Term without
such a vote shall be permitted only with the approval of the Board (including the affirmative vote of at least one Macrocure Designated
Director, provided that there is at least one Macrocure Designated Director serving as a member of the Board at the time of such approval.</STRIKE></FONT><FONT STYLE="text-decoration: underline double; color: blue">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><A NAME="ss03"></A>Exhibit 10.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEAP THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSULTING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Effective Date: November&nbsp;11, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>This Consulting Agreement</B>
(the &ldquo;<B><I>Agreement</I></B>&rdquo;) is made as of the Effective Date set forth above by and between Leap Therapeutics,&nbsp;Inc.
(&ldquo;<B><I>Client</I></B>&rdquo;) and the consultant named on the signature page&nbsp;hereto (&ldquo;<B><I>Consultant</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Engagement
of Services.</B> Client may issue Project Assignments to Consultant in the form attached to this Agreement as <B>Exhibit&nbsp;A</B> (each,
a &ldquo;<B><I>Project Assignment</I></B>&rdquo;). Subject to the terms of this Agreement, Consultant will render the services set forth
in Project Assignment(s)&nbsp;accepted by Consultant (the &ldquo;<B><I>Services</I></B>&rdquo;) by the completion dates set forth therein.
Except as otherwise provided in the applicable Project Assignment, Consultant will be free of control and direction from the Client (other
than general oversight and control over the results of the Services), and will have exclusive control over the manner and means of performing
the Services, including the choice of place and time. Consultant will provide, at Consultant&rsquo;s own expense, a place of work and
all equipment, tools and other materials necessary to complete the Services; however, to the extent necessary to facilitate performance
of the Services, Client may, in its discretion, make certain of its equipment or facilities available to Consultant at Consultant&rsquo;s
request. While on the Client&rsquo;s premises, Consultant agrees to comply with Client&rsquo;s then-current access rules&nbsp;and procedures,
including those related to safety, security and confidentiality. Consultant agrees and acknowledges that Consultant has no expectation
of privacy with respect to Client&rsquo;s telecommunications, networking or information processing systems (including stored computer
files, email messages and voice messages) and that Consultant&rsquo;s activities, including the sending or receiving of any files or messages,
on or using those systems may be monitored, and the contents of such files and messages may be reviewed and disclosed, at any time, without
notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Compensation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Consulting
Fees.</B> Client will pay Consultant the fee set forth in each Project Assignment for Services rendered pursuant to this Agreement as
Consultant&rsquo;s sole compensation for such Services (in addition to the equity compensation provided by Client to Consultant pursuant
to Section&nbsp;2.2 and Section&nbsp;2.3 below). If a Project Assignment for Services does not provide for the payment by Client to Consultant
of any fee for the Services to be rendered by Consultant to Client pursuant to such Project Assignment for Services, then Consultant&rsquo;s
sole compensation for rendering such Services shall be the equity compensation provided by Client to Consultant pursuant to Section&nbsp;2.2
and Section&nbsp;2.3 below. Consultant will be reimbursed only for expenses that are expressly provided for in a Project Assignment or
that have been approved in advance in writing by Client, provided Consultant has furnished such documentation for authorized expenses
as Client may reasonably request. Payment of Consultant&rsquo;s fees and expenses will be in accordance with the applicable Project Assignment.
Upon termination of this Agreement for any reason, Consultant will be paid fees on the basis stated in the Project Assignment(s)&nbsp;for
work that has been completed. Unless otherwise provided in a Project Assignment, payment to Consultant of undisputed fees will be due
30 days following Client&rsquo;s receipt of an invoice that contains accurate records of the work performed that are sufficient to substantiate
the invoiced fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;First
RSU Grant</B>.&#8239;&#8239;&#8239;&#8239;&nbsp;Subject to approval by the Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;)
or the Compensation Committee of the Board, Consultant shall be granted, as additional consideration and compensation for Consultant&rsquo;s
performance of the Services, an award of 2,411,700 restricted stock units (subject to proportionate and equitable adjustment upon any
stock split, stock dividend, reverse stock split, reclassification or other similar events with respect to the Company&rsquo;s common
stock, $0.001 par value per share (&ldquo;<B>Common Stock</B>&rdquo;), that is effected at any time after the date of this Agreement and
prior to such grant, the &ldquo;<B>First RSUs</B>&rdquo;) under or pursuant to an equity incentive plan of the Company, each of which
First RSUs shall entitle Consultant, upon settlement thereof in accordance with its terms, to one share of Common Stock. The First RSUs
shall vest according to the following schedule: 12/36th of the First RSUs will vest on October&nbsp;8, 2026, and 1/36th of the First RSUs
will vest each month thereafter on the 8th day of the applicable month, subject to Consultant&rsquo;s continuous and ongoing service provider
relationship with the Company through each such vesting date. The date on which the First RSUs shall be granted to Consultant (the &ldquo;<B>First
Grant Date</B>&rdquo;) shall be the date on which the Board or the Compensation Committee of the Board adopts a resolution granting the
First RSUs to Consultant. The grant of the First RSUs to Consultant shall be evidenced by a restricted stock unit grant agreement to be
entered into by the Company and Consultant on or as soon as practicable after the First Grant Date, which restricted stock unit grant
agreement shall have terms and conditions that are consistent with the provisions of this Section&nbsp;2.2. Settlement of any First RSUs
that vest in accordance with the terms set forth above in this Section&nbsp;2.2 shall be upon such terms and conditions as shall be set
forth in such restricted stock unit grant agreement, including terms providing that First RSUs that so vest shall not be settled on or
promptly after their respective applicable vesting dates but instead shall be settled on the earliest to occur after their respective
applicable vesting dates of (i)&nbsp;the Company&rsquo;s first payroll date on or after the date on which Consultant ceases to be a service
provider to the Company, (ii)&nbsp;the Company&rsquo;s first payroll date on or after June&nbsp;8 of the applicable calendar year, or
(iii)&nbsp;the Company&rsquo;s first payroll date on or after December&nbsp;8 of the applicable calendar year, unless the terms of such
restricted stock unit grant agreement expressly provide for a further delay, deferral or postponement of the settlement of any vested
First RSUs in accordance with such terms. The First RSUs shall be governed in all aspects by the equity plan of the Company under or pursuant
to which the First RSUs are granted to Consultant and by the restricted stock unit grant agreement entered by the Company and Consultant
with respect to the First RSUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>2.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Second
RSU Grant</B>.&#8239;&#8239;&#8239;&#8239;Subject to (i)&nbsp;the adoption of resolutions by the Company&rsquo;s stockholders to
amend the Company&rsquo;s certificate of incorporation to effect a reverse stock split of the Common Stock and/or to increase the number
of authorized shares of Common Stock to at least 490,000,000 shares of Common Stock, (ii)&nbsp;the adoption of resolutions by the Company&rsquo;s
stockholders to adopt a new equity plan with a sufficient number of shares of Common Stock in the pool, (iii)&nbsp;the Company having
registered the securities that can be granted pursuant to such plan with the Securities and Exchange Commission on a Registration Statement
on Form&nbsp;S-8, and (iv)&nbsp;approval by the Board or the Compensation Committee of the Board, Consultant shall be granted, as additional
consideration and compensation for Consultant&rsquo;s performance of the Services, an award of 3,036,457 restricted stock units (subject
to proportionate and equitable adjustment upon any stock split, stock dividend, reverse stock split, reclassification or other similar
events with respect to the Common Stock that is effected at any time after the date of this Agreement and prior to such grant, the &ldquo;<B>Second
RSUs</B>&rdquo;) under or pursuant to an equity incentive plan of the Company, each of which Second RSUs shall entitle Consultant, upon
settlement thereof in accordance with its terms, to one share of Common Stock. The Second RSUs shall vest according to the following schedule:
12/36th of the Second RSUs will vest on October&nbsp;8, 2026, and 1/36th of the Second RSUs will vest each month thereafter on the 8<SUP>th</SUP>
day of the applicable month, subject to Consultant&rsquo;s continuous and ongoing service provider relationship with the Company through
each such vesting date. The date on which the Second RSUs shall be granted to Consultant (the &ldquo;<B>Second Grant Date</B>&rdquo;)
shall be the date on which the Board or the Compensation Committee of the Board adopts a resolution granting the Second RSUs to Consultant.
The grant of the Second RSUs to Consultant shall be evidenced by a restricted stock unit grant agreement to be entered into by the Company
and Consultant on or as soon as practicable after the Second Grant Date, which restricted stock unit grant agreement shall have terms
and conditions that are consistent with the provisions of this Section&nbsp;2.3. Settlement of any Second RSUs that vest in accordance
with the terms set forth above in this Section&nbsp;2.3 shall be upon such terms and conditions as shall be set forth in such restricted
stock unit grant agreement, including terms providing that Second RSUs that so vest shall not be settled on or promptly after their respective
applicable vesting dates but instead shall be settled on the earliest to occur after their respective applicable vesting dates of (i)&nbsp;the
Company&rsquo;s first payroll date on or after the date on which Consultant ceases to be a service provider to the Company, (ii)&nbsp;the
Company&rsquo;s first payroll date on or after June&nbsp;8 of the applicable calendar year, or (iii)&nbsp;the Company&rsquo;s first payroll
date on or after December&nbsp;8 of the applicable calendar year, unless the terms of such restricted stock unit grant agreement expressly
provide for a further delay, deferral or postponement of the settlement of any vested Second RSUs in accordance with such terms. The Second
RSUs shall be governed in all aspects by the equity plan of the Company under or pursuant to which the Second RSUs are granted to Consultant
and by the restricted stock unit grant agreement entered by the Company and Consultant with respect to the Second RSUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Ownership
of Work Product.</B> Consultant hereby irrevocably assigns to Client all right, title and interest worldwide in and to any deliverables
specified in a Project Assignment and to any ideas, concepts, processes, discoveries, inventions, developments, formulae, information,
materials, improvements, designs, artwork, content, software programs, other works of authorship, and any other work product created,
conceived or developed by Consultant (whether alone or jointly with others) for Client during or before the term of this Agreement, including
all copyrights, patents, trademarks, trade secrets, and other intellectual property rights therein (including all rights to priority and
rights to file patent applications and/or registered designs) (collectively, the &ldquo;<B><I>Work Product</I></B>&rdquo;). Consultant
retains no rights to use the Work Product and agrees not to challenge the validity of Client&rsquo;s ownership of, or intellectual property
rights in, the Work Product. Consultant agrees to execute, at Client&rsquo;s request and expense, all documents and other instruments
necessary or desirable to confirm such assignment, including without limitation, any copyright assignment or patent assignment provided
by the Client. Consultant hereby irrevocably appoints Client as Consultant&rsquo;s attorney-in-fact for the purpose of executing such
documents on Consultant&rsquo;s behalf, which appointment is coupled with an interest. At Client&rsquo;s request, Consultant will promptly
record any such patent assignment with the United States Patent and Trademark Office. Client will reimburse Consultant for any reasonable
out-of-pocket expenses actually incurred by Consultant in fulfilling its obligations under this section. Consultant will deliver each
item of Work Product specified in each Project Assignment and disclose promptly in writing to Client all other Work Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Other
Rights.</B> If Consultant has any rights, including without limitation &ldquo;artist&rsquo;s rights&rdquo; or &ldquo;moral rights,&rdquo;
in the Work Product that cannot be assigned, Consultant hereby unconditionally and irrevocably grants to Client an exclusive (even as
to Consultant), worldwide, fully paid and royalty-free, irrevocable, perpetual license, with rights to sublicense through multiple tiers
of sublicensees, to use, reproduce, distribute, create derivative works of, publicly perform and publicly display the Work Product in
any medium or format, whether now known or later developed. In the event that Consultant has any rights in the Work Product that cannot
be assigned or licensed, Consultant unconditionally and irrevocably waives the enforcement of such rights, and all claims and causes of
action of any kind against Client or Client&rsquo;s customers and channel partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>License
to Preexisting IP.</B> Consultant agrees not to use or incorporate into Work Product any intellectual property developed by any third
party or by Consultant other than in the course of performing services for Client (&ldquo;<B><I>Preexisting IP</I></B>&rdquo;) unless
the Preexisting IP has been specifically identified and described in the applicable Project Assignment. In the event Consultant uses or
incorporates Preexisting IP into Work Product, Consultant hereby grants to Client a non-exclusive, worldwide, fully-paid and royalty-free,
irrevocable, perpetual license, with the right to sublicense through multiple tiers of sublicensees, to use, reproduce, distribute, digitally
transmit, create derivative works of, publicly perform and publicly display in any medium or format, whether now known or later developed,
such Preexisting IP incorporated or used in Work Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Representations
and Warranties.</B> Consultant represents and warrants that: (a)&nbsp;the Services will be performed in a professional manner and in accordance
with the industry standards and the Work Product will comply with the requirements and specifications set forth in the applicable Project
Assignment, (b)&nbsp;the Work Product will be an original work of Consultant, (c)&nbsp;Consultant has the right and unrestricted ability
to assign the ownership of Work Product to Client as set forth in Section&nbsp;3 (including without limitation the right to assign the
ownership of any Work Product created by Consultant&rsquo;s employees or contractors), (d)&nbsp;neither the Work Product nor any element
thereof will infringe upon or misappropriate any copyright, patent, trademark, trade secret, right of publicity or privacy, or any other
proprietary right of any person, whether contractual, statutory or common law, (e)&nbsp;Consultant has an unqualified right to grant to
Client the license to Preexisting IP set forth in Section&nbsp;5, (f)&nbsp;none of the Work Product incorporates any software code licensed
under the GNU General Public License, Lesser General Public License, Affero General Public License, &ldquo;copyleft&rdquo; license or
any other license that, by its terms, requires or conditions the use or distribution of such code on the disclosure, licensing, or distribution
of any source code owned or licensed by Client, except as expressly agreed by the Client in writing, and (g)&nbsp;Consultant will comply
with all applicable federal, state, local and foreign laws governing self-employed individuals, including laws requiring the payment of
taxes, such as income and employment taxes, and social security, disability, and other contributions. Consultant further represents and
warrants that Consultant is self-employed in an independently established trade, occupation, or business; maintains and operates a business
that is separate and independent from Client&rsquo;s business; holds themself out to the public as independently competent and available
to provide applicable services similar to the Services; has obtained and/or expects to obtain clients or customers other than Client for
whom Consultant performs services; and will perform work for Client that Consultant understands is outside the usual course of Client&rsquo;s
business. Consultant agrees to indemnify and hold Client harmless from any and all damages, costs, claims, expenses or other liability
(including reasonable attorneys&rsquo; fees) arising from or relating to the breach or alleged breach by Consultant of this Agreement,
including any of the representations and warranties set forth in this Section&nbsp;6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Independent
Contractor Relationship.</B> Consultant&rsquo;s relationship with Client is that of an independent contractor, and nothing in this Agreement
is intended to, or should be construed to, create a partnership, agency, joint venture or employment relationship between Client and any
of Consultant&rsquo;s employees or agents. Consultant is not authorized to make any representation, contract or commitment on behalf of
Client. Consultant (if Consultant is an individual) and Consultant&rsquo;s employees will not be entitled to any of the benefits that
Client may make available to its employees, including, but not limited to, group health or life insurance, profit-sharing or retirement
benefits. Because Consultant is an independent contractor, Client will not withhold or make payments for social security, make unemployment
insurance or disability insurance contributions, or obtain workers&rsquo; compensation insurance on behalf of Consultant. Consultant is
solely responsible for, and will file, on a timely basis, all tax returns and payments required to be filed with, or made to, any federal,
state or local tax authority with respect to the performance of Services and receipt of fees under this Agreement. Consultant is solely
responsible for, and must maintain adequate records of, expenses incurred in the course of performing Services under this Agreement. No
part of Consultant&rsquo;s compensation will be subject to withholding by Client for the payment of any social security, federal, state
or any other employee payroll taxes. Client will regularly report amounts paid to Consultant by filing Form&nbsp;1099-NEC with the Internal
Revenue Service as required by law. If, notwithstanding the foregoing, Consultant is reclassified as an employee of Client, or any affiliate
of Client, by the U.S. Internal Revenue Service, the U.S. Department of Labor, or any other federal or state or foreign agency as the
result of any administrative or judicial proceeding, Consultant agrees that Consultant will not, as the result of such reclassification,
be entitled to or eligible for, on either a prospective or retrospective basis, any employee benefits under any plans or programs established
or maintained by Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Confidential
Information.</B> During the term of this Agreement and thereafter Consultant (i)&nbsp;will not use or permit the use of Client&rsquo;s
Confidential Information in any manner or for any purpose not expressly set forth in this Agreement, (ii)&nbsp;will hold such Confidential
Information in confidence and protect it from unauthorized use and disclosure, and (iii)&nbsp;will not disclose such Confidential Information
to any third parties except as set forth in this section and in Section&nbsp;9 below. Consultant will protect Client&rsquo;s Confidential
Information from accidental loss and unauthorized use, access or disclosure in the same manner as Consultant protects its own confidential
information of a similar nature, but in no event will it exercise less than reasonable care. Notwithstanding the foregoing or anything
to the contrary in this Agreement or any other agreement between Client and Consultant, nothing in this Agreement shall limit Consultant&rsquo;s
right to report possible violations of law or regulation with any federal, state, or local government agency. &ldquo;<B><I>Confidential
Information</I></B>&rdquo; as used in this Agreement means all information disclosed by Client to Consultant, whether during or before
the term of this Agreement, that is not generally known in the Client&rsquo;s trade or industry and will include, without limitation:
(a)&nbsp;concepts and ideas relating to the development and distribution of content in any medium or to the current, future and proposed
products or services of Client or its subsidiaries or affiliates; (b)&nbsp;trade secrets, drawings, inventions, know-how, software programs,
and software source documents; (c)&nbsp;information regarding plans for research, development, new service offerings or products, marketing
and selling, business plans, business forecasts, budgets and unpublished financial statements, licenses and distribution arrangements,
prices and costs, suppliers and customers; (d)&nbsp;existence of any business discussions, negotiations or agreements between the parties;
and (e)&nbsp;any information regarding the skills and compensation of employees, contractors or other agents of Client or its subsidiaries
or affiliates. Confidential Information also includes proprietary or confidential information of any third party who may disclose such
information to Client or Consultant in the course of Client&rsquo;s business. Confidential Information does not include information that
(x)&nbsp;is or becomes a part of the public domain through no act or omission of Consultant, (y)&nbsp;is disclosed to Consultant by a
third party without restrictions on disclosure, or (z)&nbsp;was in Consultant&rsquo;s lawful possession without obligation of confidentiality
prior to the disclosure and was not obtained by Consultant either directly or indirectly from Client. In addition, this section will not
be construed to prohibit disclosure of Confidential Information to the extent that such disclosure is required by law or valid order of
a court or other governmental authority; <I>provided, however</I>, that Consultant will first have given notice to Client and will have
made a reasonable effort to obtain a protective order requiring that the Confidential Information so disclosed be used only for the purposes
for which the order was issued. All Confidential Information furnished to Consultant by Client is the sole and exclusive property of Client
or its suppliers or customers. Upon request by Client, Consultant agrees to promptly deliver to Client the original and any copies of
the Confidential Information. Notwithstanding the foregoing nondisclosure obligations, pursuant to 18 U.S.C. Section&nbsp;1833(b), Consultant
will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is
made: (1)&nbsp;in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and
solely for the purpose of reporting or investigating a suspected violation of law; or (2)&nbsp;in a complaint or other document filed
in a lawsuit or other proceeding, if such filing is made under seal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>8.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Personal
Information</B>. With respect to any information that Consultant collects, receives, stores, processes, generates, uses, transfers, discloses,
makes accessible, protects, secures, disposes of, and transmits (collectively, processes) in connection with the Services that relates
to an identified or identifiable natural person or which otherwise constitutes personal data, personal information, personally identifiable
information or similar information under applicable privacy or data security laws (collectively, &ldquo;<B><I>Personal Information</I></B>&rdquo;),
Consultant shall not (i)&nbsp;sell or share Personal Information, (ii)&nbsp;retain, use or disclose Personal Information for any purpose
other than the business purpose specified in this Agreement, (iii)&nbsp;retain, use, or disclose the Personal Information outside of the
direct business relationship between Consultant and Client, or (iv)&nbsp;combine the Personal Information Consultant receives from, or
on behalf of, Client with Personal Information that it receives from, or on behalf of, another person or persons, or collects from its
own interaction with consumers. For the avoidance of doubt, the foregoing prohibits Consultant from &ldquo;selling&rdquo; Personal Information,
as defined in the California Consumer Privacy Act of 2018 (as amended, the &ldquo;<B><I>CCPA</I></B>&rdquo;), and from retaining, using,
or disclosing Personal Information outside of the direct business relationship between Consultant and Client or for a &ldquo;commercial
purpose&rdquo; (as defined in the CCPA). Client retains the right to take reasonable and appropriate steps to ensure that Consultant uses
the Personal Information transferred in a manner consistent with Client&rsquo;s obligations under the CCPA. Client retains the right to,
upon notice, take reasonable and appropriate steps to stop and remediate unauthorized use of Personal Information. Consultant hereby certifies
that it understands the obligations under this Section&nbsp;8.1 and will comply with them, and agrees to notify Client if Consultant is
no longer able to meet the obligations under this Section&nbsp;8.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B>Consultant
shall comply with applicable obligations under the CCPA, as amended, and provide the same level of privacy protection as required for
Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B>Consultant
shall use reasonable security measures appropriate to the nature of any Personal Information in its possession or control to protect the
Personal Information from unauthorized access, destruction, use, modification, or disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B>The
parties acknowledge and agree that Consultant&rsquo;s access to Personal Information is not part of the consideration exchanged by the
parties in respect of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B>If
any individual contacts Consultant to make a request pertaining to their Personal Information, Consultant shall promptly forward the request
to Client and shall not respond to the individual except as instructed by Client. Consultant shall promptly take such actions and provide
such information as Client may request to help Client fulfill requests of individuals to exercise their rights under the applicable privacy
or data security laws, including, without limitation, requests to access, delete, opt-out of the sale of, or receive information about
the processing of, Personal Information pertaining to them. Consultant agrees to cooperate with Client to further amend the Agreement
as may be necessary to address compliance with applicable privacy or data security laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Consultant&rsquo;s
Employees, Consultants and Agents.</B> Consultant shall have the right to disclose Confidential Information only to those of its employees,
consultants, and agents who have a need to know such information for the purpose of performing Services and who have entered into a binding
written agreement that is expressly for the benefit of Client and protects Client&rsquo;s rights and interests in and to the Confidential
Information to at least the same degree as this Agreement. Client reserves the right to refuse or limit Consultant&rsquo;s use of any
employee, consultant or agent or to require Consultant to remove any employee, consultant or agent already engaged in the performance
of the Services. Client&rsquo;s exercise of such right will in no way limit Consultant&rsquo;s obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Term
and Termination.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.1&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Term.</B>
The initial term of this Agreement is for three (3)&nbsp;years from the Effective Date set forth above, unless earlier terminated as provided
in this Agreement. Thereafter, this Agreement will automatically renew on its anniversary date, for one (1)&nbsp;year terms, unless Client
provides 15 days&rsquo; written notice prior to any such anniversary date that the Agreement will not renew.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.2&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Termination
Without Cause.</B> Client may terminate this Agreement with or without cause, at any time upon 5 days&rsquo; prior written notice to Consultant.
Consultant may terminate this Agreement without cause, at any time when no Project Assignment is in effect upon 15 days&rsquo; prior written
notice to Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.3&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Termination
for Cause.</B> Either party may terminate this Agreement immediately in the event the other party has materially breached the Agreement
and failed to cure such breach within 3 days after notice by the non-breaching party is given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>10.4&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Survival.</B>
The rights and obligations contained in Sections&nbsp;3 (&ldquo;<B><I>Ownership of Work Product</I></B>&rdquo;), 4 (&ldquo;<B><I>Other
Rights</I></B>&rdquo;), 5 (&ldquo;<B><I>License to Preexisting IP</I></B>&rdquo;), 6 (&ldquo;<B><I>Representations and Warranties</I></B>&rdquo;),
8 (&ldquo;<B><I>Confidential Information</I></B>&rdquo;) and 12 (&ldquo;<B><I>Non-solicitation</I></B>&rdquo;) will survive any termination
or expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>No
Conflicts.</B>&nbsp; Consultant will refrain from any activity, and will not enter into any agreement or make any commitment, that is
inconsistent or incompatible with Consultant&rsquo;s obligations under this Agreement, including Consultant&rsquo;s ability to perform
the Services.&nbsp; Consultant represents and warrants that Consultant is not subject to any contract or duty that would be breached by
Consultant&rsquo;s entering into or performing Consultant&rsquo;s obligations under this Agreement or that is otherwise inconsistent with
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Non-solicitation.
</B>Consultant agrees that during the Term of this Agreement, and for one year thereafter, Consultant will not either directly or indirectly,
solicit or attempt to solicit any employee, independent contractor, or consultant of Client to terminate their relationship with Client
in order to become an employee, consultant, or independent contractor to or for any other person or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Successors
and Assigns.</B> Consultant may not subcontract or otherwise delegate or assign this Agreement or any of its obligations under this Agreement
without Client&rsquo;s prior written consent. Any attempted assignment in violation of the foregoing will be null and void. Subject to
the foregoing, this Agreement will be for the benefit of Client&rsquo;s successors and assigns, and will be binding on Consultant&rsquo;s
assignees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Notices.</B>
Any notice required or permitted by this Agreement will be in writing and will be delivered as follows with notice deemed given as indicated:
(i)&nbsp;by personal delivery when delivered personally; (ii)&nbsp;by overnight courier upon written verification of receipt; (iii)&nbsp;by
email (<I>provided, however</I>, if the sender receives an automatically generated notification that such email was not delivered, such
attempted email notice shall be ineffective and deemed to not have been given); or (iv)&nbsp;by certified or registered mail, return receipt
requested, upon verification of receipt. Notice will be sent to the addresses set forth below or such other address as either party may
specify in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Governing
Law.</B> This Agreement will be governed in all respects by the laws of the United States of America and by the laws of the Commonwealth
of Massachusetts, without giving effect to any conflicts of laws principles that require the application of the law of a different jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Severability.</B>
Should any provisions of this Agreement be held by a court of law to be illegal, invalid or unenforceable, the legality, validity and
enforceability of the remaining provisions of this Agreement will not be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Waiver.</B>
The waiver by Client of a breach of any provision of this Agreement by Consultant will not operate or be construed as a waiver of any
other or subsequent breach by Consultant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Injunctive
Relief for Breach.</B> Consultant&rsquo;s obligations under this Agreement are of a unique character that gives them particular value;
breach of any of such obligations will result in irreparable and continuing damage to Client for which there will be no adequate remedy
at law; and, in the event of such breach, Client will be entitled to injunctive relief and/or a decree for specific performance, and such
other and further relief as may be proper (including monetary damages if appropriate).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>Entire
Agreement.</B> This Agreement constitutes the entire agreement between the parties relating to this subject matter and supersedes all
prior or contemporaneous oral or written agreements concerning such subject matter. The terms of this Agreement will govern all services
undertaken by Consultant for Client; <I>provided, however</I>, that in the event of any conflict between the terms of this Agreement and
any Project Assignment, the terms of the applicable Project Assignment will control, provided that the Project Assignment specifically
calls out the applicable Section&nbsp;number of this Agreement to be superseded and has been signed by an authorized officer of Client.
This Agreement may only be changed or amended by mutual agreement of authorized representatives of the parties in writing. This Agreement
may be executed in two or more counterparts, each of which will be deemed an original, but all of which together will constitute one and
the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying
with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and
any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[Remainder of page&nbsp;intentionally left
blank]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->.</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The parties have executed this Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLIENT:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leap Therapeutics,&nbsp;Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President&nbsp;&amp; CEO</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">donsi@leaptx.com</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47 Thorndike Street Suite&nbsp;B1-1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cambridge, MA 02141</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(617) 714-0360</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSULTANT:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CoinXit Ltd</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Khing Oei</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khing Oei</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[omitted]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[omitted]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[omitted]</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: italic 10pt Times New Roman, Times, Serif">For copyright registration purposes only, Consultant must provide the following information:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; white-space: nowrap; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 15%">Nationality or domicile:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 35%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<I>Signature Page to Consulting
Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Project Assignment #1_ Under Consulting Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Dated: November&nbsp;11, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Project:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consultant will render the consulting and advisory
services to Client as Client may from time to time request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Reimbursement of Expenses:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consultant will be reimbursed for third party
expenses (at cost) incurred by Consultant if approved in writing in advance by Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consultant will invoice Client monthly for reimbursable
third party expenses and will provide such reasonable receipts or other documentation of expenses as Client might request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment terms: Client will be invoiced on the
first day of each month for reimbursable third party expenses incurred by Consultant during the previous month.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties have executed
this Project Assignment as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLIENT:</B></FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leap
    Therapeutics,&nbsp;Inc.</B></FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Doulas E. Onsi</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 3%; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid; width: 42%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Douglas
    E. Onsi</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President&nbsp;&amp;
    CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSULTANT:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CoinXit Ltd</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Khing Oei</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 42%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khing Oei</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><A NAME="ss04"></A>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEAP THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RESTRICTED STOCK UNIT GRANT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This RESTRICTED STOCK UNIT
GRANT AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;), dated as of November&nbsp;11, 2025 (the &ldquo;<U>Date of Grant</U>&rdquo;), is
delivered by Leap Therapeutics,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;) to CoinXit Ltd (the &ldquo;<U>Participant</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>RECITALS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the terms of the
Consulting Agreement, dated November&nbsp;11, 2025, between the Company and the Participant (as it may be amended from time to time, the
&ldquo;<U>Consulting Agreement</U>&rdquo;), the Participant is to be granted a restricted stock unit award on the terms and subject to
the conditions set forth herein. The Leap Therapeutics,&nbsp;Inc. 2022 Equity Incentive Plan, as amended and in effect on the date hereof
(the &ldquo;<U>Plan</U>&rdquo;), provides for the grant of Restricted Stock Units (as defined in the Plan) in accordance with the terms
and conditions of the Plan. The Committee (as defined in the Plan) has decided to make this grant of Restricted Stock Units to comply
with the Company&rsquo;s agreements and obligations under the Consulting Agreement and as an inducement for the Participant to promote
the best interests of the Company and its stockholders. This Agreement is made pursuant to the Plan and is subject in its entirety to
all applicable provisions of the Plan. Capitalized terms used herein and not otherwise defined will have the meanings set forth in the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
of Restricted Stock Units</U>. Subject to the terms, conditions and restrictions set forth in this Agreement and in the Plan, the Company
hereby grants to the Participant 2,411,700 Restricted Stock Units (the &ldquo;<U>Stock Units</U>&rdquo;). Each Stock Unit represents the
right of the Participant to receive a share of common stock of the Company (&ldquo;<U>Stock</U>&rdquo;), if and when the specified conditions
are met in Section&nbsp;3 below, and on the applicable settlement date set forth in Section&nbsp;5 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Rights Prior to Settlement</U>. Stock Units represent hypothetical shares of Stock, and not actual shares of Stock. No shares of Stock
shall be issued to the Participant at the time the grant of the Stock Units is made, and the Participant shall not be, and shall not have
any of the rights or privileges of, a stockholder of the Company with respect to any Stock Units. The Participant shall not have any interest
in any fund or specific assets of the Company by reason of this award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Vesting</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
of the date of this Agreement, all of the Stock Units shall be unvested and subject to a Risk of Forfeiture pursuant to Section&nbsp;4
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
to the terms of this Section&nbsp;3, the Stock Units shall vest in accordance with the following vesting schedule: (i)&nbsp;12/36ths of
the Stock Units will vest on October&nbsp;8, 2026 and (ii)&nbsp;1/36<SUP>ths </SUP>of the Stock Units will vest on the eighth (8<SUP>th</SUP>)
day of each month thereafter, <U>provided</U> that the Participant continues to be employed by, or provide service as a consultant, director
or advisor of or to, the Company or one of its Affiliates from the Date of Grant until the Stock Units vest in accordance with the provisions
of this Section&nbsp;3. For purposes of this Agreement, the term &ldquo;<U>Vesting Date</U>&rdquo; shall mean a date on which any or all
of the Stock Units vest in accordance with the provisions of this Section&nbsp;3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
vesting of the Stock Units shall be cumulative, but shall not exceed 100% of the Stock Units. If the foregoing schedule would produce
fractional Stock Units, the number of Stock Units that vest shall be rounded down to the nearest whole Stock Unit and the fractional Stock
Units will be accumulated so that the resulting whole Stock Units will be included in the number of Stock Units that become vested on
the last Vesting Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>In
the event of a Change of Control or a Transaction before all of the Stock Units vest in accordance with Section&nbsp;3(a)&nbsp;above,
the applicable provisions of the Plan shall apply to the Stock Units, and the Committee may take such actions as it deems appropriate
pursuant to the provisions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>In
the event that (i)&nbsp;Participant&rsquo;s consulting or advisory relationship with the Company or any of its Affiliates is terminated
at any time by the Company or any of its Affiliates for any reason other than Cause (as defined in Section&nbsp;3(g)&nbsp;below) or is
terminated at any time by Participant for Good Reason (as defined in Section&nbsp;3(h)&nbsp;below) and (ii)&nbsp;immediately after any
such termination of such consulting or advisory relationship, Participant does not have a service provider relationship of any kind (including,
without limitation, as an officer, director, employee, consultant or advisor) with any of the Company and its Affiliates, then, effective
immediately prior to any such termination of such consulting or advisory relationship, any and all Stock Units that are then unvested
and subject to Risk of Forfeiture pursuant to Section&nbsp;4 below shall automatically become fully vested and free from Risk of Forfeiture
pursuant to Section&nbsp;4 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Those
Stock Units that vest pursuant to this Section&nbsp;3 or pursuant to any action taken by the Committee pursuant to the Plan shall become
free from the Risk of Forfeiture pursuant to Section&nbsp;4 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>For
purposes of this Agreement, the term &ldquo;<U>Cause</U>&rdquo; shall mean the occurrence of any of the following: (i)&nbsp;a conviction
of Participant, or a plea of nolo contendere, to a felony (other than a felony related to the operation of a motor vehicle); or (ii)&nbsp;willful
misconduct or gross negligence by Participant resulting, in either case, in material harm to the Company or any of its Affiliates; or
(iii)&nbsp;a willful failure by Participant to carry out the reasonable and lawful directions of the Board and failure by Participant
to remedy such willful failure within thirty (30) days after receipt of written notice of same from the Board; or (iv)&nbsp;fraud, embezzlement,
theft or dishonesty of a material nature by Participant, or a willful material violation by Participant of a written policy or procedure
of the Company or any of its Affiliates, resulting, in any case, in material harm to the Company or any of its Affiliates; or (v)&nbsp;a
material breach by Participant of any agreement between Participant and the Company or any of its Affiliates, and failure by Participant
to remedy the material breach within thirty (30) days after receipt of written notice of such material breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>For
purposes of this Agreement, the term &ldquo;<U>Good Reason</U>&rdquo; shall mean a material breach by the Company or any Affiliate of
the Company of any agreement between Participant and the Company or any Affiliate of the Company, and failure by the Company or any Affiliate
of the Company to remedy such material breach within thirty (30) days after receipt from Participant of written notice of such material
breach. For purposes of this Agreement, Good Reason shall not be deemed to exist unless Participant provides the Company with written
notice of the material breach within ninety (90) days after the initial existence of such material breach and Participant&rsquo;s termination
of the Consulting Agreement for Good Reason occurs within one hundred eighty days after Participant provides such written notice to the
Company on a timely basis regarding the existence of such material breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Termination
of Stock Units</U>. Subject to the provisions of Section&nbsp;3(e)&nbsp;above, if the Participant ceases to be a service provider to the
Company and its Affiliates in all capacities as an employee, consultant, director and/or advisor of the Company and its Affiliates for
any reason before all of the Stock Units vest, any unvested Stock Units shall automatically terminate and shall be forfeited as of the
date of the Participant&rsquo;s termination of such employment or service. No settlement or payment shall be made with respect to any
unvested Stock Units that terminate as described in this Section&nbsp;4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Settlement
of Stock Units and Tax Withholding</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>If
a Stock Unit vests in accordance with the provisions of Section&nbsp;3 above, then, subject to the provisions of this Section&nbsp;5(a)&nbsp;and
Sections 5(b), 5(c)&nbsp;and 12 below, the Company shall issue to the Participant one share of Stock for such vested Stock Unit, subject
to applicable tax withholding obligations, on the earliest to occur of (1)&nbsp;the first payroll period on or after the date the Participant&rsquo;s
employment with or service to the Company ceases, (2)&nbsp;the first payroll period on or after the eighth (8<SUP>th</SUP>) day of the
calendar month of June&nbsp;following any such Vesting Date applicable to such vested Stock Unit or (3)&nbsp;the first payroll period
on or after the eighth (8<SUP>th</SUP>) day of the month of December&nbsp;following any such Vesting Date applicable to such vested Stock
Unit; <U>provided</U>, <U>however</U>, that the Company shall not be required to issue to the Participant any share of Stock pursuant
to the foregoing provisions of this Section&nbsp;5(a)&nbsp;with respect to any vested Stock Unit (or otherwise settle any such vested
Stock Unit in shares of Stock) on any date that the Committee, in its sole discretion, determines the Participant is subject to any limitation
or restriction (including, without limitation, (1)&nbsp;any limitation or restriction under the Company&rsquo;s insider trading policy
as then in effect and (2)&nbsp;any limitation or restriction imposed by securities laws or other laws such as Rule&nbsp;144 promulgated
under the Securities Act of 1933, as amended, and Section&nbsp;16(b)&nbsp;of the Securities Exchange Act of 1934, as amended) that does
not permit the Participant to offer to sell or sell on the public market on such date all of the shares of Stock that otherwise would
be issued to Participant on such date pursuant to this Section&nbsp;5(a)&nbsp;in settlement of such vested Stock Unit. Notwithstanding
anything express or implied in the foregoing provisions of this Section&nbsp;5(a)&nbsp;to the contrary, in no event shall settlement of
a vested Stock Unit occur later than the fifteenth day of the third calendar month following the calendar year in which the Vesting Date
applicable to such vested Stock Unit occurs, and in no event shall the Participant be permitted, directly or indirectly, to designate
the calendar year of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>All
obligations of the Company under this Agreement shall be subject to the right of the Company as set forth in the Plan to require the Participant
to remit to the Company an amount sufficient to satisfy statutory minimum federal, state, local, foreign or other withholding tax requirements
if, when, and to the extent required by law prior to the issuance of shares of Stock. The obligations of the Company under this Agreement
shall be conditional on satisfaction of all such statutory minimum withholding obligations and the Company shall, to the extent permitted
by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant or to utilize any other
withholding method prescribed by the Committee from time to time. However, the Participant may elect, subject to the approval of the Committee,
acting in its sole discretion, to satisfy an applicable statutory minimum withholding requirement, in whole or in part, by having the
Company withhold shares of Stock to satisfy the Participant&rsquo;s tax obligations. Any such election shall be irrevocable, made in writing,
signed by the Participant, and shall be subject to any restrictions or limitations that the Committee deems appropriate. If shares of
Stock are withheld to satisfy an applicable withholding requirement, the shares of Stock withheld shall have a Market Value on the date
the tax is to be determined equal to the minimum statutory total tax that could be imposed on the transaction unless the Committee determines
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
obligation of the Company to deliver Stock shall also be subject to the condition that if at any time the Board shall determine in its
discretion that the listing, registration or qualification of any shares of Stock on any securities exchange or under any state or federal
law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with,
the issuance of such shares, such shares may not be issued in whole or in part unless such listing, registration, qualification, consent
or approval shall have been effected or obtained free of any conditions not acceptable to the Board. The issuance of shares of Stock,
if any, to the Participant pursuant to this Agreement is subject to any applicable taxes and other laws or regulations of the United States
or of any state, municipality or other country having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Stockholder Rights</U>. Neither the Participant, nor any permitted transferee of the Stock Units, shall have any of the rights and privileges
of a stockholder with respect to shares of Stock, including voting or dividend rights, until such shares of Stock have been issued upon
settlement of Stock Units. The Participant acknowledges that no election under Section&nbsp;83(b)&nbsp;of the Code is available with respect
to Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
Subject to Plan Provisions</U>. This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and
in all respects shall be interpreted in accordance with the Plan. The grant and settlement of the Stock Units are subject to the provisions
of the Plan and to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee
in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (a)&nbsp;rights and obligations
with respect to withholding taxes, (b)&nbsp;the registration, qualification or listing of the shares of Stock, (c)&nbsp;changes in capitalization
of the Company and (d)&nbsp;other requirements of applicable law. The Committee shall have the authority to interpret and construe the
Stock Units pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Service or Other Rights</U>. The grant of the Stock Units shall not confer upon the Participant any right to be retained by or in the
employ or service of the Company or any Affiliate and shall not interfere in any way with the right of the Company or any Affiliate to
terminate the Participant&rsquo;s employment or service at any time. The right of the Company and any Affiliate to terminate at will the
Participant&rsquo;s employment or service at any time for any reason is specifically reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Assignment
and Transfers</U>. Under the Plan, the Stock Units are generally not transferable, and shall not be sold, transferred, pledged, assigned,
or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution, and all of the Participant's rights
in the Stock Units may be exercised only by the Participant. The rights and protections of the Company hereunder shall extend to any successors
or assigns of the Company and to its Affiliates. This Agreement may be assigned by the Company without the Participant&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Governing
Law</U>. The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with
the laws of the Commonwealth of Massachusetts, without giving effect to the conflicts of laws provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice</U>.
Any notice to the Company provided for in this instrument shall be addressed to the Company in care of its Chief Financial Officer at
the Company's principal place of business, and any notice to the Participant shall be addressed to the Participant at Participant&rsquo;s
business address last filed with the Company. Any notice shall be delivered in accordance with Section&nbsp;17 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Application
of Section&nbsp;409A of the Code</U>. This Agreement is intended to be exempt from or otherwise comply with the provisions of Section&nbsp;409A
of the Code. Notwithstanding the foregoing, if any Stock Units constitute &ldquo;deferred compensation&rdquo; under Section&nbsp;409A
of the Code and such Stock Units become vested upon the Participant&rsquo;s termination of service, settlement of such vested Stock Units
shall be delayed for a period of six months after the Participant&rsquo;s termination of service if the Participant is a &ldquo;specified
employee&rdquo; as defined under Section&nbsp;409A of the Code and if required pursuant to Section&nbsp;409A of the Code. If settlement
of any Stock Units is delayed in accordance with the foregoing provisions of this Section&nbsp;12, such Stock Units shall be settled within
thirty (30) days after the date that is six (6)&nbsp;months following the Participant&rsquo;s termination of service. To the extent subject
to Section&nbsp;409A of the Code, settlement of the Stock Units may only be made in a manner and upon an event permitted by Section&nbsp;409A
of the Code, and each settlement of the Stock Units shall be treated as a separate payment, and the right to a series of installment payments
under the Stock Units shall be treated as a right to a series of separate payments. In no event shall the Participant, directly or indirectly,
designate the calendar year of payment. The Company may change or modify the terms of this Agreement without the Participant&rsquo;s consent
or signature if the Company determines, in its sole discretion, that such change or modification is necessary for purposes of compliance
with or exemption from the requirements of Section&nbsp;409A of the Code or any regulations or other guidance issued thereunder. Notwithstanding
the previous sentence, the Company may also amend the Plan or this Agreement or revoke the Stock Units to the extent permitted by the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[Signature Page&nbsp;Follows]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused its duly authorized officer to execute this Agreement, and the Participant has executed this Agreement, effective as of the
Date of Grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">LEAP THERAPEUTICS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: &#8239;&#8239;President&nbsp;&amp; CEO</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby accept the award of Stock Units described
in this Agreement, and I agree to be bound by the terms of this Agreement and the incorporated provisions of the Plan. I hereby agree
that all decisions and determinations of the Committee with respect to the Stock Units shall be final and binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Participant</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">CoinXit Ltd</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"> <FONT STYLE="font-size: 10pt">/s/ Khing Oei</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Khing Oei</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Director</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Date: November&nbsp;11, 2025</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<I>Signature Page to RSU
Grant Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><A NAME="ss05"></A>Exhibit 10.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>EXECUTIVE
EMPLOYMENT AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Executive Employment
Agreement (&ldquo;<B><I>Agreement</I></B>&rdquo;) is made and entered into as of this 11th day of November, 2025 (the &ldquo;<B>Effective
Date</B>&rdquo;), by and between Leap Therapeutics,&nbsp;Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), and William
McEvoy (hereinafter, the &ldquo;<B><I>Executive</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>WITNESSETH:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company desires to employ the Executive
as the Chief Investment Officer of the Company effective as of the Effective Date here, and the Executive desires to be employed by the
Company as the Chief Investment Officer of the Company effective as of the Effective Date, on the terms herein described.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and mutual covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which
are mutually acknowledged, the Company and the Executive hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I><U>Definitions</U></I></B>.
When used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Accrued
Obligations</I></B>&rdquo; means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
accrued but unpaid Base Salary through the end of the Term of Employment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any
unpaid or unreimbursed expenses incurred in accordance with Company policy, including amounts due under Section&nbsp;5(a)&nbsp;hereof,
to the extent incurred during the Term of Employment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any
accrued but unpaid benefits provided under the Company&rsquo;s employee benefit plans, subject to and in accordance with the terms of
those plans;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any
earned and unpaid Bonus in respect to any completed fiscal year that has ended on or prior to the end of the Term of Employment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any
accrued but unpaid rights to indemnification by virtue of the Executive&rsquo;s position as an officer or director of the Company or its
subsidiaries and the benefits under any directors&rsquo; and officers&rsquo; liability insurance policy maintained by the Company, in
accordance with its terms thereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;any
accrued but unused vacation pay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Base
Salary</I></B>&rdquo; means the salary amount provided for in Section&nbsp;4(a)&nbsp;hereof or any increase thereto as salary granted
to Executive pursuant to Section&nbsp;4(a)&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Beneficial
Ownership</I></B>&rdquo; shall have the meaning ascribed to such term in Rule&nbsp;13d-3 promulgated under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Board</I></B>&rdquo;
means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 61; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Bonus</I></B>&rdquo;
means any bonus earned and payable to the Executive pursuant to Section&nbsp;4(b)&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Cause</I></B>&rdquo;
means the occurrence of any of the following: (i)&nbsp;a conviction of the Executive, or a plea of nolo contendere, to a felony (other
than a felony related to the operation of a motor vehicle); or (ii)&nbsp;willful misconduct or gross negligence by the Executive resulting,
in either case, in material harm to the Company or any Related Entities; or (iii)&nbsp;a willful failure by the Executive to carry out
the reasonable and lawful directions of the Board and failure by the Executive to remedy such willful failure within thirty (30) days
after receipt of written notice of same from the Board; or (iv)&nbsp;fraud, embezzlement, theft or dishonesty of a material nature by
the Executive, or a willful material violation by the Executive of a written policy or procedure of the Company or any Related Entity,
resulting, in any case, in material harm to the Company or any Related Entity; (v)&nbsp;the exclusion, suspension or debarment of Executive
from participation in a federal health care program or before the United States Food and Drug Administration or other similar regulatory
authority or the existence of any pending debarment or similar proceedings against Executive; or (vi)&nbsp;a material breach by the Executive
of this Agreement, and failure by the Executive to remedy the material breach within thirty (30) days after receipt of written notice
of same, by the Board. For clarity, the inability of Executive to perform any or all of his duties, responsibilities or obligations under
this Agreement on account of Executive&rsquo;s death or disability shall not be deemed or treated as a material breach of this Agreement
by the Executive and shall not constitute Cause for any purpose of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Change
in Control</I></B>&rdquo; means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
acquisition by any Person of Beneficial Ownership of at least twenty percent (20%) of either (A)&nbsp;the value of the then outstanding
shares of common stock of the Company (the &ldquo;<B><I>Outstanding Company Common Stock</I></B>&rdquo;) or (B)&nbsp;the combined voting
power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the &ldquo;<B><I>Outstanding
Company Voting Securities</I></B>&rdquo;) (the foregoing Beneficial Ownership hereinafter being referred to as a &ldquo;<B><I>Controlling
Interest</I></B>&rdquo;); <I>provided, however</I>, that for purposes of this definition, the following acquisitions shall not constitute
or result in a Change in Control: (v)&nbsp;any acquisition directly from the Company; (w)&nbsp;any acquisition by the Company; (x)&nbsp;any
acquisition by any person that owns, or by any person that collectively with such person&rsquo;s affiliates own, Beneficial Ownership
of a Controlling Interest on the Effective Date; (y)&nbsp;any acquisition by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any subsidiary of the Company; or (z)&nbsp;any acquisition by any corporation or other Person pursuant to
a transaction which complies with clauses (A), (B)&nbsp;and (C)&nbsp;of subsection (ii)&nbsp;below; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Consummation
of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the Company or any of
its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or
stock or equity interests of another entity by the Company or any of its subsidiaries (each a &ldquo;<B><I>Business Combination</I></B>&rdquo;),
in each case, unless, immediately following such Business Combination, (A)&nbsp;all or substantially all of the Persons who were the Beneficial
Owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business
Combination beneficially own, directly or indirectly, more than fifty percent (50%) of the then combined voting power of the then outstanding
voting securities entitled to vote generally in the election of directors (or equivalent persons) of the corporation or other Person resulting
from such Business Combination (including, without limitation, a corporation or other Person which as a result of such transaction owns
the Company or all or substantially all of the Company&rsquo;s assets either directly or through one or more subsidiaries) (such resulting
or acquiring corporation or other Person is referred to herein as the &ldquo;<B><I>Acquiring Person</I></B>&rdquo;) in substantially the
same proportions as their beneficial ownership, immediately prior to such Business Combination, of the combined voting power of the Outstanding
Company Voting Securities, and (B)&nbsp;at least a majority of the members of the Board of Directors or equivalent body of the corporation
or other Person resulting from such Business Combination were members of the incumbent Board at the time of the execution of the initial
agreement, or of the action of the Board, providing for such Business Combination; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;approval
by the stockholders of the Company of a complete liquidation or dissolution of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>COBRA</I></B>&rdquo;
means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Code</I></B>&rdquo;
means the Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Common
Stock</I></B>&rdquo; means the common stock, $0.001 par value per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Date
of Termination</I></B>&rdquo; means the earliest of: (i)&nbsp;immediately after the Company gives notice to Executive of Executive&rsquo;s
termination, with or without Cause, unless the Company specifies a later date, in which case, termination shall be effective as of such
later date; (ii)&nbsp;immediately upon the Executive&rsquo;s death; (iii)&nbsp;thirty (30) days after the Company gives notice to Executive
of Executive&rsquo;s termination on account of Executive&rsquo;s Disability, unless the Company specifies a later date, in which case,
termination shall be effective as of such later date, provided, that Executive has not returned to the full time performance of Executive&rsquo;s
duties prior to such date; or (iv)&nbsp;thirty (30) days after the Executive gives written notice to the Company of Executive&rsquo;s
resignation with or without Good Reason. Executive will receive compensation through any required notice period. In the event notice of
a termination under subsections (i), (iii)&nbsp;and (iv)&nbsp;is given orally, at the other party&rsquo;s request, the party giving notice
must provide written confirmation of such notice within five business days of the request in compliance with the requirement of Section&nbsp;14
below. In the event of a termination for Cause or Good Reason written confirmation shall specify the subsection(s)&nbsp;of the definition
of Cause or Good Reason relied on to support the decision to terminate but shall not include further explanation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Disability</I></B>&rdquo;
means the Executive&rsquo;s inability, or failure, to perform the essential functions of his position, with or without reasonable accommodation,
for any period of ninety (90) consecutive days, or (ii)&nbsp;for one-hundred and eighty (180) days in the aggregate during any twelve
(12) month period or based on the written certification by two licensed physicians of the likely continuation of such condition for either
such period. This definition shall be interpreted and applied consistent with the Americans with Disabilities Act, the Family and Medical
Leave Act, and other applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>&ldquo;Equity
Awards</I></B>&rdquo; means any stock options, restricted stock, restricted stock units, stock appreciation rights, phantom stock or other
equity based awards granted by the Company to the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Exchange
Act</I></B>&rdquo; means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(o)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Excise
Tax</I></B>&rdquo; means any excise tax imposed by Section&nbsp;4999 of the Code, together with any interest and penalties imposed with
respect thereto, or any interest or penalties that are incurred by the Executive with respect to any such excise tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(p)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Good
Reason</I></B>&rdquo; means the occurrence of any of the following: (i)&nbsp;a material diminution in the Executive&rsquo;s Base Salary;
or (ii)&nbsp;the Company&rsquo;s or Related Entity&rsquo;s requiring the Executive to be based at any office or location outside of fifty
(50) miles from New York, New York, except for travel reasonably required in the performance of the Executive&rsquo;s responsibilities;
or (iii)&nbsp;any other action or inaction that constitutes a material breach by the Company of this Agreement. For purposes of this Agreement,
Good Reason shall not be deemed to exist unless the Executive&rsquo;s termination of employment for Good Reason occurs within one hundred
eighty days following the initial existence of one of the conditions specified in clauses (i)&nbsp;through (v)&nbsp;above, the Executive
provides the Company with written notice of the existence of such condition within ninety (90) days after the initial existence of the
condition, and the Company fails to remedy the condition within thirty (30) days after its receipt of such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(q)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Person</I></B>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3(a)(9)&nbsp;of the Exchange Act and used in Sections 13(d)&nbsp;and 14(d)&nbsp;thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(r)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Related
Entity</I></B>&rdquo; means any Person controlling, controlled by or under common control with the Company or any of its subsidiaries.
For this purpose, the terms &ldquo;controlling,&rdquo; &ldquo;controlled by&rdquo; and &ldquo;under common control with&rdquo; mean the
possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether
through the ownership of voting securities, as trustee or executor, by contract or otherwise, including (without limitation) the ownership,
directly or indirectly, of securities having the power to elect a majority of the board of directors or similar body governing the affairs
of such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(s)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Severance
Amount</I></B>&rdquo; shall mean an amount equal to the Executive&rsquo;s annualized Base Salary, as in effect immediately prior to the
Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(t)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Target
Bonus</I></B>&rdquo; has the meaning described in Section&nbsp;4(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(u)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Term
of Employment</I></B>&rdquo; means the period during which the Executive shall be employed by the Company pursuant to the terms of this
Agreement, which period shall begin effective as of the Effective Date and continue until terminated in accordance with Section&nbsp;6
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B><I>Termination
Date</I></B>&rdquo; means the date on which the Term of Employment ends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I><U>Employment</U></I></B>.
The Company hereby agrees to continue to employ the Executive, and the Executive hereby agrees to continue to serve the Company, during
the Term of Employment on the terms and conditions set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I><U>Duties
of Executive</U></I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Position
and Position Duties</I></B>. During the Term of Employment, the Executive shall be employed and serve as the Chief Investment Officer
of the Company, and shall have such duties typically associated with such title.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Duties
in General.</I></B> The Executive shall faithfully and diligently perform all services as may be assigned to him by the President and
Chief Executive Officer or the Board, and shall exercise such power and authority as may from time to time be delegated to him by the
President and Chief Executive Officer or the Board. The Executive shall devote time, attention and efforts to the performance of his duties
under this Agreement, render such services to the best of his ability, and use his reasonable best efforts to promote the interests of
the Company. The Executive shall not engage in any other business or occupation during the Term of Employment that (i)&nbsp;conflicts
with the interests of the Company or its subsidiaries, (ii)&nbsp;interferes with the proper and efficient performance of his duties for
the Company, or (iii)&nbsp;interferes with the exercise of his judgment in the Company&rsquo;s best interests. Notwithstanding the foregoing
or any other provision of this Agreement, it shall not be a breach or violation of this Agreement for the Executive to (v)&nbsp;serve
as a manager or employee of Winklevoss Treasury Investments, LLC, Winklevoss Capital Management, LLC, and Winklevoss Capital Fund, LLC,
(w)&nbsp;serve on outside advisory boards with prior written notice to the Company, (x)&nbsp;serve on civic or charitable boards or committees,
(y)&nbsp;deliver lectures, fulfill speaking engagements or teach at educational institutions, or (z)&nbsp;manage personal investments,
so long as such activities do not significantly interfere with or significantly detract from the performance of the Executive&rsquo;s
responsibilities to the Company in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Company
Policies and Procedures</I></B>. The employment relationship between the parties also shall be subject to the Company&rsquo;s personnel
and compliance policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company&rsquo;s
sole discretion. The Company reserves the right to change, alter, or terminate any such policy or procedure in its sole discretion. Notwithstanding
the foregoing, in the event that the terms of this Agreement differ from or are in conflict with the Company&rsquo;s general employment
policies or practices, this Agreement shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Compensation</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Base
Salary</I></B>. The Executive shall receive a Base Salary at the annualized rate of $250,000 during the Term of Employment, with such
Base Salary payable in installments consistent with the Company&rsquo;s normal payroll schedule, subject to applicable withholding and
other taxes. The Base Salary shall be reviewed, at least annually, for merit increases and may, by action and in the discretion of the
Board, be increased at any time or from time to time, but may not be decreased from the then current Base Salary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Bonuses</I></B>.
During the Term of Employment, the Executive shall participate in the Company&rsquo;s annual incentive compensation plan, program and/or
arrangements applicable to senior-level executives, as established and modified from time to time by the Compensation Committee of the
Board (for the avoidance of doubt, for any period during which there is not a Compensation Committee, all matters under this Agreement
shall be addressed by the Board) in its sole discretion. During the Term of Employment, the Executive shall have a target bonus opportunity
under such plan or program equal to 40% of his current Base Salary (the &ldquo;<B><I>Target Bonus</I></B>&rdquo;), based on satisfaction
of performance criteria to be established by the Compensation Committee of the Board within the first three months of each fiscal year
that begins during the Term of Employment. Payment of annual incentive compensation awards shall be made in the same manner and at the
same time that other senior-level executives receive their annual incentive compensation awards and, except as otherwise provided herein,
will be subject to the Executive&rsquo;s continued employment through the applicable payment date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>RSU
Grant.</I></B> Subject to (i)&nbsp;the adoption of resolutions by the Company&rsquo;s stockholders to amend the Company&rsquo;s certificate
of incorporation to effect a reverse stock split of the Common Stock and/or to increase the number of authorized shares of Common Stock
to at least 490,000,000 shares of Common Stock, (ii)&nbsp;the adoption of resolutions by the Company&rsquo;s stockholders to adopt a new
equity plan with a sufficient number of shares of Common Stock in the pool, (iii)&nbsp;the Company having registered the securities that
can be granted pursuant to such plan with the Securities and Exchange Commission on a Registration Statement on Form&nbsp;S-8, and (iv)&nbsp;approval
by the Board or the Compensation Committee of the Board, the Executive shall be granted, pursuant to an equity plan of the Company, an
additional award of 5,616,906 restricted stock units (subject to proportionate and equitable adjustment upon any stock split, stock dividend,
reverse stock split, reclassification or other similar events with respect to the Common Stock that is effected at any time after the
date of this Agreement and prior to such grant, the &ldquo;<B><I>RSUs</I></B>&rdquo;), each of which RSUs shall entitle the Executive,
upon settlement thereof in accordance with its terms, to one share of Common Stock. The RSUs shall vest according to the following schedule:
12/36th of the RSUs will vest on October&nbsp;8, 2026, and 1/36th of the RSUs will vest each month thereafter on the 8<SUP>th</SUP> day
of the applicable month subject to continuous and ongoing employment or other service provider relationship with the Company through each
such vesting date. The date on which the RSUs shall be granted to the Executive (the &ldquo;<B><I>Grant Date</I></B>&rdquo;) shall be
the date on which the Board or the Compensation Committee of the Board adopts a resolution granting the RSUs to the Executive. The grant
of the RSUs to the Executive shall be evidenced by a restricted stock unit grant agreement to be entered into by the Company and the Executive
on or as soon as practicable after the Grant Date, which restricted stock unit grant agreement shall have terms and conditions that are
consistent with the provisions of this Section&nbsp;4(c). Settlement of any RSUs that vest in accordance with the terms set forth above
in this Section&nbsp;4(c)&nbsp;shall be upon such terms and conditions as shall be set forth in such restricted stock unit grant agreement,
including terms providing that RSUs that so vest shall not be settled on or promptly after their respective applicable vesting date but
instead shall be settled on the earliest to occur after their respective applicable vesting dates of (i)&nbsp;the Company&rsquo;s first
payroll date on or after the date on which the Executive ceases to be a service provider to the Company, (ii)&nbsp;the Company&rsquo;s
first payroll date on or after June&nbsp;8 of the applicable calendar year, or (iii)&nbsp;the Company&rsquo;s first payroll date on or
after December&nbsp;8 of the applicable calendar year, unless the terms of such restricted stock unit grant agreement expressly provide
for a further delay, deferral or postponement of the settlement of any vested RSUs in accordance with such terms. The RSUs shall be governed
in all aspects by the equity plan of the Company under or pursuant to which the RSUs are granted to the Executive and by the restricted
stock unit grant agreement entered by the Company and the Executive with respect to the RSUs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT><B><I>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Equity
Awards</I></B>. Any and all existing Equity Awards that the Executive has or holds in the Company will be treated consistent with the
terms of the applicable plans and agreements under which such Equity Awards have been granted. The Executive may be granted additional
Equity Awards from time to time in accordance with the Company&rsquo;s normal business practice and in the sole discretion of the Compensation
Committee of the Board. The terms of any future Equity Awards granted to the Executive will be consistent with any plan under which such
Equity Awards are granted and the terms of the applicable agreement for such Equity Awards. Notwithstanding the foregoing, any and all
outstanding unvested Equity Awards shall automatically become fully vested and exercisable on an accelerated basis immediately prior to
any Change of Control that is consummated at any time after the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I><U>Expense
Reimbursement and Other Benefits</U></I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Reimbursement
of Expenses</I></B>. Upon the submission of proper substantiation by the Executive, and subject to such rules&nbsp;and guidelines as the
Company may from time to time adopt with respect to the reimbursement of expenses of executive personnel, the Company shall reimburse
the Executive for all reasonable expenses actually paid or incurred by the Executive during the Term of Employment in the course of and
pursuant to the business of the Company. The Executive shall account to the Company in writing for all expenses for which reimbursement
is sought and shall supply to the Company copies of all relevant invoices, receipts or other evidence reasonably requested by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Compensation/Benefit
Programs</I></B>. During the Term of Employment, the Executive shall be entitled to participate in all benefit plans on the same basis
as similarly situated executives in the Company&rsquo;s benefit plans in effect from time to time during Executive&rsquo;s employment.
All matters of eligibility for coverage or benefits under any benefit plan shall be determined in accordance with the provisions of such
plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Working
Facilities</I></B>. During the Term of Employment, the Company shall furnish the Executive with an office, administrative help, and such
other facilities and services suitable to his position and adequate for the performance of his duties hereunder. The Executive&rsquo;s
principal place of employment (subject to reasonable travel) shall be New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Vacation</I></B>.
The Executive shall be entitled to paid vacation each calendar year during the Term of Employment pursuant to the policies of the Company
applicable to Executives, to be taken at such times as the Executive and the Company shall mutually determine and provided that no vacation
time shall significantly interfere with the duties required to be rendered by the Executive hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Termination</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>General</I></B>.
The Term of Employment shall terminate upon the earliest to occur of (i)&nbsp;the Executive&rsquo;s death, (ii)&nbsp;a termination by
the Company by reason of the Executive&rsquo;s Disability, (iii)&nbsp;a termination by the Company with or without Cause, or (iv)&nbsp;a
termination by Executive with or without Good Reason. Upon any termination of Executive&rsquo;s employment for any reason, except as may
otherwise be requested by the Company in writing and agreed upon in writing by Executive, the Executive shall resign from any and all
directorships, committee memberships or any other positions Executive holds with the Company or any of its Related Entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Termination
By Company for Cause.</I></B> In the event the Executive is terminated by the Company for Cause, the Company&rsquo;s obligation to make
payments under this Agreement shall cease upon the Date of Termination, except that the Company shall pay Executive any Base Salary earned
but unpaid prior to termination, all accrued but unused vacation and any business expenses that were incurred but not reimbursed as of
the Date of Termination. Vesting of any unvested stock options and/or other equity securities shall cease on the Date of Termination,
unless otherwise provided in any plan, instrument or agreement to which such unvested stock options and/or other equity securities may
be subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Disability</I></B>.
The Company shall have the option, in accordance with applicable law, to terminate the Term of Employment upon written notice to the Executive,
at any time during which the Executive is suffering from a Disability. In the event that the Term of Employment is terminated due to the
Executive&rsquo;s Disability, the Executive shall be entitled to (i)&nbsp;the Accrued Obligations, payable as and when those amounts would
have been paid had the Term of Employment not ended, and (ii)&nbsp;any insurance benefits to which he and his beneficiaries are entitled
as a result of his Disability. Vesting of any unvested stock options and/or other equity securities shall cease on the Date of Termination,
unless otherwise provided in any plan, instrument or agreement to which such unvested stock options and/or other equity securities may
be subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Death</I></B>.
In the event that the Term of Employment is terminated due to the Executive&rsquo;s death, the Executive&rsquo;s estate shall be entitled
to (i)&nbsp;the Accrued Obligations, payable as and when those amounts would have been paid had the Term of Employment not ended, and
(ii)&nbsp;any insurance benefits to which he and his beneficiaries are entitled as a result of his death. Vesting of any unvested stock
options and/or other equity securities shall cease on the Date of Termination, unless otherwise provided in any plan, instrument or agreement
to which such unvested stock options and/or other equity securities may be subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Termination
Without Cause or Resignation With Good Reason</I></B>. The Company may terminate the Term of Employment without Cause, and the Executive
may terminate the Term of Employment for Good Reason, at any time upon written notice, and upon compliance with Section&nbsp;6(g)&nbsp;below.
If the Term of Employment is terminated by the Company without Cause (other than due to the Executive&rsquo;s death or Disability) or
by the Executive for Good Reason, the Executive shall be entitled to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Accrued Obligations, payable as and when those amounts would have been paid had the Term of Employment not ended;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Severance Amount, payable in equal installments consistent with the Company&rsquo;s normal payroll schedule over the twelve (12)-month
period beginning with the first regularly scheduled payroll date that occurs more than thirty (30) days following the Termination Date;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Provided
that the Executive timely elects continued coverage under COBRA, the Company will reimburse the Executive for the monthly COBRA cost of
continued health and dental coverage of the Executive and his qualified beneficiaries paid by the Executive under the health and dental
plans of the Company, less the amount that the Executive would be required to contribute for health and dental coverage if the Executive
were an active employee of the Company, for twelve (12) months (or, if less, for the duration that such COBRA coverage is available to
Executive), payable in equal installments consistent with the Company&rsquo;s normal payroll schedule over the twelve (12)-month period
beginning with the first regularly scheduled payroll date that occurs more than thirty (30) days following the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Termination
by Executive Without Good Reason</I></B>. The Executive may terminate his employment without Good Reason at any time by providing the
Company 30 days&rsquo; written notice of such termination. In the event of a termination of employment by the Executive under this Section&nbsp;6(f),
the Executive shall be entitled only to the Accrued Obligations payable as and when those amounts would have been payable had the Term
of Employment not ended. In the event of termination of the Executive&rsquo;s employment under this Section&nbsp;6(f), the Company may,
in its sole and absolute discretion, by written notice, accelerate the Date of Termination and still have it treated as a termination
without Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Release</I></B>.
All rights, payments and benefits due to the Executive under this Article&nbsp;6 (other than the Accrued Obligations) shall be conditioned
on the Executive&rsquo;s execution of a general release of claims against the Company and its affiliates substantially in the form attached
hereto as <U>Exhibit&nbsp;A</U> within 60 days of the Date of Termination (the &ldquo;<B><I>Release</I></B>&rdquo;) and on that Release
becoming irrevocable within sixty (60) days following the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Section&nbsp;280G
Certain Reductions of Payments by the Company</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that a Change in Control occurs at any time during the Term of Employment, and the severance and other benefits provided for
in this Agreement or otherwise payable to Executive (a)&nbsp;constitute &ldquo;parachute payments&rdquo; within the meaning of Section&nbsp;280G
of the Code and (b)&nbsp;but for this Section, would be subject to the excise tax imposed by Section&nbsp;4999 of the Code, then Executive&rsquo;s
severance and other benefits constituting parachute payments will be either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;delivered
in full, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;delivered
as to such lesser extent which would result in no portion of such severance and other benefits being subject to the excise tax under Section&nbsp;4999
of the Code,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">whichever of the foregoing amounts, taking into
account the applicable federal, state and local income taxes and the excise tax imposed by Section&nbsp;4999 of the Code, results in the
receipt by Executive, on an after-tax basis, of the greatest amount of severance and other benefits, notwithstanding that all or some
portion of such severance and other benefits may be taxable under Section&nbsp;4999 of the Code.&nbsp; If a reduction in the severance
and other benefits constituting &ldquo;parachute payments&rdquo; is necessary so that no portion of such severance and other benefits
is subject to the excise tax under Section&nbsp;4999 of the Code, the reduction shall occur in the following order:&nbsp; (a)&nbsp;reduction
of the cash severance payments; (b)&nbsp;cancellation of accelerated vesting of equity awards; and (c)&nbsp;reduction of continued employee
benefits.&nbsp; In the event that acceleration of vesting of equity award compensation is to be reduced, such acceleration of vesting
shall be cancelled in the reverse order of the date of grant of Executive&rsquo;s equity awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;A
nationally recognized certified professional services firm selected by the Company, the Company&rsquo;s legal counsel or such other person
or entity to which the parties mutually agree (the &ldquo;<B>Firm</B>&rdquo;) shall perform the foregoing calculations related to the
Excise Tax.&nbsp; The Company shall bear all expenses with respect to the determinations by the Firm required to be made hereunder.&nbsp;
For purposes of making the calculations required by this Section&nbsp;6(h),&nbsp;the Firm may make reasonable assumptions and approximations
concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999
of the Code.&nbsp; The Company and Executive will furnish to the Firm such information and documents as the Firm may reasonably request
in order to make a determination under this Section&nbsp;6(h).&nbsp; The Firm engaged to make the determinations hereunder shall provide
its calculations, together with detailed supporting documentation, to the Company and Executive within 15 calendar days after the date
on which Executive&rsquo;s right to the severance benefits or other payments is triggered (if requested at that time by the Company or
Executive) or such other time as requested by the Company or Executive.&nbsp; Any good faith determinations of the Firm made hereunder
shall be final, binding, and conclusive upon the Company and Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Cooperation</I></B>.
Following the Term of Employment, the Executive shall give his assistance and cooperation willingly, upon reasonable advance notice with
due consideration for his other business or personal commitments, in any matter relating to his position with the Company, or his expertise
or experience as the Company may reasonably request, including his attendance and truthful testimony where deemed appropriate by the Company,
with respect to any investigation or the Company&rsquo;s defense or prosecution of any existing or future claims or litigations or other
proceedings relating to matters in which he was involved or potentially had knowledge by virtue of his employment with the Company. In
no event shall his cooperation materially interfere with his services for a subsequent employer or other similar service recipient. To
the extent permitted by law, the Company agrees that (i)&nbsp;it shall promptly reimburse the Executive for his reasonable and documented
expenses in connection with him rendering assistance and/or cooperation under this Section&nbsp;6(i)&nbsp;upon his presentation of documentation
for such expenses and (ii)&nbsp;the Executive shall be reasonably compensated for any continued material services as required under this
Section&nbsp;6(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Return
of Company Property</I></B>. Following the Termination Date, the Executive or his personal representative shall immediately return all
Company property in his possession, including but not limited to all computer equipment (hardware and software), telephones, facsimile
machines, tablets and other communication devices, credit cards, office keys, security access cards, badges, identification cards and
all copies (including drafts) of any documentation or information (however stored) relating to the business of the Company, its customers
and clients or its prospective customers and clients (provided that the Executive may retain a copy of the addresses contained in his
rolodex, smartphone or similar device or the Company and, at the Executive&rsquo;s request, the Company shall provide a thumb drive of
his contacts).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Compliance
with Section&nbsp;409A</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>General</I></B>.
It is the intention of both the Company and the Executive that the benefits and rights to which the Executive could be entitled pursuant
to this Agreement comply with Section&nbsp;409A of the Code and the Treasury Regulations and other guidance promulgated or issued thereunder
(&ldquo;<B><I>Section&nbsp;409A</I></B>&rdquo;), to the extent that the requirements of Section&nbsp;409A are applicable thereto, and
the provisions of this Agreement shall be construed in a manner consistent with that intention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Distributions
on Account of Separation from Service</I></B>. If and to the extent required to comply with Section&nbsp;409A, no payment or benefit required
to be paid under this Agreement on account of termination of the Executive&rsquo;s employment shall be made unless and until the Executive
incurs a &ldquo;separation from service&rdquo; within the meaning of Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Six
Month Delay for Specified Employees</I></B>. If the Executive is a &ldquo;specified employee&rdquo; (within the meaning of Section&nbsp;409A(a)(2)(B)(i)&nbsp;of
the Code), then no payment or benefit that is payable on account of the Executive&rsquo;s &ldquo;separation from service&rdquo;, as that
term is defined for purposes of Section&nbsp;409A, shall be made before the date that is six (6)&nbsp;months after the Executive&rsquo;s
&ldquo;separation from service&rdquo; (or, if earlier, the date of the Executive&rsquo;s death) if and to the extent that such payment
or benefit constitutes deferred compensation (or may be nonqualified deferred compensation) under Section&nbsp;409A and such deferral
is required to comply with the requirements of Section&nbsp;409A. Any payment or benefit delayed by reason of the prior sentence shall
be paid out or provided in a single lump sum at the end of such required delay period in order to catch up to the original payment schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Treatment
of Each Installment as a Separate Payment</I></B>. For purposes of applying the provisions of Section&nbsp;409A to this Agreement, each
separately identified amount to which the Executive is entitled under this Agreement shall be treated as a separate payment. In addition,
any series of installment payments under this Agreement shall be treated as a right to a series of separate payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Taxable
Reimbursements and In-Kind Benefits</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
reimbursements by the Company to the Executive of any eligible expenses under this Agreement that are not excludable from the Executive&rsquo;s
income for Federal income tax purposes (the &ldquo;<B><I>Taxable Reimbursements</I></B>&rdquo;) shall be made by no later than the last
day of the taxable year of the Executive following the year in which the expense was incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
amount of any Taxable Reimbursements, and the value of any in-kind benefits to be provided to the Executive, during any taxable year of
the Executive shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year
of the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(C)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
right to Taxable Reimbursement, or in-kind benefits, shall not be subject to liquidation or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Company
Discretion</I></B>. Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that the payment of
the COBRA premiums under Section&nbsp;6(e)(iv)&nbsp;above would result in a violation of the nondiscrimination rules&nbsp;of Section&nbsp;105(h)(2)&nbsp;of
the Code or any statute or regulation of similar effect (including but not limited to the 2010 Patient Protection and Affordable Care
Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of providing the COBRA premiums, the Company may
instead pay Executive, fully taxable cash payments equal to and paid at the same time as the COBRA premiums that otherwise would have
been paid, subject to applicable tax withholdings. In the event the COBRA premium reimbursement is made on an after-tax basis, the Company
will provide a tax gross-up to the Executive equal to the amount of taxes withheld on the COBRA premium reimbursement with such amount
to be paid at the same time of the COBRA premium reimbursement. To receive the payments under Section&nbsp;6(e)(ii)&nbsp;above, Executive&rsquo;s
termination or resignation must constitute a &ldquo;separation from service<B>&rdquo; </B>within the meaning of Section&nbsp;409A, and
Executive must execute and allow the Release to become effective within sixty (60) days of Executive&rsquo;s termination or resignation.
Such payments shall not be paid prior to the sixtieth (60th) day following Executive&rsquo;s termination or resignation, rather, subject
to the aforementioned conditions, on the sixtieth (60th) day following Executive&rsquo;s termination or resignation, the Company will
pay Executive such payments in a lump sum that Executive would have received on or prior to such date under the original schedule, with
the balance of such payments being paid as originally scheduled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Timing
of Payment and Execution of Release</I>. </B>Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing
of the execution of the Release, directly or indirectly, result in the Executive designating the calendar year of a payment, and if a
payment that is subject to execution of the Release could be made in more than one taxable year, payment shall be made in the later taxable
year to the extent required under Section&nbsp;409A. In no event may the Executive, directly or indirectly, designate the calendar year
of a payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(viii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>No
Guaranty of 409A Compliance</I></B>. Notwithstanding the foregoing, the Company does not make any representation to the Executive that
the payments or benefits provided under this Agreement are exempt from, or satisfy, the requirements of Section&nbsp;409A, and the Company
shall have no liability or other obligation to indemnify or hold harmless the Executive or any beneficiary of the Executive for any tax,
additional tax, interest or penalties that the Executive or any beneficiary of the Executive may incur in the event that any provision
of this Agreement, or any amendment or modification thereof, or any other action taken with respect thereto, is deemed to violate any
of the requirements of Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Proprietary
Information,&nbsp;Invention, Non-Competition, and Non-Solicitation</I></B>. The Executive and the Company have entered into that certain
Employee Proprietary Information,&nbsp;Invention, Non-Competition and Non-Solicitation Agreement, dated as of October&nbsp;__, 2025, between
the Company and the Executive (the &ldquo;Confidentiality Agreement&rdquo;), and the terms and provisions of the Confidentiality Agreement
shall be incorporated into this Agreement by reference for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Representations
and Warranties of Executive</I></B>. The Executive represents and warrants to the Company that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Executive&rsquo;s employment has not conflicted with or resulted in, and will not conflict with or result in, his breach of any agreement
to which he is a party or otherwise may be bound;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Executive has not violated, and in connection with his employment with the Company will not violate, any non-solicitation, non-competition
or other similar covenant or agreement of a prior employer by which he is or may be bound; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
connection with Executive&rsquo;s employment with the Company, he has not used, and will not use, any confidential or proprietary information
that he may have obtained in connection with employment with any prior employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Taxes</I></B>.
All payments or transfers of property made by the Company to the Executive or his estate or beneficiaries shall be subject to the withholding
of such amounts relating to taxes as the Company may reasonably determine it should withhold pursuant to any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Assignment</I></B>.
The Company shall have the right to assign this Agreement and its rights and obligations hereunder in whole, but not in part, to any corporation
or other entity with or into which the Company may hereafter merge or consolidate or to which the Company may transfer all or substantially
all of its assets, if in any such case said corporation or other entity shall by operation of law or expressly in writing assume all obligations
of the Company hereunder as fully as if it had been originally made a party hereto, but may not otherwise assign this Agreement or its
rights and obligations hereunder. The Executive may not assign or transfer this Agreement or any rights or obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Governing
Law</I></B>. This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the Commonwealth of
Massachusetts, without regard to principles of conflict of laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">12.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Jurisdiction
and Venue</I></B>. The parties acknowledge that a substantial portion of the negotiations, anticipated performance and execution of this
Agreement occurred or shall occur in Cambridge, Massachusetts, and that, therefore, without limiting the jurisdiction or venue of any
other federal or state courts, each of the parties irrevocably and unconditionally (i)&nbsp;agrees that any suit, action or legal proceeding
arising out of or relating to this Agreement which is expressly permitted by the terms of this Agreement to be brought in a court of law,
may be brought in the courts of record of the Commonwealth of Massachusetts (Middlesex or Suffolk Counties) or the court of the United
States, District of Massachusetts; (ii)&nbsp;consents to the jurisdiction of each such court in any such suit, action or proceeding; (iii)&nbsp;waives
any objection which it or he may have to the laying of venue of any such suit, action or proceeding in any of such courts; and (iv)&nbsp;agrees
that service of any court papers may be effected on such party by mail, as provided in this Agreement, or in such other manner as may
be provided under applicable laws or court rules&nbsp;in such courts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">13.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Entire
Agreement;; Amendment</I></B>. This Agreement, together with the exhibit attached hereto, constitutes the entire agreement between the
parties hereto with respect to the subject matter hereof and, upon its effectiveness, shall supersede all prior agreements, understandings
and arrangements, both oral and written, between the Executive and the Company (or any of its Related Entities) with respect to such subject
matter. This Agreement may not be modified in any way unless by a written instrument signed by both the Company and the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Notices</I></B>.
All notices required or permitted to be given hereunder shall be in writing and shall be personally delivered by courier, sent by registered
or certified mail, return receipt requested or sent by confirmed facsimile transmission addressed as set forth herein. Notices personally
delivered, sent by facsimile or sent by overnight courier shall be deemed given on the date of delivery and notices mailed in accordance
with the foregoing shall be deemed given upon receipt by the addressee, as evidenced by the return receipt thereof. Notice shall be sent
(i)&nbsp;if to the Company, addressed to its headquarters, Attention: President, and (ii)&nbsp;if to the Executive, to his address as
reflected on the payroll records of the Company, or to such other address as either party shall request by notice to the other in accordance
with this provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Benefits;
Binding Effect.</I></B> This Agreement shall be for the benefit of and binding upon the parties hereto and their respective heirs, personal
representatives, legal representatives, successors and, where permitted and applicable, assigns, including, without limitation, any successor
to the Company, whether by merger, consolidation, sale of stock, sale of assets or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">16.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Right
to Consult with Counsel; No Drafting Party</I></B>. The Executive acknowledges having read and considered all of the provisions of this
Agreement carefully, and having had the opportunity to consult with counsel of his own choosing, and, given this, the Executive agrees
that the obligations created hereby are not unreasonable. The Executive acknowledges that he has had an opportunity to negotiate any and
all of these provisions and no rule&nbsp;of construction shall be used that would interpret any provision in favor of or against a party
on the basis of who drafted the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">17.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Severability</I></B>.
The invalidity of any one or more of the words, phrases, sentences, clauses, provisions, sections or articles contained in this Agreement
shall not affect the enforceability of the remaining portions of this Agreement or any part thereof, all of which are inserted conditionally
on their being valid in law, and, in the event that any one or more of the words, phrases, sentences, clauses, provisions, sections or
articles contained in this Agreement shall be declared invalid, this Agreement shall be construed as if such invalid word or words, phrase
or phrases, sentence or sentences, clause or clauses, provisions or provisions, section or sections or article or articles had not been
inserted. If such invalidity is caused by length of time or size of area, or both, the otherwise invalid provision will be considered
to be reduced to a period or area which would cure such invalidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">18.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Waivers</I></B>.
The waiver by either party hereto of a breach or violation of any term or provision of this Agreement shall not operate nor be construed
as a waiver of any subsequent breach or violation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">19.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Damages;
Attorneys&rsquo; Fees</I></B>. Nothing contained herein shall be construed to prevent the Company or the Executive from seeking and recovering
from the other damages sustained by either or both of them as a result of its or his breach of any term or provision of this Agreement.
Each party shall bear its own costs and attorneys&rsquo; fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">20.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Waiver
of Jury Trial</I></B>. The Executive hereby knowingly, voluntarily and intentionally waives any right that the Executive may have to a
trial by jury in respect of any litigation based hereon, or arising out of, under or in connection with this Agreement and any agreement,
document or instrument contemplated to be executed in connection herewith, or any course of conduct, course of dealing statements (whether
verbal or written) or actions of any party hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">21.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>No
Set-off or Mitigation</I></B>. The Company&rsquo;s obligation to make the payments provided for in this Agreement and otherwise to perform
its obligations hereunder shall not be affected by any set off, counterclaim, recoupment, defense or other claim, right or action which
the Company may have against the Executive or others. In the event of any termination of the Executive&rsquo;s employment under this Agreement,
he shall be under no obligation to seek other employment or otherwise in any way to mitigate the amount of any payment provided for hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">22.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>Defend
Trade Secrets Act</B>. Pursuant to 18 U.S.C. &sect; 1833(b), Executive will not be held criminally or civilly liable under any Federal
or State trade secret law for the disclosure of a trade secret of the Company or its affiliates that (a)&nbsp;is made (i)&nbsp;in confidence
to a Federal, State, or local government official, either directly or indirectly, or to Executive's attorney and (ii)&nbsp;solely for
the purpose of reporting or investigating a suspected violation of law; or (b)&nbsp;is made in a complaint or other document that is filed
under seal in a lawsuit or other proceeding. If Executive files a lawsuit for retaliation by the Company for reporting a suspected violation
of law, Executive may disclose the trade secret to Executive's attorney and use the trade secret information in the court proceeding,
if Executive (x)&nbsp;files any document containing the trade secret under seal, and (y)&nbsp;does not disclose the trade secret, except
pursuant to court order. Nothing in this Agreement is intended to conflict with 18 U.S.C. &sect; 1833(b)&nbsp;or create liability for
disclosures of trade secrets that are expressly allowed by such section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">23.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Section&nbsp;Headings</I></B>.
The article, section and paragraph headings contained in this Agreement are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">24.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>No
Third Party Beneficiary</I></B>. The Related Entities are intended third party beneficiaries of this Agreement. Otherwise, nothing expressed
or implied in this Agreement is intended, or shall be construed, to confer upon or give any person other than the Company, the parties
hereto and their respective heirs, personal representatives, legal representatives, successors and permitted assigns, any rights or remedies
under or by reason of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">25.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B><I>Counterparts</I></B>.
This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together
shall constitute one and the same instrument and agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have executed this Agreement on the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">COMPANY:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">LEAP THERAPEUTICS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:&#8239;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/ Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Douglas E. Onsi</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">President&nbsp;&amp; Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">EXECUTIVE:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ William McEvoy</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: William McEvoy</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Employment Agreement
(William McEvoy)</I>]</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><U>Exhibit&nbsp;A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>General Release of Claims</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[_________]
(&ldquo;<B><I>Executive</I></B>&rdquo;), for himself and his family, heirs, executors, administrators, legal representatives and their
respective successors and assigns, in exchange for the consideration (other than the Accrued Obligations) received pursuant to Article&nbsp;6
of the Employment Agreement (the &ldquo;<B><I>Severance Benefits</I></B>&rdquo;) to which this release is attached as <U>Exhibit&nbsp;A</U>
(the &ldquo;<B><I>Employment Agreement</I></B>&rdquo;), does hereby release and forever discharge Leap Therapeutics,&nbsp;Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;),
its subsidiaries, affiliated companies, successors and assigns, and its current or former directors, officers, employees, stockholders
or agents in such capacities (collectively with the Company, the &ldquo;<B><I>Released Parties</I></B>&rdquo;) from any and all actions,
causes of action, suits, controversies, claims and demands whatsoever, whether known or unknown, from the beginning of time through the
date upon which Executive signs this General Release of Claims, including, without limitation, claims under any applicable laws, in each
case in connection with Executive's employment or termination thereof, whether for tort, breach of express or implied employment contract,
wrongful discharge, intentional infliction of emotional distress, or defamation or injuries incurred on the job or incurred as a result
of loss of employment. Without limiting the generality of the release provided above, Executive expressly waives any and all claims under
Age Discrimination in Employment Act (&ldquo;<B><I>ADEA</I></B>&rdquo;) that he may have as of the date hereof. Executive further understands
that, by signing this General Release of Claims, he is in fact waiving, releasing and forever giving up any claim under the ADEA as well
as all other laws within the scope of this paragraph 1 that may have existed on or prior to the date hereof, including, but not limited
to, [<I>additional citations to be added prior to execution at the time of separation</I>]. Notwithstanding anything in this paragraph
1 to the contrary, this General Release of Claims shall not apply to (i)&nbsp;any rights to receive any payments or benefits to which
the Executive is entitled under the Employment Agreement or COBRA, (ii)&nbsp;any rights or claims that may arise as a result of events
occurring after the date this General Release of Claims is executed, (iii)&nbsp;any indemnification and advancement rights Executive may
have as a former employee, officer or director of the Company or its subsidiaries or affiliated companies (including any rights under
any directors' and officers' indemnification agreement or under the Company&rsquo;s charter or bylaws), (iv)&nbsp;any claims for benefits
under any directors' and officers' liability policy maintained by the Company or its subsidiaries or affiliated companies in accordance
with the terms of such policy, (v)&nbsp;rights to vested benefits under the Company&rsquo;s 401(k)&nbsp;plan or other employee benefits
plans, (vi)&nbsp;any rights as a holder of equity securities or debt securities/notes of the Company and (vii)&nbsp;any rights that Executive
may have under any contracts or agreements with the Company or any of its subsidiaries or affiliated companies (other than the Employment
Agreement) to the extent that such rights do not pertain to compensation or remuneration in connection with Executive&rsquo;s employment
with the Company or any of its subsidiaries or affiliated companies or the termination of such employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive
represents that he has not filed against the Released Parties any complaints, charges, or lawsuits arising out of his employment, or any
other matter arising on or prior to the date of this General Release of Claims, and covenants and agrees that he will never individually
or with any person file, or commence the filing of any lawsuits, complaints or proceedings with any governmental agency, or against the
Released Parties with respect to any of the matters released by Executive pursuant to paragraph 1 hereof; provided, that nothing herein
shall prevent Executive from filing a charge or complaint with the Equal Employment Opportunity Commission (&ldquo;<B><I>EEOC</I></B>&rdquo;)
or similar federal or state agency or Executive&rsquo;s ability to participate in any investigation or proceeding conducted by such agency.
Executive does agree, however, that he is waiving his right to recover any money in connection with such an investigation or charge filed
by him or by any other individual, or a charge filed by the Equal Employment Opportunity Commission or any other federal, state or local
agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 76; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive
acknowledges that, in the absence of his execution of this General Release of Claims, the Severance Benefits would not otherwise be due
to him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive
acknowledges and agrees that he received adequate consideration in exchange for agreeing to the covenants contained in the Confidentiality
Agreement and incorporated into the Employment Agreement by virtue of Section&nbsp;7 of the Employment Agreement, that such covenants
remain reasonable and necessary to protect the legitimate business interests of the Company and its affiliates and that he will continue
to comply with those covenants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive
hereby acknowledges that the Company has informed him that he has up to twenty-one (21) days to sign this General Release of Claims and
he may knowingly and voluntarily waive that twenty-one (21)-day period by signing this General Release of Claims earlier. Executive is
advised to consult with an attorney before signing this General Release of Claims. Executive also understands that he shall have seven
(7)&nbsp;days following the date on which he signs this General Release of Claims within which to revoke it by providing a written notice
of his revocation to the Company in the manner described in Section&nbsp;14 of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive
expressly acknowledges and agrees that Executive will not make any statements that are professionally or personally disparaging about,
or adverse to, the Company or its business (including its officers, directors, employees and consultants) including, but not limited to,
any statements that disparage any person, product, service, finances, financial condition, capability or any other aspect of the business
of the Company, and that Executive shall not engage in any conduct which could reasonably be expected to harm professionally or personally
the reputation of the Company (including its officers, directors, employees and consultants). Notwithstanding the foregoing, Executive
shall not be (i)&nbsp;required to make any statement Executive believes to be false or inaccurate or (ii)&nbsp;restricted in connection
with any litigation, arbitration or similar proceeding or with respect to Executive&rsquo;s response to any legal process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive
acknowledges and agrees that this General Release of Claims will be governed by and construed and enforced in accordance with the internal
laws of the Commonwealth of Massachusetts applicable to contracts made and to be performed entirely within such state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Executive
acknowledges that he has read this General Release of Claims, that he has been advised that he should consult with an attorney before
he executes this general release of claims, and that he understands all of its terms and executes it voluntarily and with full knowledge
of its significance and the consequences thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
General Release of Claims shall become irrevocable on the eighth day following Executive's execution of this General Release of Claims,
unless previously revoked in accordance with paragraph 5, above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Intending to be legally bound
hereby, Executive has executed this General Release of Claims on ___________&nbsp;____, ______.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">EXECUTIVE:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="ss06"></A>Exhibit&nbsp;10.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEAP THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2016 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RESTRICTED STOCK UNIT GRANT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This RESTRICTED STOCK UNIT
GRANT AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;), dated as of November&nbsp;11, 2025 (the &ldquo;<U>Date of Grant</U>&rdquo;), is
delivered by Leap Therapeutics,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;) to __________ (the &ldquo;<U>Participant</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>RECITALS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Leap Therapeutics,&nbsp;Inc.
2016 Equity Incentive Plan, as amended and in effect on the date hereof (the &ldquo;Plan&rdquo;), provides for the grant of Restricted
Stock Units (as defined in the Plan) in accordance with the terms and conditions of the Plan. The Committee (as defined in the Plan) has
decided to make this grant of Restricted Stock Units as an inducement for the Participant to promote the best interests of the Company
and its stockholders. This Agreement is made pursuant to the Plan and is subject in its entirety to all applicable provisions of the Plan.
Capitalized terms used herein and not otherwise defined will have the meanings set forth in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
of Restricted Stock Units</U>. Subject to the terms, conditions and restrictions set forth in this Agreement and in the Plan, the Company
hereby grants the Participant ________ Restricted Stock Units (the &ldquo;<U>Stock Units</U>&rdquo;). Each Stock Unit represents the right
of the Participant to receive a share of common stock of the Company (&ldquo;<U>Stock</U>&rdquo;) on the applicable settlement date set
forth in Section&nbsp;5 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Rights Prior to Settlement</U>. Stock Units represent hypothetical shares of Stock, and not actual shares of Stock. No shares of Stock
shall be issued to the Participant at the time the grant of the Stock Units is made, and the Participant shall not be, and shall not have
any of the rights or privileges of, a stockholder of the Company with respect to any Stock Units. The Participant shall not have any interest
in any fund or specific assets of the Company by reason of this award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Vesting</U>.
As of the date of this Agreement, all of the Stock Units shall be fully vested and shall not be subject to any Risk of Forfeiture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Settlement
of Stock Units and Tax Withholding</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
to the provisions of this Section&nbsp;4(a)&nbsp;and Sections 4(b), 4(c)&nbsp;and 11 below, the Company shall issue to the Participant
one share of Stock for each Stock Unit, subject to applicable tax withholding obligations, on [alt 1: the fifth (5<SUP>th</SUP>) business
day after the Date of Grant] [alt 2: as soon as practicable following the earlier to occur of (1)&nbsp;the date the Participant ceases
for any reason to be a member of the Company&rsquo;s Board of Directors or (2)&nbsp;the date of the first annual meeting of stockholders
of the Company that occurs following the Date of Grant]<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT>; <U>provided</U>, <U>however</U>,
that the Company shall not be required to issue to Participant any share of Stock pursuant to the foregoing provisions of this Section&nbsp;4(a)&nbsp;with
respect to any Stock Unit (or otherwise settle any such Stock Unit in shares of Stock) on any date that the Committee, in its sole discretion,
determines Participant is subject to any limitation or restriction (including, without limitation, (1)&nbsp;any limitation or restriction
under the Company&rsquo;s insider trading policy as then in effect and (2)&nbsp;any limitation or restriction imposed by securities laws
or other laws such as Rule&nbsp;144 promulgated under the Securities Act of 1933, as amended, and Section&nbsp;16(b)&nbsp;of the Securities
Exchange Act of 1934, as amended) that does not permit Participant to offer to sell or sell on the public market on such date all of the
shares of Stock that otherwise would be issued to Participant on such date pursuant to this Section&nbsp;4(a)&nbsp;in settlement of such
Stock Unit. Notwithstanding anything express or implied in the foregoing provisions of this Section&nbsp;4(a)&nbsp;to the contrary, in
no event shall settlement of a Stock Unit occur later than the fifteenth day of the third calendar month following the calendar year in
which the Date of Grant occurs, and in no event shall Participant be permitted, directly or indirectly, to designate the calendar year
of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
Chose the applicable settlement date alternative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>All
obligations of the Company under this Agreement shall be subject to the right of the Company as set forth in the Plan to require the Participant
to remit to the Company an amount sufficient to satisfy statutory minimum federal, state, local, foreign or other withholding tax requirements
if, when, and to the extent required by law prior to the issuance of shares of Stock. The obligations of the Company under this Agreement
shall be conditional on satisfaction of all such statutory minimum withholding obligations and the Company shall, to the extent permitted
by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant or to utilize any other
withholding method prescribed by the Committee from time to time. However, the Participant may elect, subject to the approval of the Committee,
acting in its sole discretion, to satisfy an applicable statutory minimum withholding requirement, in whole or in part, by having the
Company withhold shares of Stock to satisfy the Participant's tax obligations. Any such election shall be irrevocable, made in writing,
signed by the Participant, and shall be subject to any restrictions or limitations that the Committee deems appropriate. If shares of
Stock are withheld to satisfy an applicable withholding requirement, the shares of Stock withheld shall have a Market Value on the date
the tax is to be determined equal to the minimum statutory total tax that could be imposed on the transaction unless the Committee determines
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
obligation of the Company to deliver Stock shall also be subject to the condition that if at any time the Board shall determine in its
discretion that the listing, registration or qualification of any shares of Stock on any securities exchange or under any state or federal
law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with,
the issuance of such shares, such shares may not be issued in whole or in part unless such listing, registration, qualification, consent
or approval shall have been effected or obtained free of any conditions not acceptable to the Board. The issuance of shares of Stock,
if any, to the Participant pursuant to this Agreement is subject to any applicable taxes and other laws or regulations of the United States
or of any state, municipality or other country having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Stockholder Rights</U>. Neither the Participant, nor any person entitled to receive Stock Units in the event of the Participant&rsquo;s
death, shall have any of the rights and privileges of a stockholder with respect to shares of Stock, including voting or dividend rights,
until such shares of Stock have been issued upon settlement of Stock Units. The Participant acknowledges that no election under Section&nbsp;83(b)&nbsp;of
the Code is available with respect to Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
Subject to Plan Provisions</U>. This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and
in all respects shall be interpreted in accordance with the Plan. The grant and settlement of the Stock Units are subject to the provisions
of the Plan and to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee
in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (a)&nbsp;rights and obligations
with respect to withholding taxes, (b)&nbsp;the registration, qualification or listing of the shares of Stock, (c)&nbsp;changes in capitalization
of the Company and (d)&nbsp;other requirements of applicable law. The Committee shall have the authority to interpret and construe the
Stock Units pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Service or Other Rights</U>. The grant of the Stock Units shall not confer upon the Participant any right to be retained by or in the
employ or service of the Company or any Affiliate and shall not interfere in any way with the right of the Company or any Affiliate to
terminate the Participant&rsquo;s employment or service at any time. The right of the Company and any Affiliate to terminate at will the
Participant&rsquo;s employment or service at any time for any reason is specifically reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Assignment
and Transfers</U>. The Stock Units are not transferable, and shall not be sold, transferred, pledged, assigned, or otherwise alienated
or hypothecated, other than by will or by the laws of descent and distribution. All of the Participant's rights in the Stock Units may
be exercised during the life of the Participant only by the Participant or the Participant's legal representative. The rights and protections
of the Company hereunder shall extend to any successors or assigns of the Company and to its Affiliates. This Agreement may be assigned
by the Company without the Participant&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Governing
Law</U>. The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with
the laws of the Commonwealth of Massachusetts, without giving effect to the conflicts of laws provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice</U>.
Any notice to the Company provided for in this instrument shall be addressed to the Company in care of its Chief Financial Officer at
the Company's principal place of business, and any notice to the Participant shall be addressed to such Participant at his or her residence
address last filed with the Company. Any notice shall be delivered in accordance with Section&nbsp;17 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Application
of Section&nbsp;409A of the Code</U>. This Agreement is intended to be exempt from or otherwise comply with the provisions of Section&nbsp;409A
of the Code. To the extent subject to Section&nbsp;409A of the Code, settlement of the Stock Units may only be made in a manner and upon
an event permitted by Section&nbsp;409A of the Code, and each settlement of the Stock Units shall be treated as a separate payment, and
the right to a series of installment payments under the Stock Units shall be treated as a right to a series of separate payments. In no
event shall the Participant, directly or indirectly, designate the calendar year of payment. The Company may change or modify the terms
of this Agreement without the Participant&rsquo;s consent or signature if the Company determines, in its sole discretion, that such change
or modification is necessary for purposes of compliance with or exemption from the requirements of Section&nbsp;409A of the Code or any
regulations or other guidance issued thereunder. Notwithstanding the previous sentence, the Company may also amend the Plan or this Agreement
or revoke the Stock Units to the extent permitted by the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused its duly authorized officer to execute this Agreement, and the Participant has executed this Agreement, effective as of the
Date of Grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">LEAP THERAPEUTICS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby accept the award of Stock Units described
in this Agreement, and I agree to be bound by the terms of this Agreement and the incorporated provisions of the Plan. I hereby agree
that all decisions and determinations of the Committee with respect to the Stock Units shall be final and binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt">Date&#8239;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt">Participant</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><A NAME="ss07"></A>Exhibit 10.5</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEAP THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2022 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RESTRICTED STOCK UNIT GRANT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This RESTRICTED STOCK UNIT
GRANT AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;), dated as of November&nbsp;11, 2025 (the &ldquo;<U>Date of Grant</U>&rdquo;), is
delivered by Leap Therapeutics,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;) to __________ (the &ldquo;<U>Participant</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>RECITALS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Leap Therapeutics,&nbsp;Inc.
2022 Equity Incentive Plan, as amended and in effect on the date hereof (the &ldquo;Plan&rdquo;), provides for the grant of Restricted
Stock Units (as defined in the Plan) in accordance with the terms and conditions of the Plan. The Committee (as defined in the Plan) has
decided to make this grant of Restricted Stock Units as an inducement for the Participant to promote the best interests of the Company
and its stockholders. This Agreement is made pursuant to the Plan and is subject in its entirety to all applicable provisions of the Plan.
Capitalized terms used herein and not otherwise defined will have the meanings set forth in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
of Restricted Stock Units</U>. Subject to the terms, conditions and restrictions set forth in this Agreement and in the Plan, the Company
hereby grants the Participant ________ Restricted Stock Units (the &ldquo;<U>Stock Units</U>&rdquo;). Each Stock Unit represents the right
of the Participant to receive a share of common stock of the Company (&ldquo;<U>Stock</U>&rdquo;) on the applicable settlement date set
forth in Section&nbsp;5 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Rights Prior to Settlement</U>. Stock Units represent hypothetical shares of Stock, and not actual shares of Stock. No shares of Stock
shall be issued to the Participant at the time the grant of the Stock Units is made, and the Participant shall not be, and shall not have
any of the rights or privileges of, a stockholder of the Company with respect to any Stock Units. The Participant shall not have any interest
in any fund or specific assets of the Company by reason of this award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Vesting</U>.
As of the date of this Agreement, all of the Stock Units shall be fully vested and shall not be subject to any Risk of Forfeiture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Settlement
of Stock Units and Tax Withholding</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
to the provisions of this Section&nbsp;4(a)&nbsp;and Sections 4(b), 4(c)&nbsp;and 11 below, the Company shall issue to the Participant
one share of Stock for each Stock Unit, subject to applicable tax withholding obligations, on [alt 1: the fifth (5<SUP>th</SUP>) business
day after the Date of Grant] [alt 2: as soon as practicable following the earlier to occur of (1)&nbsp;the date the Participant ceases
for any reason to be a member of the Company&rsquo;s Board of Directors or (2)&nbsp;the date of the first annual meeting of stockholders
of the Company that occurs following the Date of Grant]<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT>; <U>provided</U>, <U>however</U>,
that the Company shall not be required to issue to Participant any share of Stock pursuant to the foregoing provisions of this Section&nbsp;4(a)&nbsp;with
respect to any Stock Unit (or otherwise settle any such Stock Unit in shares of Stock) on any date that the Committee, in its sole discretion,
determines Participant is subject to any limitation or restriction (including, without limitation, (1)&nbsp;any limitation or restriction
under the Company&rsquo;s insider trading policy as then in effect and (2)&nbsp;any limitation or restriction imposed by securities laws
or other laws such as Rule&nbsp;144 promulgated under the Securities Act of 1933, as amended, and Section&nbsp;16(b)&nbsp;of the Securities
Exchange Act of 1934, as amended) that does not permit Participant to offer to sell or sell on the public market on such date all of the
shares of Stock that otherwise would be issued to Participant on such date pursuant to this Section&nbsp;4(a)&nbsp;in settlement of such
Stock Unit. Notwithstanding anything express or implied in the foregoing provisions of this Section&nbsp;4(a)&nbsp;to the contrary, in
no event shall settlement of a Stock Unit occur later than the fifteenth day of the third calendar month following the calendar year in
which the Date of Grant occurs, and in no event shall Participant be permitted, directly or indirectly, to designate the calendar year
of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
Chose the applicable settlement date alternative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>All
obligations of the Company under this Agreement shall be subject to the right of the Company as set forth in the Plan to require the Participant
to remit to the Company an amount sufficient to satisfy statutory minimum federal, state, local, foreign or other withholding tax requirements
if, when, and to the extent required by law prior to the issuance of shares of Stock. The obligations of the Company under this Agreement
shall be conditional on satisfaction of all such statutory minimum withholding obligations and the Company shall, to the extent permitted
by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant or to utilize any other
withholding method prescribed by the Committee from time to time. However, the Participant may elect, subject to the approval of the Committee,
acting in its sole discretion, to satisfy an applicable statutory minimum withholding requirement, in whole or in part, by having the
Company withhold shares of Stock to satisfy the Participant's tax obligations. Any such election shall be irrevocable, made in writing,
signed by the Participant, and shall be subject to any restrictions or limitations that the Committee deems appropriate. If shares of
Stock are withheld to satisfy an applicable withholding requirement, the shares of Stock withheld shall have a Market Value on the date
the tax is to be determined equal to the minimum statutory total tax that could be imposed on the transaction unless the Committee determines
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
obligation of the Company to deliver Stock shall also be subject to the condition that if at any time the Board shall determine in its
discretion that the listing, registration or qualification of any shares of Stock on any securities exchange or under any state or federal
law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with,
the issuance of such shares, such shares may not be issued in whole or in part unless such listing, registration, qualification, consent
or approval shall have been effected or obtained free of any conditions not acceptable to the Board. The issuance of shares of Stock,
if any, to the Participant pursuant to this Agreement is subject to any applicable taxes and other laws or regulations of the United States
or of any state, municipality or other country having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Stockholder Rights</U>. Neither the Participant, nor any person entitled to receive Stock Units in the event of the Participant&rsquo;s
death, shall have any of the rights and privileges of a stockholder with respect to shares of Stock, including voting or dividend rights,
until such shares of Stock have been issued upon settlement of Stock Units. The Participant acknowledges that no election under Section&nbsp;83(b)&nbsp;of
the Code is available with respect to Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
Subject to Plan Provisions</U>. This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and
in all respects shall be interpreted in accordance with the Plan. The grant and settlement of the Stock Units are subject to the provisions
of the Plan and to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee
in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (a)&nbsp;rights and obligations
with respect to withholding taxes, (b)&nbsp;the registration, qualification or listing of the shares of Stock, (c)&nbsp;changes in capitalization
of the Company and (d)&nbsp;other requirements of applicable law. The Committee shall have the authority to interpret and construe the
Stock Units pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Service or Other Rights</U>. The grant of the Stock Units shall not confer upon the Participant any right to be retained by or in the
employ or service of the Company or any Affiliate and shall not interfere in any way with the right of the Company or any Affiliate to
terminate the Participant&rsquo;s employment or service at any time. The right of the Company and any Affiliate to terminate at will the
Participant&rsquo;s employment or service at any time for any reason is specifically reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Assignment
and Transfers</U>. The Stock Units are not transferable, and shall not be sold, transferred, pledged, assigned, or otherwise alienated
or hypothecated, other than by will or by the laws of descent and distribution. All of the Participant's rights in the Stock Units may
be exercised during the life of the Participant only by the Participant or the Participant's legal representative. The rights and protections
of the Company hereunder shall extend to any successors or assigns of the Company and to its Affiliates. This Agreement may be assigned
by the Company without the Participant&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Governing
Law</U>. The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with
the laws of the Commonwealth of Massachusetts, without giving effect to the conflicts of laws provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice</U>.
Any notice to the Company provided for in this instrument shall be addressed to the Company in care of its Chief Financial Officer at
the Company's principal place of business, and any notice to the Participant shall be addressed to such Participant at his or her residence
address last filed with the Company. Any notice shall be delivered in accordance with Section&nbsp;17 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Application
of Section&nbsp;409A of the Code</U>. This Agreement is intended to be exempt from or otherwise comply with the provisions of Section&nbsp;409A
of the Code. To the extent subject to Section&nbsp;409A of the Code, settlement of the Stock Units may only be made in a manner and upon
an event permitted by Section&nbsp;409A of the Code, and each settlement of the Stock Units shall be treated as a separate payment, and
the right to a series of installment payments under the Stock Units shall be treated as a right to a series of separate payments. In no
event shall the Participant, directly or indirectly, designate the calendar year of payment. The Company may change or modify the terms
of this Agreement without the Participant&rsquo;s consent or signature if the Company determines, in its sole discretion, that such change
or modification is necessary for purposes of compliance with or exemption from the requirements of Section&nbsp;409A of the Code or any
regulations or other guidance issued thereunder. Notwithstanding the previous sentence, the Company may also amend the Plan or this Agreement
or revoke the Stock Units to the extent permitted by the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused its duly authorized officer to execute this Agreement, and the Participant has executed this Agreement, effective as of the
Date of Grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">LEAP THERAPEUTICS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby accept the award of Stock Units described
in this Agreement, and I agree to be bound by the terms of this Agreement and the incorporated provisions of the Plan. I hereby agree
that all decisions and determinations of the Committee with respect to the Stock Units shall be final and binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt">Date&#8239;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt">Participant</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><A NAME="ss08"></A>Exhibit 10.6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEAP THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2016 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RESTRICTED STOCK UNIT GRANT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This RESTRICTED STOCK UNIT
GRANT AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;), dated as of November&nbsp;11, 2025 (the &ldquo;<U>Date of Grant</U>&rdquo;), is
delivered by Leap Therapeutics,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;) to __________ (the &ldquo;<U>Participant</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>RECITALS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Leap Therapeutics,&nbsp;Inc.
2016 Equity Incentive Plan, as amended and in effect on the date hereof (the &ldquo;<U>Plan</U>&rdquo;), provides for the grant of Restricted
Stock Units (as defined in the Plan) in accordance with the terms and conditions of the Plan. The Committee (as defined in the Plan) has
decided to make this grant of Restricted Stock Units as an inducement for the Participant to promote the best interests of the Company
and its stockholders. This Agreement is made pursuant to the Plan and is subject in its entirety to all applicable provisions of the Plan.
Capitalized terms used herein and not otherwise defined will have the meanings set forth in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
of Restricted Stock Units</U>. Subject to the terms, conditions and restrictions set forth in this Agreement and in the Plan, the Company
hereby grants the Participant ________ Restricted Stock Units (the &ldquo;<U>Stock Units</U>&rdquo;). Each Stock Unit represents the right
of the Participant to receive a share of common stock of the Company (&ldquo;<U>Stock</U>&rdquo;), if and when the specified conditions
are met in Section&nbsp;3 below, and on the applicable settlement date set forth in Section&nbsp;5 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Rights Prior to Settlement</U>. Stock Units represent hypothetical shares of Stock, and not actual shares of Stock. No shares of Stock
shall be issued to the Participant at the time the grant of the Stock Units is made, and the Participant shall not be, and shall not have
any of the rights or privileges of, a stockholder of the Company with respect to any Stock Units. The Participant shall not have any interest
in any fund or specific assets of the Company by reason of this award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Vesting</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
of the date of this Agreement, all of the Stock Units shall be unvested and subject to a Risk of Forfeiture pursuant to Section&nbsp;4
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
to the terms of this Section&nbsp;3, the Stock Units shall vest in accordance with the following vesting schedule: (i)&nbsp;12/36ths of
the Stock Units will vest on October&nbsp;8, 2026 and (ii)&nbsp;1/36<SUP>ths </SUP>of the Stock Units will vest on the eighth (8<SUP>th</SUP>)
day of each month thereafter, <U>provided</U> that the Participant continues to be employed by, or provide service as a consultant, director
or advisor of or to, the Company or one of its Affiliates from the Date of Grant until the Stock Units vest in accordance with the provisions
of this Section&nbsp;3. For purposes of this Agreement, the term &ldquo;<U>Vesting Date</U>&rdquo; shall mean a date on which any or all
of the Stock Units vest in accordance with the provisions of this Section&nbsp;3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
vesting of the Stock Units shall be cumulative, but shall not exceed 100% of the Stock Units. If the foregoing schedule would produce
fractional Stock Units, the number of Stock Units that vest shall be rounded down to the nearest whole Stock Unit and the fractional Stock
Units will be accumulated so that the resulting whole Stock Units will be included in the number of Stock Units that become vested on
the last Vesting Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>In
the event of a Change of Control or a Transaction before all of the Stock Units vest in accordance with Section&nbsp;3(a)&nbsp;above,
the applicable provisions of the Plan shall apply to the Stock Units, and the Committee may take such actions as it deems appropriate
pursuant to the provisions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>In
the event that (i)&nbsp;Participant&rsquo;s employment with the Company or any of its Affiliates is terminated at any time by the Company
or any of its Affiliates for any reason other than Cause (as defined in Section&nbsp;3(g)&nbsp;below) or is terminated at any time by
Participant for Good Reason (as defined in Section&nbsp;3(h)&nbsp;below) and (ii)&nbsp;immediately after any such termination of employment,
Participant does not have a service provider relationship of any kind (including, without limitation, as an officer, director, employee,
consultant or advisor) with any of the Company and its Affiliates, then, effective immediately prior to any such termination of employment,
any and all Stock Units that are then unvested and subject to Risk of Forfeiture pursuant to Section&nbsp;4 below shall automatically
become fully vested and free from Risk of Forfeiture pursuant to Section&nbsp;4 below. For clarity, and notwithstanding the foregoing
provisions of this Section&nbsp;3(e), this Section&nbsp;3(e)&nbsp;shall not be applicable to any termination of Participant&rsquo;s employment
with the Company or any of its Affiliates as a result of Participant&rsquo;s death or disability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Those
Stock Units that vest pursuant to this Section&nbsp;3 or pursuant to any action taken by the Committee pursuant to the Plan shall become
free from the Risk of Forfeiture pursuant to Section&nbsp;4 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>For
purposes of this Agreement, the term &ldquo;<U>Cause</U>&rdquo; shall mean the occurrence of any of the following: (i)&nbsp;a conviction
of Participant, or a plea of nolo contendere, to a felony (other than a felony related to the operation of a motor vehicle); or (ii)&nbsp;willful
misconduct or gross negligence by Participant resulting, in either case, in material harm to the Company or any of its Affiliates; or
(iii)&nbsp;a willful failure by Participant to carry out the reasonable and lawful directions of the Board and failure by Participant
to remedy such willful failure within thirty (30) days after receipt of written notice of same from the Board; or (iv)&nbsp;fraud, embezzlement,
theft or dishonesty of a material nature by Participant, or a willful material violation by Participant of a written policy or procedure
of the Company or any of its Affiliates, resulting, in any case, in material harm to the Company or any of its Affiliates; or (v)&nbsp;a
material breach by Participant of any agreement between Participant and the Company or any of its Affiliates, and failure by Participant
to remedy the material breach within thirty (30) days after receipt of written notice of such material breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>For
purposes of this Agreement, the term &ldquo;<U>Good Reason</U>&rdquo; shall mean the occurrence of any of the following: (i)&nbsp;the
occurrence of any of the following: (i)&nbsp;a material diminution in Participant&rsquo;s base salary; or (ii)&nbsp;the Company&rsquo;s
or any Affiliate of the Company requiring Participant to be based at any office or location outside of fifty (50) miles from Cambridge,
Massachusetts, except for travel reasonably required in the performance of Participant&rsquo;s responsibilities; or (iii)&nbsp;a material
breach by the Company or any Affiliate of the Company of any agreement between Participant and the Company or any Affiliate of the Company,
and failure by the Company or any Affiliate of the Company to remedy such material breach within thirty (30) days after receipt of written
notice of such material breach. For purposes of this Agreement, Good Reason shall not be deemed to exist unless Participant&rsquo;s termination
of employment for Good Reason occurs within one hundred eighty days following the initial existence of one of the conditions specified
in clauses (i)&nbsp;through (iii)&nbsp;above, Participant provides the Company with written notice of the existence of such condition
within ninety (90) days after the initial existence of the condition, and the Company or any Affiliate of the Company fails to remedy
the condition within thirty (30) days after the Company&rsquo;s receipt of such notice from Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Termination
of Stock Units</U>. Subject to the provisions of Section&nbsp;3(e)&nbsp;above, if the Participant ceases to be a service provider to the
Company and its Affiliates in all capacities as an employee, consultant, director and/or advisor of the Company and its Affiliates for
any reason before all of the Stock Units vest, any unvested Stock Units shall automatically terminate and shall be forfeited as of the
date of the Participant&rsquo;s termination of such employment or service. No settlement or payment shall be made with respect to any
unvested Stock Units that terminate as described in this Section&nbsp;4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Settlement
of Stock Units and Tax Withholding</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>If
a Stock Unit vests in accordance with the provisions of Section&nbsp;3 above, then, subject to the provisions of this Section&nbsp;5(a)&nbsp;and
Sections 5(b), 5(c)&nbsp;and 12 below, the Company shall issue to the Participant one share of Stock for such vested Stock Unit, subject
to applicable tax withholding obligations, on the earliest to occur of (1)&nbsp;the first payroll period on or after the date the Participant&rsquo;s
employment with or service to the Company ceases, (2)&nbsp;the first payroll period on or after the eighth (8<SUP>th</SUP>) day of the
calendar month of June&nbsp;following any such Vesting Date applicable to such vested Stock Unit or (3)&nbsp;the first payroll period
on or after the eighth (8<SUP>th</SUP>) day of the month of December&nbsp;following any such Vesting Date applicable to such vested Stock
Unit; <U>provided</U>, <U>however</U>, that the Company shall not be required to issue to Participant any share of Stock pursuant to the
foregoing provisions of this Section&nbsp;5(a)&nbsp;with respect to any vested Stock Unit (or otherwise settle any such vested Stock Unit
in shares of Stock) on any date that the Committee, in its sole discretion, determines Participant is subject to any limitation or restriction
(including, without limitation, (1)&nbsp;any limitation or restriction under the Company&rsquo;s insider trading policy as then in effect
and (2)&nbsp;any limitation or restriction imposed by securities laws or other laws such as Rule&nbsp;144 promulgated under the Securities
Act of 1933, as amended, and Section&nbsp;16(b)&nbsp;of the Securities Exchange Act of 1934, as amended) that does not permit Participant
to offer to sell or sell on the public market on such date all of the shares of Stock that otherwise would be issued to Participant on
such date pursuant to this Section&nbsp;5(a)&nbsp;in settlement of such vested Stock Unit. Notwithstanding anything express or implied
in the foregoing provisions of this Section&nbsp;5(a)&nbsp;to the contrary, in no event shall settlement of a vested Stock Unit occur
later than the fifteenth day of the third calendar month following the calendar year in which the Vesting Date applicable to such vested
Stock Unit occurs, and in no event shall Participant be permitted, directly or indirectly, to designate the calendar year of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>All
obligations of the Company under this Agreement shall be subject to the right of the Company as set forth in the Plan to require the Participant
to remit to the Company an amount sufficient to satisfy statutory minimum federal, state, local, foreign or other withholding tax requirements
if, when, and to the extent required by law prior to the issuance of shares of Stock. The obligations of the Company under this Agreement
shall be conditional on satisfaction of all such statutory minimum withholding obligations and the Company shall, to the extent permitted
by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant or to utilize any other
withholding method prescribed by the Committee from time to time. However, the Participant may elect, subject to the approval of the Committee,
acting in its sole discretion, to satisfy an applicable statutory minimum withholding requirement, in whole or in part, by having the
Company withhold shares of Stock to satisfy the Participant's tax obligations. Any such election shall be irrevocable, made in writing,
signed by the Participant, and shall be subject to any restrictions or limitations that the Committee deems appropriate. If shares of
Stock are withheld to satisfy an applicable withholding requirement, the shares of Stock withheld shall have a Market Value on the date
the tax is to be determined equal to the minimum statutory total tax that could be imposed on the transaction unless the Committee determines
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 89 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
obligation of the Company to deliver Stock shall also be subject to the condition that if at any time the Board shall determine in its
discretion that the listing, registration or qualification of any shares of Stock on any securities exchange or under any state or federal
law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with,
the issuance of such shares, such shares may not be issued in whole or in part unless such listing, registration, qualification, consent
or approval shall have been effected or obtained free of any conditions not acceptable to the Board. The issuance of shares of Stock,
if any, to the Participant pursuant to this Agreement is subject to any applicable taxes and other laws or regulations of the United States
or of any state, municipality or other country having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Stockholder Rights</U>. Neither the Participant, nor any person entitled to receive Stock Units in the event of the Participant&rsquo;s
death, shall have any of the rights and privileges of a stockholder with respect to shares of Stock, including voting or dividend rights,
until such shares of Stock have been issued upon settlement of Stock Units. The Participant acknowledges that no election under Section&nbsp;83(b)&nbsp;of
the Code is available with respect to Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
Subject to Plan Provisions</U>. This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and
in all respects shall be interpreted in accordance with the Plan. The grant and settlement of the Stock Units are subject to the provisions
of the Plan and to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee
in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (a)&nbsp;rights and obligations
with respect to withholding taxes, (b)&nbsp;the registration, qualification or listing of the shares of Stock, (c)&nbsp;changes in capitalization
of the Company and (d)&nbsp;other requirements of applicable law. The Committee shall have the authority to interpret and construe the
Stock Units pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Employment or Other Rights</U>. The grant of the Stock Units shall not confer upon the Participant any right to be retained by or in the
employ or service of the Company or any Affiliate and shall not interfere in any way with the right of the Company or any Affiliate to
terminate the Participant&rsquo;s employment or service at any time. The right of the Company and any Affiliate to terminate at will the
Participant&rsquo;s employment or service at any time for any reason is specifically reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 90 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Assignment
and Transfers</U>. The Stock Units are not transferable, and shall not be sold, transferred, pledged, assigned, or otherwise alienated
or hypothecated, other than by will or by the laws of descent and distribution. All of the Participant's rights in the Stock Units may
be exercised during the life of the Participant only by the Participant or the Participant's legal representative. The rights and protections
of the Company hereunder shall extend to any successors or assigns of the Company and to its Affiliates. This Agreement may be assigned
by the Company without the Participant&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Governing
Law</U>. The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with
the laws of the Commonwealth of Massachusetts, without giving effect to the conflicts of laws provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice</U>.
Any notice to the Company provided for in this instrument shall be addressed to the Company in care of its Chief Financial Officer at
the Company's principal place of business, and any notice to the Participant shall be addressed to such Participant at his or her residence
address last filed with the Company. Any notice shall be delivered in accordance with Section&nbsp;17 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Application
of Section&nbsp;409A of the Code</U>. This Agreement is intended to be exempt from or otherwise comply with the provisions of Section&nbsp;409A
of the Code. Notwithstanding the foregoing, if any Stock Units constitute &ldquo;deferred compensation&rdquo; under Section&nbsp;409A
of the Code and such Stock Units become vested upon the Participant&rsquo;s termination of employment, settlement of such vested Stock
Units shall be delayed for a period of six months after the Participant&rsquo;s termination of employment if the Participant is a &ldquo;specified
employee&rdquo; as defined under Section&nbsp;409A of the Code and if required pursuant to Section&nbsp;409A of the Code. If settlement
of any Stock Units is delayed in accordance with the foregoing provisions of this Section&nbsp;11, such Stock Units shall be settled within
thirty (30) days after the date that is six (6)&nbsp;months following the Participant&rsquo;s termination of employment. To the extent
subject to Section&nbsp;409A of the Code, settlement of the Stock Units may only be made in a manner and upon an event permitted by Section&nbsp;409A
of the Code, and each settlement of the Stock Units shall be treated as a separate payment, and the right to a series of installment payments
under the Stock Units shall be treated as a right to a series of separate payments. In no event shall the Participant, directly or indirectly,
designate the calendar year of payment. The Company may change or modify the terms of this Agreement without the Participant&rsquo;s consent
or signature if the Company determines, in its sole discretion, that such change or modification is necessary for purposes of compliance
with or exemption from the requirements of Section&nbsp;409A of the Code or any regulations or other guidance issued thereunder. Notwithstanding
the previous sentence, the Company may also amend the Plan or this Agreement or revoke the Stock Units to the extent permitted by the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[Signature Page&nbsp;Follows]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused its duly authorized officer to execute this Agreement, and the Participant has executed this Agreement, effective as of the
Date of Grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-size: 10pt">LEAP THERAPEUTICS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby accept the award of Stock Units described
in this Agreement, and I agree to be bound by the terms of this Agreement and the incorporated provisions of the Plan. I hereby agree
that all decisions and determinations of the Committee with respect to the Stock Units shall be final and binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt">Date&#8239;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt">Participant</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 92 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><A NAME="ss09"></A>Exhibit 10.7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEAP THERAPEUTICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2022 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RESTRICTED STOCK UNIT GRANT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This RESTRICTED STOCK UNIT
GRANT AGREEMENT (the &ldquo;<U>Agreement</U>&rdquo;), dated as of November&nbsp;11, 2025 (the &ldquo;<U>Date of Grant</U>&rdquo;), is
delivered by Leap Therapeutics,&nbsp;Inc. (the &ldquo;<U>Company</U>&rdquo;) to __________ (the &ldquo;<U>Participant</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>RECITALS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Leap Therapeutics,&nbsp;Inc.
2022 Equity Incentive Plan, as amended and in effect on the date hereof (the &ldquo;<U>Plan</U>&rdquo;), provides for the grant of Restricted
Stock Units (as defined in the Plan) in accordance with the terms and conditions of the Plan. The Committee (as defined in the Plan) has
decided to make this grant of Restricted Stock Units as an inducement for the Participant to promote the best interests of the Company
and its stockholders. This Agreement is made pursuant to the Plan and is subject in its entirety to all applicable provisions of the Plan.
Capitalized terms used herein and not otherwise defined will have the meanings set forth in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
of Restricted Stock Units</U>. Subject to the terms, conditions and restrictions set forth in this Agreement and in the Plan, the Company
hereby grants the Participant ________ Restricted Stock Units (the &ldquo;<U>Stock Units</U>&rdquo;). Each Stock Unit represents the right
of the Participant to receive a share of common stock of the Company (&ldquo;<U>Stock</U>&rdquo;), if and when the specified conditions
are met in Section&nbsp;3 below, and on the applicable settlement date set forth in Section&nbsp;5 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Rights Prior to Settlement</U>. Stock Units represent hypothetical shares of Stock, and not actual shares of Stock. No shares of Stock
shall be issued to the Participant at the time the grant of the Stock Units is made, and the Participant shall not be, and shall not have
any of the rights or privileges of, a stockholder of the Company with respect to any Stock Units. The Participant shall not have any interest
in any fund or specific assets of the Company by reason of this award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Vesting</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>As
of the date of this Agreement, all of the Stock Units shall be unvested and subject to a Risk of Forfeiture pursuant to Section&nbsp;4
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
to the terms of this Section&nbsp;3, the Stock Units shall vest in accordance with the following vesting schedule: (i)&nbsp;12/36ths of
the Stock Units will vest on October&nbsp;8, 2026 and (ii)&nbsp;1/36<SUP>ths </SUP>of the Stock Units will vest on the eighth (8<SUP>th</SUP>)
day of each month thereafter, <U>provided</U> that the Participant continues to be employed by, or provide service as a consultant, director
or advisor of or to, the Company or one of its Affiliates from the Date of Grant until the Stock Units vest in accordance with the provisions
of this Section&nbsp;3. For purposes of this Agreement, the term &ldquo;<U>Vesting Date</U>&rdquo; shall mean a date on which any or all
of the Stock Units vest in accordance with the provisions of this Section&nbsp;3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
vesting of the Stock Units shall be cumulative, but shall not exceed 100% of the Stock Units. If the foregoing schedule would produce
fractional Stock Units, the number of Stock Units that vest shall be rounded down to the nearest whole Stock Unit and the fractional Stock
Units will be accumulated so that the resulting whole Stock Units will be included in the number of Stock Units that become vested on
the last Vesting Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 93 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>In
the event of a Change of Control or a Transaction before all of the Stock Units vest in accordance with Section&nbsp;3(a)&nbsp;above,
the applicable provisions of the Plan shall apply to the Stock Units, and the Committee may take such actions as it deems appropriate
pursuant to the provisions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>In
the event that (i)&nbsp;Participant&rsquo;s employment with the Company or any of its Affiliates is terminated at any time by the Company
or any of its Affiliates for any reason other than Cause (as defined in Section&nbsp;3(g)&nbsp;below) or is terminated at any time by
Participant for Good Reason (as defined in Section&nbsp;3(h)&nbsp;below) and (ii)&nbsp;immediately after any such termination of employment,
Participant does not have a service provider relationship of any kind (including, without limitation, as an officer, director, employee,
consultant or advisor) with any of the Company and its Affiliates, then, effective immediately prior to any such termination of employment,
any and all Stock Units that are then unvested and subject to Risk of Forfeiture pursuant to Section&nbsp;4 below shall automatically
become fully vested and free from Risk of Forfeiture pursuant to Section&nbsp;4 below. For clarity, and notwithstanding the foregoing
provisions of this Section&nbsp;3(e), this Section&nbsp;3(e)&nbsp;shall not be applicable to any termination of Participant&rsquo;s employment
with the Company or any of its Affiliates as a result of Participant&rsquo;s death or disability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Those
Stock Units that vest pursuant to this Section&nbsp;3 or pursuant to any action taken by the Committee pursuant to the Plan shall become
free from the Risk of Forfeiture pursuant to Section&nbsp;4 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>For
purposes of this Agreement, the term &ldquo;<U>Cause</U>&rdquo; shall mean the occurrence of any of the following: (i)&nbsp;a conviction
of Participant, or a plea of nolo contendere, to a felony (other than a felony related to the operation of a motor vehicle); or (ii)&nbsp;willful
misconduct or gross negligence by Participant resulting, in either case, in material harm to the Company or any of its Affiliates; or
(iii)&nbsp;a willful failure by Participant to carry out the reasonable and lawful directions of the Board and failure by Participant
to remedy such willful failure within thirty (30) days after receipt of written notice of same from the Board; or (iv)&nbsp;fraud, embezzlement,
theft or dishonesty of a material nature by Participant, or a willful material violation by Participant of a written policy or procedure
of the Company or any of its Affiliates, resulting, in any case, in material harm to the Company or any of its Affiliates; or (v)&nbsp;a
material breach by Participant of any agreement between Participant and the Company or any of its Affiliates, and failure by Participant
to remedy the material breach within thirty (30) days after receipt of written notice of such material breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>For
purposes of this Agreement, the term &ldquo;<U>Good Reason</U>&rdquo; shall mean the occurrence of any of the following: (i)&nbsp;the
occurrence of any of the following: (i)&nbsp;a material diminution in Participant&rsquo;s base salary; or (ii)&nbsp;the Company&rsquo;s
or any Affiliate of the Company requiring Participant to be based at any office or location outside of fifty (50) miles from Cambridge,
Massachusetts, except for travel reasonably required in the performance of Participant&rsquo;s responsibilities; or (iii)&nbsp;a material
breach by the Company or any Affiliate of the Company of any agreement between Participant and the Company or any Affiliate of the Company,
and failure by the Company or any Affiliate of the Company to remedy such material breach within thirty (30) days after receipt of written
notice of such material breach. For purposes of this Agreement, Good Reason shall not be deemed to exist unless Participant&rsquo;s termination
of employment for Good Reason occurs within one hundred eighty days following the initial existence of one of the conditions specified
in clauses (i)&nbsp;through (iii)&nbsp;above, Participant provides the Company with written notice of the existence of such condition
within ninety (90) days after the initial existence of the condition, and the Company or any Affiliate of the Company fails to remedy
the condition within thirty (30) days after the Company&rsquo;s receipt of such notice from Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 94 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Termination
of Stock Units</U>. Subject to the provisions of Section&nbsp;3(e)&nbsp;above, if the Participant ceases to be a service provider to the
Company and its Affiliates in all capacities as an employee, consultant, director and/or advisor of the Company and its Affiliates for
any reason before all of the Stock Units vest, any unvested Stock Units shall automatically terminate and shall be forfeited as of the
date of the Participant&rsquo;s termination of such employment or service. No settlement or payment shall be made with respect to any
unvested Stock Units that terminate as described in this Section&nbsp;4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Settlement
of Stock Units and Tax Withholding</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>If
a Stock Unit vests in accordance with the provisions of Section&nbsp;3 above, then, subject to the provisions of this Section&nbsp;5(a)&nbsp;and
Sections 5(b), 5(c)&nbsp;and 12 below, the Company shall issue to the Participant one share of Stock for such vested Stock Unit, subject
to applicable tax withholding obligations, on the earliest to occur of (1)&nbsp;the first payroll period on or after the date the Participant&rsquo;s
employment with or service to the Company ceases, (2)&nbsp;the first payroll period on or after the eighth (8<SUP>th</SUP>) day of the
calendar month of June&nbsp;following any such Vesting Date applicable to such vested Stock Unit or (3)&nbsp;the first payroll period
on or after the eighth (8<SUP>th</SUP>) day of the month of December&nbsp;following any such Vesting Date applicable to such vested Stock
Unit; <U>provided</U>, <U>however</U>, that the Company shall not be required to issue to Participant any share of Stock pursuant to the
foregoing provisions of this Section&nbsp;5(a)&nbsp;with respect to any vested Stock Unit (or otherwise settle any such vested Stock Unit
in shares of Stock) on any date that the Committee, in its sole discretion, determines Participant is subject to any limitation or restriction
(including, without limitation, (1)&nbsp;any limitation or restriction under the Company&rsquo;s insider trading policy as then in effect
and (2)&nbsp;any limitation or restriction imposed by securities laws or other laws such as Rule&nbsp;144 promulgated under the Securities
Act of 1933, as amended, and Section&nbsp;16(b)&nbsp;of the Securities Exchange Act of 1934, as amended) that does not permit Participant
to offer to sell or sell on the public market on such date all of the shares of Stock that otherwise would be issued to Participant on
such date pursuant to this Section&nbsp;5(a)&nbsp;in settlement of such vested Stock Unit. Notwithstanding anything express or implied
in the foregoing provisions of this Section&nbsp;5(a)&nbsp;to the contrary, in no event shall settlement of a vested Stock Unit occur
later than the fifteenth day of the third calendar month following the calendar year in which the Vesting Date applicable to such vested
Stock Unit occurs, and in no event shall Participant be permitted, directly or indirectly, to designate the calendar year of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>All
obligations of the Company under this Agreement shall be subject to the right of the Company as set forth in the Plan to require the Participant
to remit to the Company an amount sufficient to satisfy statutory minimum federal, state, local, foreign or other withholding tax requirements
if, when, and to the extent required by law prior to the issuance of shares of Stock. The obligations of the Company under this Agreement
shall be conditional on satisfaction of all such statutory minimum withholding obligations and the Company shall, to the extent permitted
by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant or to utilize any other
withholding method prescribed by the Committee from time to time. However, the Participant may elect, subject to the approval of the Committee,
acting in its sole discretion, to satisfy an applicable statutory minimum withholding requirement, in whole or in part, by having the
Company withhold shares of Stock to satisfy the Participant's tax obligations. Any such election shall be irrevocable, made in writing,
signed by the Participant, and shall be subject to any restrictions or limitations that the Committee deems appropriate. If shares of
Stock are withheld to satisfy an applicable withholding requirement, the shares of Stock withheld shall have a Market Value on the date
the tax is to be determined equal to the minimum statutory total tax that could be imposed on the transaction unless the Committee determines
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 95 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
obligation of the Company to deliver Stock shall also be subject to the condition that if at any time the Board shall determine in its
discretion that the listing, registration or qualification of any shares of Stock on any securities exchange or under any state or federal
law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with,
the issuance of such shares, such shares may not be issued in whole or in part unless such listing, registration, qualification, consent
or approval shall have been effected or obtained free of any conditions not acceptable to the Board. The issuance of shares of Stock,
if any, to the Participant pursuant to this Agreement is subject to any applicable taxes and other laws or regulations of the United States
or of any state, municipality or other country having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Stockholder Rights</U>. Neither the Participant, nor any person entitled to receive Stock Units in the event of the Participant&rsquo;s
death, shall have any of the rights and privileges of a stockholder with respect to shares of Stock, including voting or dividend rights,
until such shares of Stock have been issued upon settlement of Stock Units. The Participant acknowledges that no election under Section&nbsp;83(b)&nbsp;of
the Code is available with respect to Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Grant
Subject to Plan Provisions</U>. This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and
in all respects shall be interpreted in accordance with the Plan. The grant and settlement of the Stock Units are subject to the provisions
of the Plan and to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee
in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (a)&nbsp;rights and obligations
with respect to withholding taxes, (b)&nbsp;the registration, qualification or listing of the shares of Stock, (c)&nbsp;changes in capitalization
of the Company and (d)&nbsp;other requirements of applicable law. The Committee shall have the authority to interpret and construe the
Stock Units pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Employment or Other Rights</U>. The grant of the Stock Units shall not confer upon the Participant any right to be retained by or in the
employ or service of the Company or any Affiliate and shall not interfere in any way with the right of the Company or any Affiliate to
terminate the Participant&rsquo;s employment or service at any time. The right of the Company and any Affiliate to terminate at will the
Participant&rsquo;s employment or service at any time for any reason is specifically reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 96 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Assignment
and Transfers</U>. The Stock Units are not transferable, and shall not be sold, transferred, pledged, assigned, or otherwise alienated
or hypothecated, other than by will or by the laws of descent and distribution. All of the Participant's rights in the Stock Units may
be exercised during the life of the Participant only by the Participant or the Participant's legal representative. The rights and protections
of the Company hereunder shall extend to any successors or assigns of the Company and to its Affiliates. This Agreement may be assigned
by the Company without the Participant&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Governing
Law</U>. The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with
the laws of the Commonwealth of Massachusetts, without giving effect to the conflicts of laws provisions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice</U>.
Any notice to the Company provided for in this instrument shall be addressed to the Company in care of its Chief Financial Officer at
the Company's principal place of business, and any notice to the Participant shall be addressed to such Participant at his or her residence
address last filed with the Company. Any notice shall be delivered in accordance with Section&nbsp;17 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Application
of Section&nbsp;409A of the Code</U>. This Agreement is intended to be exempt from or otherwise comply with the provisions of Section&nbsp;409A
of the Code. Notwithstanding the foregoing, if any Stock Units constitute &ldquo;deferred compensation&rdquo; under Section&nbsp;409A
of the Code and such Stock Units become vested upon the Participant&rsquo;s termination of employment, settlement of such vested Stock
Units shall be delayed for a period of six months after the Participant&rsquo;s termination of employment if the Participant is a &ldquo;specified
employee&rdquo; as defined under Section&nbsp;409A of the Code and if required pursuant to Section&nbsp;409A of the Code. If settlement
of any Stock Units is delayed in accordance with the foregoing provisions of this Section&nbsp;11, such Stock Units shall be settled within
thirty (30) days after the date that is six (6)&nbsp;months following the Participant&rsquo;s termination of employment. To the extent
subject to Section&nbsp;409A of the Code, settlement of the Stock Units may only be made in a manner and upon an event permitted by Section&nbsp;409A
of the Code, and each settlement of the Stock Units shall be treated as a separate payment, and the right to a series of installment payments
under the Stock Units shall be treated as a right to a series of separate payments. In no event shall the Participant, directly or indirectly,
designate the calendar year of payment. The Company may change or modify the terms of this Agreement without the Participant&rsquo;s consent
or signature if the Company determines, in its sole discretion, that such change or modification is necessary for purposes of compliance
with or exemption from the requirements of Section&nbsp;409A of the Code or any regulations or other guidance issued thereunder. Notwithstanding
the previous sentence, the Company may also amend the Plan or this Agreement or revoke the Stock Units to the extent permitted by the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[Signature Page&nbsp;Follows]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 97 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused its duly authorized officer to execute this Agreement, and the Participant has executed this Agreement, effective as of the
Date of Grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">LEAP THERAPEUTICS,&nbsp;INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby accept the award of Stock Units described
in this Agreement, and I agree to be bound by the terms of this Agreement and the incorporated provisions of the Plan. I hereby agree
that all decisions and determinations of the Committee with respect to the Stock Units shall be final and binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt">Date&#8239;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%"><FONT STYLE="font-size: 10pt">Participant</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 98 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ss10"></A>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm2530735d3_defa14aimg01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leap
Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Khing
Oei appointed Chairman of the Board;&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Will
McEvoy appointed Chief Investment Officer and Member of the Board;&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cypherpunk
Technologies Inc. </B><I>announces acquisition of 203,775.27 ZEC.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cambridge,
Mass., November&nbsp;12, 2025 </B>&ndash; Leap Therapeutics,&nbsp;Inc. (Nasdaq: LPTX) today announced it will change its name to <B>Cypherpunk
Technologies Inc.</B>, and unveiled a digital asset treasury strategy to accumulate Zcash&rsquo;s native coin, ZEC. Cypherpunk has to
date used $50 million of proceeds from the previously announced private placement to purchase 203,775.27 ZEC at an average purchase price
of $245.37 per ZEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the company also plans to change its ticker symbol to (Nasdaq: <B>CYPH) </B>as part of the rebranding under the <B>Cypherpunk
</B>name. The company will begin trading under its new name and ticker symbol CYPH on Thursday, November&nbsp;13. Until then, investors
can continue to buy and sell the company&rsquo;s stock under the current ticker symbol <B>LPTX</B> without interruption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cypherpunk
also announced the appointment of <B>Khing Oei </B>and <B>Will McEvoy </B>to its Board of Directors, effective November&nbsp;11, 2025.
This strategic move comes as part of the Company&rsquo;s recently completed $58.88 million private placement led by Winklevoss Capital
to initiate a digital asset treasury strategy. Notably, Winklevoss Capital was the only institutional investor in the private placement,
contributing a majority of the total raised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;The
recent weak performance of digital asset treasury companies stems from PIPEs dominated by short-term, mercenary capital. We&rsquo;ve
taken a different path by building a syndicate of value-aligned investors who believe in the long-term importance of Zcash and privacy
for the United States and the world.&rdquo; </I>&ndash; <B>Will McEvoy, Chief Investment Officer of Cypherpunk</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Khing
Oei </B>has been appointed Chairman of the Board, while <B>Will McEvoy </B>will also serve as the company&rsquo;s first-ever Chief Investment
Officer, effective in each case as of November&nbsp;11, 2025. Concurrently with Mr.&nbsp;Oei&rsquo;s appointment, <B>Christopher Mirabelli</B>,
PhD, will step down from his role as Chairman, while remaining a member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;We
are pleased to welcome Khing and Will to the Board of Directors, and to have Will serve as Chief Investment Officer as we advance our
strategy to create long-term shareholder value through active participation in Zcash. Participant control and privacy, enabled by Zcash,
are critical as financial transactions move increasingly to blockchain and tokenization. The rebranding and new leadership appointments
mark a transformational step in expanding our mission as we enter a new phase of growth.&rdquo; </I><B>&ndash; Douglas E. Onsi, President
and Chief Executive Officer of Cypherpunk</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Why
This Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cypherpunk
is a company dedicated to self-sovereignty. As the world becomes increasingly digitized, privacy has become a rare and vanishing resource.
And despite their critical importance, privacy enhancing technologies remain under-adopted. Backing privacy today is both a <B>generational
mission</B> and a <B>massive opportunity</B>. Privacy is the foundation that allows freedom of speech, thought, and association to thrive.
Without it, these societal tentpoles may exist on paper but can&rsquo;t be exercised meaningfully in practice. In other words, privacy
is the silent precondition of freedom. Additionally, in a world where privacy is scarce, it becomes the most valuable commodity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 99 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Why
Zcash?</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zcash
is one of the oldest and most respected privacy-preserving blockchains, launched in 2016 as a fork of Bitcoin with advanced cryptography
that enables selective transparency. Built on the same sound monetary principles as Bitcoin, with a fixed 21 million coin supply, Zcash
introduced a breakthrough in privacy technology through the use of <B>zero-knowledge proofs (zk-SNARKs)</B>, allowing transactions to
be verified without revealing sender, receiver, or amount. This innovation has since influenced the entire cryptographic landscape, inspiring
privacy advancements across other blockchains like Ethereum and Solana.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
its inception, Zcash has processed <B>tens of millions of transactions </B>and consistently ranked among the top <B>privacy coins by
market capitalization</B>. Its underlying protocol continues to evolve with major upgrades &mdash; including <B>Halo 2</B>, a trustless
recursive proof system that eliminates the need for trusted setup ceremonies and enhances scalability. Nearly a decade after launch,
Zcash remains one of the few digital assets with the potential for both <B>Bitcoin-level decentralization and cutting-edge privacy</B>,
offering real utility with private yet auditable digital transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cypherpunk
Technologies Inc.</B> sees Zcash as digital privacy in asset form, the same way Bitcoin has proven to be digital gold. Zcash also represents
an important hedge against the transparency of Bitcoin and the existing financial infrastructure in an AI-abundant future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
Board Members</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Khing
                                            Oei </B>is a seasoned investor with a strong track record of investing in public, private
                                            and digital markets. Oei is the Founder and CEO of Treasury, an emerging euro-denominated
                                            Bitcoin treasury firm. Before Treasury, Oei was the Founder and CEO of Captur (formerly AlphaSwap),
                                            a decentralized asset management platform. He was previously the Founder and Chief Investment
                                            Officer of Eyck Capital, a London-based event-driven hedge fund focused on distressed and
                                            special situations across credit and equities, managing over $200 million in assets. Prior
                                            to that role, Oei was a Managing Principal and Portfolio Manager at Bardin Hill (formerly
                                            Halcyon), a $10 billion multi-strategy hedge fund where, as CEO of its European operations,
                                            he led European distressed investments and managed the firm&rsquo;s $2.5 billion CLO platform.
                                            Oei began his career at Goldman Sachs in the Special Situations Group and later worked at
                                            Fortress Investment Group&rsquo;s Drawbridge Special Opportunities Fund. He holds a MSc in
                                            Econometrics from The Vrije Universiteit Amsterdam.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Will
                                            McEvoy </B>is a Principal at Winklevoss Capital, where he invests and identifies opportunities
                                            on the frontier, from crypto and space to energy, bio, and defense. He focuses on companies
                                            and technologies that slow entropy and create order in critical civilizational domains. Before
                                            joining Winklevoss Capital, Will authored Bitcoin and crypto research at Fundstrat and helped
                                            build one of Dynasty Financial Partners&rsquo; highest-performing client platforms. He also
                                            serves on the board of Real Bedford FC and holds a degree from The George Washington University.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 100 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Cypherpunk</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cypherpunk
Technologies Inc., previously known as Leap Therapeutics,&nbsp;Inc., is a company developing novel therapies for patients with cancer
and implementing a digital asset treasury strategy focused on Zcash. Following a $58.88 million private placement led by Winklevoss Capital,
the Company is aiming to build long-term shareholder value by acquiring ZEC, participating in the development of Zcash, and continuing
the development of sirexatamab and FL-501 to treat patients with cancer. For more information about the Company, visit our websites at
<U>http://www.cypherpunk.com</U> and <U>http://www.leaptx.com</U> or view our public filings with the SEC that are available via EDGAR
at <U>http://www.sec.gov</U> or via <U>https://investors.leaptx.com/</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Winklevoss Capital</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Winklevoss
Capital is an investment firm founded in 2012 by Cameron and Tyler Winklevoss that invests in frontier technologies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Channels
for Disclosure of Information</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Going
forward, we intend to announce material information to the public through filings with the Securities and Exchange Commission (SEC),
the investor relations page&nbsp;on our website (URL), press releases, public conference calls, public webcasts, our X account (@cypherpunktech),
and our </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LinkedIn page<FONT STYLE="background-color: white">.
The information disclosed in the foregoing channels could be deemed to be material information. As such, we encourage investors, the
media, and others to follow the channels listed above and to review the information disclosed through such channels. Any updates to the
list of disclosure channels through which we will announce information will be posted on the investor relations page&nbsp;on our website.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
Information and Where to Find It</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) a definitive proxy statement on Schedule 14A
(as may be supplemented or amended, the &ldquo;Definitive Proxy Statement&rdquo;) and a proxy card with respect to its solicitation of
proxies for the Special Meeting of Stockholders to be held December&nbsp;15, 2025 (the &ldquo;Special Meeting&rdquo;). The Definitive
Proxy Statement contains important information about the matters to be voted on at the Special Meeting. <B>STOCKHOLDERS ARE STRONGLY
ENCOURAGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY
HAS FILED OR WILL FILE WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT
THE COMPANY AND THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING.</B> Stockholders are able to obtain free copies of these documents,
and other documents we file with the SEC through the website maintained by the SEC at www.sec.gov. Copies will also be available at no
charge in the Investors section of our website at http://www.cypherpunk.com or http://www.leaptx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Participant
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, its directors and certain of its executive officers are deemed to be &ldquo;participants&rdquo; (as defined in Section&nbsp;14(a)&nbsp;of
the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from the Company&rsquo;s stockholders in connection with
the matters to be considered at the Special Meeting. Information about the compensation of our named executive officers and our non-employee
directors as of the fiscal year ended December&nbsp;31, 2024 is set forth in the sections titled &ldquo;Executive Compensation&rdquo;
and &ldquo;Compensation of Directors&rdquo; in the Definitive Proxy Statement. Information regarding the participants&rsquo; holdings
of Company securities can be found in the section titled &ldquo;Security Ownership of Certain Beneficial Owners and Management&rdquo;
in the Definitive Proxy Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 101 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORWARD-LOOKING
STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release includes forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, Section&nbsp;21E
of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words
such as &quot;anticipate,&quot; &quot;expect,&quot; &quot;plan,&quot; &quot;could,&quot; &quot;may,&quot; &quot;will,&quot; &quot;believe,&quot;
&quot;estimate,&quot; &quot;forecast,&quot; &quot;goal,&quot; &quot;project,&quot; and other words of similar meaning. Forward-looking
statements address various matters including statements relating to ZEC or digital assets held or to be held by the Company, the expected
future market, price and liquidity of ZEC or other digital assets the Company acquires, the macro and political conditions surrounding
Zcash or digital assets, the Company&rsquo;s plan for value creation and strategic advantages, market size and growth opportunities,
regulatory conditions, competitive position and the interest of other corporations in similar business strategies, technological and
market trends, and future financial condition and performance. Risks and uncertainties of the digital asset treasury strategy include,
among others: (a)&nbsp;the risk that the Company will fail to realize the anticipated benefits of the digital asset treasury strategy;
(b)&nbsp;changes in business, market, financial, political and regulatory conditions; (c)&nbsp;risks relating to the Company&rsquo;s
operations and business, including the highly volatile nature of the price of cryptocurrencies, including ZEC; (d)&nbsp;the risk that
the price of the Company&rsquo;s Common Stock may be highly correlated to the price of ZEC or other digital assets that it holds; (e)&nbsp;risks
related to increased competition in the industries in which the Company does and will operate; (f)&nbsp;risks relating to significant
legal, commercial, regulatory and technical uncertainty regarding digital assets generally; (g)&nbsp;risks relating to the treatment
of crypto assets for U.S. and foreign tax purposes; and (h)&nbsp;the ability to comply with the continued listing requirements of the
Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;). New risks and uncertainties may emerge from time to time, and it is not possible to predict
all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking
statements. The Company may not actually achieve the forecasts disclosed in such forward-looking statements, and you should not place
undue reliance on such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties
including but not limited to those set forth under the caption &quot;Risk Factors&quot; in the Company&rsquo;s most recent Annual Report
on Form&nbsp;10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions
of potential risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement
speaks only as of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake
any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise,
except as required by law. These forward-looking statements should not be relied upon as representing the Company&rsquo;s views as of
any date subsequent to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>###</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 102 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; margin: 0"><B><A NAME="ss11"></A>Exhibit 99.2</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm2530735d3_defa14aimg01.jpg" ALT=""></P>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cypherpunk Technologies (formerly Leap Therapeutics)
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Reports Third Quarter 2025 Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Cambridge,
MA &ndash; November 12, 2025</B></FONT> &ndash; Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX),
a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash, today
reported financial results for the third quarter of 2025 and a corporate update.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As announced earlier today, the Company has changed
its name to &ldquo;Cypherpunk Technologies Inc.&rdquo; from &ldquo;Leap Therapeutics, Inc.&rdquo; to reflect the strategic focus on acquiring
the digital asset, ZEC, participating in the development of Zcash, and the values of privacy and liberty. The Company will begin trading
on the Nasdaq Capital Market under the ticker symbol &ldquo;CYPH&rdquo; at the market open on November 13, 2025. The Company&rsquo;s ongoing
cancer research and development operations will be conducted under a wholly-owned subsidiary that will take the name &ldquo;Leap Therapeutics,
Inc.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;This past month has been transformative
for the Company, marked by closing a $58.88 million private placement led by Winklevoss Capital and successfully deploying $50 million
to build a digital asset treasury designed to create long-term shareholder value focused on active participation in the development of
Zcash and acquiring ZEC,&rdquo; said Douglas E. Onsi, President and CEO of Cypherpunk Technologies. &ldquo;In our drug development business,
we presented the final data from our randomized controlled Phase 2 trial of sirexatamab plus bevacizumab and chemotherapy in patients
with advanced colorectal cancer (CRC) at the European Society for Medical Oncology (ESMO) Congress. In addition, we will be engaging with
regulatory authorities to seek a registrational pathway for sirexatamab and optimizing the DKK1 biomarker assay that could be used to
identify CRC patients at risk of poor outcomes and who may benefit from sirexatamab.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cypherpunk Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><B>Closed a $58.88 million private placement in cash led
by Winklevoss Capital</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2025, the Company raised $58,888,888
in cash led by Winklevoss Capital to initiate the digital asset treasury strategy. In the transaction, the Company issued: (i) 15,212,311
shares of common stock, (ii) pre-funded warrants to purchase up to an aggregate of 80,768,504 shares of common stock at an exercise price
of $0.001 per share, and (ii) warrants to purchase an additional 71,985,605 shares of common stock at an exercise price of $0.5335 per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><B>Successfully established a digital asset treasury strategy
focused on Zcash (ZEC), acquiring more than 203,775.27 ZEC to date at an aggregate purchase price of approximately $50 million, or $245.37
per ZEC</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #010304; background-color: white">The
Company believes that privacy-</FONT><FONT STYLE="color: #010304; background-color: white">protecting assets and related technologies
will be critical in an increasingly digital world. The Company intends to acquire and hold ZEC</FONT>, the native coin of Zcash, <FONT STYLE="color: #010304; background-color: white">as
its primary digital asset and to be an active participant in the Zcash community. As of November 11, 2025, the Company has acquired </FONT>203,775.27
ZEC at an aggregate purchase price of approximately $50 million, or $245.37 per ZEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 103 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Zcash
functions much like Bitcoin, and it was created from the original Bitcoin code base. Like Bitcoin, Zcash is a digital currency that can
be transmitted over a peer-to-peer payment system, except that Zcash uses a protocol called &ldquo;zero-knowledge proofs&rdquo; that allows
users to engage in blockchain transactions while maintaining greater privacy. This cryptographic technology allows parties to decide whether
or not to reveal sensitive information and enables private, public, shielding, and deshielding transactions</FONT> <FONT STYLE="color: #010304">on
the Zcash blockchain. For example, the owner of a specific address is able to choose to disclose an address and transaction details to
a trusted third party, potentially for compliance or audit reasons. Alternatively, transacting can work in a similar manner to the Bitcoin
blockchain, where the sender and receiver addresses and value of the transfer are all publicly visible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><B>Appointed digital asset executives Khing Oei as Chairman
of the Board of Directors and Will McEvoy as a member of the Board of Directors and Chief Investment Officer</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 11, 2025, the Company appointed Khing
Oei as Chairman of the Board of Directors, and Will McEvoy as Chief Investment Officer and a Board member. In conjunction with these appointments,
Christopher Mirabelli stepped down from his role as Chairman of the Board of Directors, while remaining a Board member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Leap Therapeutics Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B><I>Presented final clinical data from Part B of the DeFianCe
study of sirexatamab plus bevacizumab and chemotherapy in CRC patients at ESMO Congress 2025.</I></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a Mini Oral session at the ESMO Congress in
October 2025, the Company presented the final results from Part B of the DeFianCe study, a Phase 2 study of sirexatamab, an anti-DKK1
monoclonal antibody, in combination with bevacizumab and chemotherapy (Sirexatamab Arm) compared to bevacizumab and chemotherapy (Control
Arm) in patients with microsatellite stable CRC who have received one prior systemic therapy for advanced disease. Sirexatamab demonstrated
a statistically significant benefit on overall response rate (ORR) and progression-free survival (PFS) in patients with high levels of
DKK1, along with a positive trend on ORR and PFS in the full intent-to-treat population.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">Across the DKK1-high (upper median) patients (n=88):</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>ORR was 38.0% in the Sirexatamab Arm compared to 23.7% ORR in the Control Arm.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>mPFS was 9.03 months in the Sirexatamab Arm compared to 7.06 months in the Control Arm, Hazard Ratio (HR) 0.61, p-value = 0.0255.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>mOS was not reached in the Sirexatamab Arm compared to 14.39 months in the Control Arm, HR 0.42, p-value = 0.0118.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">Across the DKK1-high (upper quartile) patients (n=44):</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>ORR was 44.0% in the Sirexatamab Arm compared to 15.8% ORR in the Control Arm.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>mPFS was 9.36 months in the Sirexatamab Arm compared to 5.88 months in the Control Arm, HR 0.46, p-value = 0.0168.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>mOS was not reached in the Sirexatamab Arm compared to 9.66 months in the Control Arm, HR 0.17, p-value &lt; 0.001.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">In the full intent-to-treat population (n=188):</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>ORR was 35.1% in the Sirexatamab Arm compared to 26.6% ORR in the Control Arm.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>mPFS was 9.2 months in the Sirexatamab Arm compared to 8.3 months in the Control Arm, HR 0.84, p-value = 0.1712.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>Event-free rate favors Sirexatamab Arm beginning at month 9 (53 vs 47%) with further separation at month 12 (34 vs 23%).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 104 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></FONT></TD><TD><B>Advancing DKK1 biomarker diagnostic test and engaging with regulatory authorities.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is in the process of engaging with
regulatory agencies in the United States and Europe to discuss the registrational pathway for sirexatamab in CRC. The Company is also
working with a leading diagnostics research laboratory to optimize the DKK1 biomarker diagnostic test that could be used to identify CRC
patients with poor prognosis and to select patients for treatment with sirexatamab. The Company expects to provide an update on the next
steps in sirexatamab development and on the registrational pathway in the first quarter of 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Selected Third Quarter 2025 Financial Results
</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
Loss was $3.3 million for the third quarter 2025, compared to </FONT>$18.2 million for the third quarter 2024. The decrease was primarily
due to a decrease in research and development and general and administrative expenses as a result of a reduction in force and the completion
of the clinical trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses were $1.2 million
for the three months ended September 30, 2025, compared to $14.9 million for the three months ended September 30, 2024. The decrease of
$13.7 million in research and development expenses during the three months ended September 30, 2025 was primarily due to a decrease of
$5.3 million in clinical trial costs and a decrease of $3.7 million in manufacturing costs. There was also a decrease of $3.3 million
in payroll and other related expenses due to a decrease in headcount of our R&amp;D full-time employees, a decrease of $0.7 million in
stock based compensation expense, and a decrease of $0.7 million in consulting fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4pt 0pt 0; text-align: justify">General and administrative expenses were
$1.9 million for the three months ended September 30, 2025, compared to $2.9 million for the three months ended September 30, 2024. The
decrease of $1.0 million in general and administrative expenses during the three months ended September 30, 2025 was due to a $0.5 million
decrease in payroll and other related expenses due to a decrease in incentive based compensation expense for our general and administrative
employees and a decrease in headcount of our general and administrative employees. There was also a decrease of $0.3 million in stock
based compensation expense and a $0.2 million decrease in professional fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents totaled $9.7 million
on September 30, 2025, prior to the completion of the $58.88 million private placement that closed in October 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About&nbsp;Cypherpunk Technologies Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cypherpunk
Technologies Inc., previously known as Leap Therapeutics, Inc., is a company developing novel therapies for patients with cancer and
implementing a digital asset treasury strategy focused on Zcash. Following a $58.88 million private placement led by Winklevoss Capital,
the Company is aiming to build long-term shareholder value by acquiring ZEC, participating in the development of Zcash, and continuing
the development of sirexatamab and FL-501 to treat patients with cancer. For more information about the Company, visit our websites at
</FONT><U>http://www.cypherpunk.com</U> and <U>http://www.leaptx.com</U> or view our public filings with the SEC that are available via
EDGAR at <U>http://www.sec.gov</U> or via <U>https://investors.leaptx.com/</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 105 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Additional Information and Where to Find It</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has filed with the U.S. Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) a definitive proxy statement on Schedule 14A (as may be supplemented or amended, the &ldquo;Definitive
Proxy Statement&rdquo;) and a proxy card with respect to its solicitation of proxies for the Special Meeting of Stockholders to be held
December 15, 2025 (the &ldquo;Special Meeting&rdquo;). The Definitive Proxy Statement contains important information about the matters
to be voted on at the Special Meeting. <B>STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS
THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY HAS FILED OR WILL FILE WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE
THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING.</B> Stockholders
are able to obtain free copies of these documents, and other documents we file with the SEC through the website maintained by the SEC
at www.sec.gov. Copies will also be available at no charge in the Investors section of our website at http://www.cypherpunk.com or http://www.leaptx.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Participant Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company, its directors and certain of its
executive officers are deemed to be &ldquo;participants&rdquo; (as defined in Section 14(a) of the Securities Exchange Act of 1934, as
amended) in the solicitation of proxies from the Company&rsquo;s stockholders in connection with the matters to be considered at the Special
Meeting. Information about the compensation of our named executive officers and our non-employee directors as of the fiscal year ended
December 31, 2024 is set forth in the sections titled &ldquo;Executive Compensation&rdquo; and &ldquo;Compensation of Directors&rdquo;
in the Definitive Proxy Statement. Information regarding the participants&rsquo; holdings of Company securities can be found in the section
titled &ldquo;Security Ownership of Certain Beneficial Owners and Management&rdquo; in the Definitive Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 106 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release includes forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended.
These forward-looking statements generally can be identified by the use of words such as &quot;anticipate,&quot; &quot;expect,&quot; &quot;plan,&quot;
&quot;could,&quot; &quot;may,&quot; &quot;will,&quot; &quot;believe,&quot; &quot;estimate,&quot; &quot;forecast,&quot; &quot;goal,&quot;
&quot;project,&quot; and other words of similar meaning. All statements, other than historical facts, including statements regarding our
future product development plans; the potential, safety, efficacy, and regulatory and clinical progress of our product candidates, including
the anticipated timing for potential regulatory submissions, approvals and timing thereof; and any assumptions underlying any of the foregoing,
are forward-looking statements. In addition, forward-looking statements address various matters including statements relating to ZEC or
digital assets held or to be held by the Company, the expected future market, price and liquidity of ZEC or other digital assets the Company
acquires, the macro and political conditions surrounding Zcash or digital assets, the Company&rsquo;s plan for value creation and strategic
advantages, market size and growth opportunities, regulatory conditions, competitive position and the interest of other corporations in
similar business strategies, technological and market trends, and future financial condition and performance. Important factors that could
cause actual results to differ materially from our drug development plans, estimates or expectations could include, but are not limited
to: (i) our ability and plan to develop and commercialize sirexatamab (DKN-01) and FL-501; (ii) the potential benefits of sirexatamab
and FL-501; (iii) the timing of our development programs and seeking regulatory approval; (iv) our estimates regarding our capital requirements
and our needs for additional financing; (v) our estimates of the size of the potential markets for sirexatamab and FL-501; (vi) the benefits
to be derived from any collaborations, license agreements, or other acquisition efforts; (vii) sources of revenues and anticipated revenues,
including contributions from any collaborations or license agreements for the development and commercialization of products; and (viii)
our intellectual property position and ability to maintain and protect our intellectual property rights. Additional risks and uncertainties
of the digital asset treasury strategy include, among others: (a) the risk that the Company will fail to realize the anticipated benefits
of the digital asset treasury strategy; (b) changes in business, market, financial, political and regulatory conditions; (c) risks relating
to the Company&rsquo;s operations and business, including the highly volatile nature of the price of cryptocurrencies, including ZEC;
(d) the risk that the price of the Company&rsquo;s Common Stock may be highly correlated to the price of ZEC or other digital assets that
it holds; (e) risks related to increased competition in the industries in which the Company does and will operate; (f) risks relating
to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; (g) risks relating to the treatment
of crypto assets for U.S. and foreign tax purposes; and (h) the ability to comply with the continued listing requirements of the Nasdaq
Capital Market (&ldquo;Nasdaq&rdquo;). New risks and uncertainties may emerge from time to time, and it is not possible to predict all
risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking
statements. The Company may not actually achieve the forecasts disclosed in such forward-looking statements, and you should not place
undue reliance on such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties
including but not limited to those set forth under the caption &quot;Risk Factors&quot; in the Company&rsquo;s most recent Annual Report
on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of
potential risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement speaks
only as of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake any obligation
to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except
as required by law. These forward-looking statements should not be relied upon as representing the Company&rsquo;s views as of any date
subsequent to the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CONTACT: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Douglas E. Onsi</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">President &amp; Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cypherpunk Technologies Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">617-714-0360</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>donsi@leaptx.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For Investors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matthew DeYoung</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Argot Partners</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">212-600-1902</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>leap@argotpartners.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For Media:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jacqueline Ortiz Ramsey<BR>
It Factor Strategies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">954-294-3249</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>jacqueline@itfactorstrategies.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 107 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Cypherpunk Technologies Inc.</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Condensed Consolidated Statements of Operations</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(in thousands, except share and per share amounts)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Unaudited)</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Unaudited)</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Three Months Ended September 30,</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended September 30,</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Research and development</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,247</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">14,915</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">24,695</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">44,099</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,919</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,940</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,742</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,833</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Restructuring charges</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,527</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,166</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">17,855</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">35,964</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">53,932</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from operations</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,166</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(17,855</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(35,964</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(53,932</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest income</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">123</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">894</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">806</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,534</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest expense</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(23</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Australian research and development incentives</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(56</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(499</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Foreign currency gain (loss)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(8</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(18</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss before income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,101</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(17,468</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(35,179</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(51,416</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(202</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(708</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(202</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(708</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(3,303</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(18,176</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(35,381</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(52,124</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Dividend attributable to down round feature of warrants</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(234</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss attributable to common stockholders</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,303</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(18,176</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(35,381</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(52,358</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Net loss per share</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Basic &amp; diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.08</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.44</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.85</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(1.44</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Weighted average common shares outstanding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Basic &amp; diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">41,444,979</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">41,209,639</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">41,386,929</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">36,307,890</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 108 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Cypherpunk Technologies Inc.</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Consolidated Balance Sheets</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(in thousands, except share and per share amounts)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">September 30,</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">December 31,</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left">Cash and cash equivalents</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">9,686</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">47,249</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Research and development incentive receivable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">743</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">704</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">69</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">86</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Total current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10,498</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">48,039</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Right of use assets, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">38</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">262</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred costs</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">80</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Deposits</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">783</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">823</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,399</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">49,124</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Liabilities and Stockholders' Equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,279</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,743</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,860</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,536</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax payable</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">527</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">531</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Lease liability</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">38</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">266</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Total current liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,704</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14,076</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,704</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,076</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Stockholders' equity:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred stock, $0.001 par value; 10,000,000 shares
    authorized; 0 shares issued and outstanding</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">Common stock, $0.001 par value; 240,000,000 shares authorized; 41,439,529 and
    38,329,894 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">41</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">38</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Additional paid-in capital</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">505,510</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">502,501</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Accumulated other comprehensive loss</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(104</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(120</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(502,752</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(467,371</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,695</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">35,048</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders' equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">11,399</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">49,124</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 109 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Cypherpunk Technologies Inc.</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Condensed Consolidated Statements of Cash Flows</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(in thousands)</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Unaudited)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Unaudited)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Three Months Ended September 30</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended September 30</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Cash used in operating activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(8,325</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(15,600</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(37,291</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(44,787</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash provided by (used in) financing activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(121</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(66</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(301</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,080</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Effect of exchange rate changes on cash and cash equivalents</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">29</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(113</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net decrease in cash and cash equivalents</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(8,444</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(15,656</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(37,563</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(7,820</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of period</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">18,130</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">78,479</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">47,249</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">70,643</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cash and cash equivalents at end of period</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,686</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">62,823</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">9,686</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">62,823</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 110; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2530735d3_defa14aimg01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2530735d3_defa14aimg01.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !: 9 # 2(  A$! Q$!_\0
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M1OT74+\!+Z\4?Z9<G@7$@ YDSQCJ223R2:H_VKJG_02O_P#P,N/_ (Y1JO\
MR$]1_P"PA>?^E$G_ ->J% %_^U=4_P"@E?\ _@9<?_'*/[5U3_H)7_\ X&7'
M_P <JA10!?\ [5U3_H)7_P#X&7'_ ,<H_M75/^@E?_\ @9<?_'*H44 7_P"U
M=4_Z"5__ .!EQ_\ '*/[5U3_ *"5_P#^!EQ_\<JA10!?_M75/^@E?_\ @9<?
M_'*/[5U3_H)7_P#X&7'_ ,<JA10!?_M75/\ H)7_ /X&7'_QRC^U=4_Z"5__
M .!EQ_\ '*H44 7_ .U=4_Z"5_\ ^!EQ_P#'*/[5U3_H)7__ (&7'_QRJ%%
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M/[5U3_H)7_\ X&7'_P <JA10!?\ [5U3_H)7_P#X&7'_ ,<H_M75/^@E?_\
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M<_\ UP?U%)_G_/I^M( HI?3'ZD=?Z?C]:.,^WU!_,\8_+CTH 2BBB@ HHHH
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MFHP66Y=R17-)1C"4Z;FXQ223DW.6LG9NT?Y1_P#AP?\ 'COXW^&8]<>*=0.
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MEZC;R7.E:YI5]&L5]I&J1P2P7:6UR(X9HKJPG@O+.[MK6ZAEW0[&^LOVZO\
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M'A?PQH6G?#Y8QI]YX>M=5@OM4:+PQ8^%E;69=2U6_B8)8V$=U_H,5L3>RRC
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M=+TPW5T3IU@3]JN>3:6Y/^OD_P"F=0_V5I?_ $#;#_P#M_\ XW0!XM17M/\
M96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P#
M.W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_
M $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\
MXW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\
M96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P#
M.W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_
M $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\
MXW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\
M96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P#
M.W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_
M $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\
MXW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\
M96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P#
M.W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_
M $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\
MXW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\
M96E_] VP_P# .W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P#
M.W_^-T?V5I?_ $#;#_P#M_\ XW0!XM17M/\ 96E_] VP_P# .W_^-T?V5I?_
M $#;#_P#M_\ XW0!XM5_2O\ D*:;GI]OL_K_ ,?$=>M?V5I?_0-L/_ .W_\
<C=36VEZ8+JUQIU@/]*MNEG;_ //>/_IG0!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
